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Placental pathologies are not uncommon in dogs.  For example, in primiparous 
bitches, the reported incidence of subinvolution of placental sites is 21% - 100%. Despite 
years  of  research  in  multiple  species,  the  mechanisms  regulating  late  gestation 
trophoblast behavior in the dog remain unexamined. Therefore, the objective of this study 
was  to  characterize  normal  in  vitro  term  canine  trophoblast  (TCT)  physiology,  with 
respect to migration, invasion, and proliferation.  In addition, the effects of interleukin-8 
(IL-8) and tissue inhibitor of metalloproteinase-2 (TIMP-2) on trophoblast physiology 
were examined.  
Following  isolation  of  primary  TCT,  the  cell  suspension  was  seeded  into  the 
migration  (wound-healing)  assay,  invasion  (Matrigel)  assay,  and  proliferation  (MTT) 
assay. Cells were cultured under the same conditions at 37ºC with 5% CO2 for each  
 
assay. Recombinant human IL-8 (200-08M, Peprotech, Rocky Hill, NJ, USA) was used 
at a concentration of 10 ng/ml for each assay. Recombinant human TIMP-2 (410-02, 
Peprotech) was used at a concentration of 0.5 µg/ml for each assay, respectively.  
For the migration assay, cells were suspended in medium supplemented with 10% 
fetal bovine serum (10% FBS). Primary TCT (1000X10
3 cells/well) were cultured in 12-
well tissue culture plates until a confluent monolayer was formed. A wound was added 
with  a  sterile  pipette  tip,  the  monolayer  was  rinsed,  and  10%  FBS  with  no  factor 
(control), with IL-8 or TIMP-2 was then added. Photomicrographs of the wound were 
taken with phase-contrast microscopy (100X) after 8 h in culture and the area of the 
wound was measured using ImageJ v.1.34 software. The experiment was performed in 
triplicate (n=5 dogs).  
The invasion assay was performed using Matrigel invasion chambers (#354480, 
BD  Biosciences).  Primary  TCT  (250X10
3)  were  suspended  in  protein-free  medium 
(PFM) with no factor (control), with IL-8 or TIMP-2 and seeded onto Matrigel-coated 
filter membranes in the upper well. Chemoattractant (10% FBS) was placed in the lower 
well and the 24-well chambers were cultured for 22 h. Non-invading cells were removed 
from  the  filters  that  were  then  fixed  and  stained.  Cells  were  counted  under  light 
microscopy  (400X).  The  experiment  was  performed  in  triplicate  (n=5  dogs).  For  the 
proliferation assay, cells were suspended in PFM.  
For the proliferation assay (CGD-1, Sigma, St. Louis, MO, USA) primary TCT 
(100X10
3 cells/well) were suspended in PFM with no factor (control) or with IL-8 and 
cultured in 96-well tissue culture plate for 28 h. Cells were then incubated with MTT for  
 
4 h, which was later replaced with 1-propanol and the plates were vigorously shaken. 
Absorbances were measured with a microplate reader at 570 nm and 690 nm (to remove 
background). Measurements were analyzed with SoftMax Pro (5.2 program SoftMax® 
Pro  Data  Acquistion  &  Analysis  Software,  Sunnyvale,  CA).  The  experiment  was 
performed in quadruplicate (n=4 dogs).  
Statistical analysis of the data ws performed using Repeated Measures ANOVA 
(migration), one-way ANOVA (invasion), or two-way ANOVA (proliferation) in PROC 
MIXED using SAS (Version 9.2, SAS Institute Inc., Cary, NC). For the migration assay, 
the mean of the control wound area at 0 h was set to 0% wound closure and the data were 
expressed as the percent wound closure of the control for each dog. For the invasion 
assay and proliferation assay, the mean of the controls was set to 100% and the data was 
expressed as the percentage of the control for each dog. Significance was defined as 
P<0.05.  
Analysis  showed  that  IL-8  increased  cell  migration  by  35%  compared  to  the 
control (P˂0.01). TIMP-2 had no significant effect on cell migration (P=0.38). There was 
no significant effect of IL-8 on cell invasion compared to the control (P=0.42), whereas 
TIMP-2 decreased cell invasion by 57% compared to the control (P˂0.05). Also, for the 
proliferation assay IL-8 had no significant effect on cell proliferation (P=0.18).  
This study was the first to investigate term canine trophoblast physiology. Future 
studies should compare differences between normal term trophoblasts and those from 
cases  of  subinvolution  of  placental  sites.    It  would  also  be  of  interest  to  compare 
differences in trophoblast physiology at different stages of gestation.   
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CHAPTER I 
 
INTRODUCTION 
 
1.1  NORMAL TROPHOBLAST PHYSIOLOGY  
 
1.1.1  Introduction 
 
  Trophoblasts  are  unique  to  mammalian  reproduction.  With  the  evolutionary 
divergence in vertebrates, there was a transition from oviparity (yolk-sac nutrition) to 
viviparity (nourishment through mother) with the emergence of the trophoblast (Moffett 
and Loke, 2006). Trophoblasts are specialized epithelial cells that form the chorion of the 
placenta. Trophoblasts serve endocrine, nutritive, and gas exchange functions between 
the mother and fetus. Originating from the trophectoderm layer of the blastocyst, these 
are the first cells during embryologic development to differentiate. The trophectoderm 
gives rise to trophoblast lineages that undergo migration, invasion, and proliferation, to 
aid in placental development.  
 
1.1.2  Origin of the trophoblast 
    
The  origin  of  the  trophoblast  begins  at  the  32-cell  blastocyst  stage  in  mice 
(Pedersen et al., 1986) when external blastomeres give rise to the trophectoderm (Pfeffer 2 
 
and Pearton, 2012). In contrast, cattle trophectoderm determination occurs at a later stage 
in  pre-gastrulation  embryos  (Berg  et  al.,  2011).  In  dogs,  embryos  enter  the  uterus 
between  the  16-cell  morula  to  early  blastocyst  stage  (Andersen,  1927;  Holst  and 
Phemister, 1971). However, studies investigating the earliest origins of the trophoblast 
have not yet been conducted in the dog.  
The trophectoderm gives rise to two main lineages of trophoblasts: uninucleated 
cytotrophoblasts and multinucleated syncytiotrophoblasts (Thiede and Rudolph, 1961). 
Subsets within these two lineages vary greatly among species (Figure 1.1). In the canine 
placenta, syncytiotrophoblasts are in contact with the maternal blood vessels; absorptive 
cytotrophoblasts are present in the necrotic zone; and phagocytotic cytotrophoblasts line 
the marginal hematomas (Barrau et al., 1975). Since mitotic divisions can only occur in 
cytotrophoblasts, cytotrophoblasts are the primary trophoblast lineage that proliferates 
and differentiates to form syncytiotrophoblasts (Barrau et al., 1975). In the dog, both 
lineages have degradative and absorptive capabilities, although syncytiotrophoblasts have 
invasive capabilities whereas cytotrophoblasts do not (Barrau et al., 1975).  
In  the  primate  placenta,  cytotrophoblasts  differentiate  into  villous 
cytotrophoblasts  and  extravillous  cytotrophoblasts  (Bischof  et  al.,  2000).  Villous 
cytotrophoblasts  proliferate  and  differentiate  into  syncytiotrophoblasts  that  cover 
placental villi. Extravillous cytotrophoblasts, located beneath the syncytiotrophoblasts, 
form  a  multilayer  of  motile  and  highly  invasive  cells.    Extravillous  cytotrophoblasts 
invade the endometrium and invade into the first third of the myometrium. Furthermore, 
extravillous  cytotrophoblasts  can  differentiate  into  endovascular  cytotrophoblasts 
Figure 1.1. A schematic diagram showing the derivation of canine (left) and primate trophoblasts (right) and their cell lineages. 
References: Andersen, 1927; Thiede and Rudolph, 1961; Wynn and Corbett, 1969; Holst and Phemister, 1971; Barrau et al., 
1975; Bischof et al., 2000.  
3
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that  migrate  into  and  remodel  the  maternal  spiral  arteries,  which  allows  increased 
maternal blood flow (Pennington et al., 2012). 
 
1.1.3  Role of the trophoblast  
  
Irrespective  of  species,  trophoblasts  migrate,  invade,  and  proliferate  to  aid  in 
subsequent  placental  development.  Initially,  trophoblasts  appose  the  endometrial 
epithelium in an unstable adhesion (Hohn and Denker, 2002). Next, trophoblasts develop 
a  stable  adherence  to  the  endometrial  epithelium  to  form  the  feto-maternal  interface 
(Staun-Ram and Shalev, 2005).  Compared to rodents and equids, trophoblast apposition 
and adhesion in dogs are delayed. Canine blastocysts exist in a free-floating stage for 7 
(Holst and Phemister, 1971) up to 16 days (Tietz and Seliger, 1967) after breeding, which 
is longer than rodents (3 days) and equids (7 days) (Austin, 1969). Finally, trophoblasts 
attach to the endometrial epithelium, which is characterized by trophoblast invasion that 
forms  an  intimate  contact  between  the  trophoblast  and  the  endometrial  epithelium 
(Gilbert, 2010). In dogs, trophoblast attachment of the blastocyst to the uterus occurs 21 
days  after  breeding  (Concannon  et  al.,  1988).  Invasion  of  trophoblasts  into  the 
endometrial epithelium involves extracellular matrix (ECM) transformation. Invasion of 
the endometrium by trophoblasts promotes firm attachment and anchoring of the placenta 
to the uterus (Hohn and Denker, 2002). Beginning as early as 13 days after breeding, 
canine  syncytiotrophoblast  invade  the  endometrium  (Barrau  et  al.,  1975). 
Syncytiotrophoblasts penetrate and become wedged between the maternal epithelial cells 5 
 
and dislodge them from the basement membrane though phaygocytosis (Barrau et al., 
1975). Syncytiotrophoblasts invade deeper within the endometrium and into the base of 
the endometrial glands (crypts) by day 18. There are notable areas of necrosis (necrotic 
zones) that are lined by invading syncytiotrophoblasts and cytotrophoblasts (Barrau et al., 
1975). By day 26 after breeding, syncytiotrophoblasts reach maximum invasion depth at 
the lacunae within the endometrium.  
A unique characteristic of carnivore placentation are marginal hematomas that are 
present  on  each  pole  of  the  villous  chorioallantois  (Barrau  et  al,  1975).  In  these 
specialized areas, trophoblasts extensively erode the maternal endometrium and blood 
vessels, resulting in large pools of stagnant maternal blood. Cytotrophoblasts that enclose 
the hematomas engulf red blood cells to supply metabolites and iron to the fetus (Wynn 
and  Corbett,  1969).  Compared  to  dogs  with  an  endotheliochorial  placenta,  primate 
trophoblasts of the hemochorial placenta are much more invasive, such that the embryo is 
fully  embedded  within  the  endometrium  (Gilbert,  2010).  Human  extravillous 
cytotrophoblasts  extensively  invade  through  the  endometrium  and  a  third  into  the 
myometrium to be in direct contact with the maternal circulation (Hohn and Denker, 
2002; Staun-Ram and Shalev, 2005). Hemochorial placentation differs from the marginal 
hematomas  in  carnivore  endotheliochorial  placentation  because  extravillous 
cytotrophoblasts come in direct contact with circulating red blood cells, where the red 
blood cells in the canine placenta are stagnant.  
 
   6 
 
1.1.4  Conclusion 
   Trophoblasts  are  extra-embryonic  epithelial  cells  originating  from  the 
trophectoderm to form the chorion of the placenta. The trophoblast lineage varies greatly 
between  species  for  each  type  of  placentation.  Depending  upon  their  phenotype, 
trophoblasts migrate, invade, proliferate, absorb, and phagocytose.  
 
 
1.2  IN VITRO METHODS FOR THE STUDY OF TROPHOBLAST PHYSIOLOGY 
 
1.2.1  Summary 
 
The use of in vivo models to study trophoblast physiology is uncommon because 
of complications that may occur during perturbation to the fetus and mother. Ex vivo 
studies on trophoblast physiology, with respect to migration, invasion, and proliferation, 
have been facilitated through the use of primary trophoblast cell culture, immortalized 
trophoblast cell lines, and in vitro assays. 
 
1.2.2  Primary trophoblast cell culture 
 
The development  of  a successful  technique for  extended  in  vitro primary  cell 
culture  of  trophoblasts  was  first  established  by  Thiede  and  Rudolph  (1961)  to  study 
trophoblast physiology. Human chorionic villi were dissected from term placenta after 7 
 
delivery (vaginal or c-section), washed, and subjected to a trypsin digestion until cells 
were isolated and plated. Freshly isolated trophoblasts are spherical then as they remain 
in culture flatten into a polygonal shape while adhering to the culture plate (Merviel et 
al., 1993) and grow into a cell monolayer to form cobblestone morphology (Tanaka et al., 
1998). A mixed culture cell monolayer of cytotrophoblasts and syncytiotrophoblasts were 
observed in vitro with subsequent differentiation into fibroblasts at 37°C with 7% CO2 
atmosphere conditions (Thiede and Rudolph, 1961). Later studies modified the culture 
conditions to 37°C with 5% CO2 atmosphere to give growth patterns of trophoblast in 
vitro that were similar to those described in vivo, including the development of filopodia-
like projections, circular growths, and syncytial sprouts (Aladjem and Lueck, 1981). In 
addition to cell morphology, in vitro cultures can preserve in vivo phenotypic destiny, 
with  primary  trophoblasts  undergoing  differentiation  into  syncytiotrophoblasts  and 
invasive cytotrophoblasts in vitro (Kilburn et al., 2000). Also, primary trophoblast cell 
cultures  maintain  the  expression  of  in  vivo  trophoblast  markers  (ie.  human  chorionic 
gonadotropin (hCG), human placental lactogen (hPL), cytokeratins, vimentins, human 
leukocyte antigens (HLA-I)) (King et al., 2000).  
  Limitations  to  using  primary  trophoblast  culture  include:  selecting  a  culture 
medium to optimize cell growth while controlling sterility, purity, and differentiation; as 
well as the challenge of preparing fresh cells for each experiment (Orendi et al., 2011). In 
particular, selecting tissue culture medium with sufficient amount of serum (e.g. fetal 
bovine serum) or serum-free supplement (e.g Nutridoma) is critical. Employing sterile 
tissue  culture  techniques  is  important  to  maintain  cell  viability  and  to  avoid 8 
 
contamination  when  working  with  primary  trophoblast  cultures.  Another  challenge  is 
obtaining a pure trophoblast sample during isolation because even a small number of 
contaminating cells (e.g. stromal fibroblasts) may overgrow the comparatively slower 
proliferating trophoblasts when in culture for an extended time (Thiede and Rudolph, 
1961;  Stromberg  et  al.,  1978).  Studies  have  successfully  characterized  the  purity  of 
isolated trophoblast cells based on the expression of cytoskeletal proteins, mainly (e.g. 
cytokeratin 7, vimentin) (Pötgens et al., 2001).   
 
1.2.3  Immortalized trophoblast lines 
 
  Immortalized trophoblast lines were developed to facilitate the investigation of 
trophoblasts  and  to  avoid  difficulties  associated  with  maintaining  primary  cultures. 
Human immortalized trophoblast lines include choriocarcinoma cells (e.g. BeWo cells) or 
primary cytotrophoblasts (e.g. HTR-8/SVneo) (Orendi et al., 2011). The advantages of 
immortalized trophoblast lines are that they are readily available, can be placed in culture 
for  extended  periods  without  differentiation  into  another  cell  type,  and  are  highly 
accessible because they can be repeatedly frozen and thawed for experiments (Kilburn et 
al.,  2000).  However,  the  comparisons  between  immortalized  trophoblast  lines  to 
trophoblasts in vivo are more variable than with primary trophoblast culture (Table 1.1).   
 
Table 1.1. A summary of trophoblast characteristics derived from primary culture and immortalized lines.    
 
  Trophoblast characteristic    Primary culture    Immortalized lines 
  Origin of cells    Primary placenta tissue    Primary placenta or choriocarcinoma 
  Availability of cells    Variable, dependent on tissue availability   Readily available, frozen until use 
  Length of culture time    Up to 10-14 days until differentiation    Unlimited 
  Recapitulate in vivo differentiation   Yes    No 
  Recapitulate in vivo migration    Yes    Yes 
  Recapitulate in vivo invasion    Yes    Yes 
  Recapitulate in vivo phenotype    Yes, express all trophoblast markers    No, express some trophoblast markers 
  References    Thiede and Rudolph, 1961; Aladjem and   
  Lueck, 1981; King et al., 2000 
  Graham et al., 1993; Kilburn et al., 2000;  
  King et al., 2000; Orendi et al., 2011 
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Studies  have shown that not  one of the established immortalized trophoblast  lines 
retain all of the same phenotypic attributes and behaviors unique to trophoblasts in 
vivo  (King  et  al.,  2000).  For  example,  HTR-8/SVneo  is  a  commonly  used 
immortalized  trophoblast  line  derived  from  first-trimester  human  cytotrophoblasts 
(HTR) from villous explants that were transfected with Simian Virus (SV) 40 large T 
antigen and passaged about 8 times to result in a nontumorigenic cell line with an 
extended  lifespan  (Graham  et  al.,  1993).  HTR-8/SVneo  shares  some  phenotypic 
features with primary cytotrophoblast cultures (including expression of cytokeratin, 
hCG, and type IV collagenase), but does not express the trophoblast-specific major 
histocompatibility protein, human leukocyte antigen type G (HLA-G) (Kilburn et al., 
2000).  Another  limitation  to  HTR-8/SVneo  cells  is  that  unlike  primary  culture 
trophoblasts,  they  are  unable  to  differentiate  into  the  invasive  extravillous 
cytotrophoblast  phenotype.  Scientists  should  exercise  caution  when  selecting  an 
immortalized cell line for studying trophoblast physiology, such that they consider the 
limitations of each cell line as these relate to their research goals (King et al., 2000). 
 
1.2.4  Migration assays  
 
Two-dimensional in vitro assays allow a simple way to observe cell migration. 
Three commonly used methods include: the scratch assay, stencil-based scratch assay, 
and the Boyden chamber assay (Table 1.2). Migration is defined as the two-   
 
Table 1.2. A comparison of characteristics of three trophoblast migration assays.  
IF- Immunofluorescence, IHC- Immunohistochemistry, PC- Polycarbonate, PE- polyethylenterephthalate 
  Assay characteristic    Scratch assay    Stencil scratch assay    Boyden chamber assay 
  Chemotaxis    No    No    Yes 
  Measurement    Migration area    Migration area    Cell count, flourescence 
  Live imaging    Yes    Yes    No 
  IF, IHC     Yes    Yes    Yes 
  Substrate    Plastic, glass or coated    Plastic, glass or coated    PC, PE membrane or coated 
  Direction of movement    Horizontal    Horizontal    Horizontal then vertical 
  Recapitulate in vivo migration     Collective sheet migration    Collective sheet migration    Single cell migration 
  Cell applicability    Adherent cells only    Adherent cells only    Adherent/suspension cells 
  References     Liang et al., 2007; Kramer et al.,  
  2013 
  Liang et al., 2007; Kramer et al.,  
  2013 
   Boyden, 1962; Kramer et al., 2013 
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dimensional movement of cells on a substrate (e.g. extracellular matrix (ECM) fibers, 
plastic of the plate) (Kramer et al., 2013). Cell motility is characterized by a duality 
between collective and individual behaviors. On the one hand, the motility within the cell 
monolayer is long range, involving an orchestrated movement of many cells together. On 
the other hand, there are transient, active leader cells that destabilize the scratch border by 
“fingering” the border. The sides of the “fingers” have an actin belt that may regulate the 
mechanical signaling between the leader and the follower cells, supporting the hypothesis 
of migration where a mechanical communication between the cells occurs in response to 
the free plate surface (Poujade et al., 2007). 
Two scratch assays are widely used in the study of trophoblast migration: the 
scratch (or wound-healing) assay and the stencil-based scratch assay. Both follow the 
same  general  procedure.  Trophoblasts  are  plated  onto  a  tissue  culture  plate  and 
supplemented  with  a  culture  medium  containing  serum.  The  cells  are  incubated  and 
allowed to grow into a confluent cell monolayer. A scratch is added into the monolayer, 
by inflicting the wound or using a stencil, and loosened cells are rinsed away and the 
culture medium is replaced for the remaining duration of the assay. Microphotographs of 
the wound are taken at regular incubation intervals to quantify the number of migrating 
cells as they close the wound (Liang et al., 2007). 
There are several advantages of the scratch assay. First, it mimics the migration of 
cells in vivo, where fillopodia-like extensions of the active leader cells develop to close 
the  wound  (Aladjem  and  Lueck,  1981).  Second,  this  assay  allows  the  study  of  the 
regulation of cell migration by cell interaction with the extracellular matrix (ECM) and   13 
cell–cell  interactions.  Third,  the  scratch  assay  can  be  combined  with  time  lapse 
microscopy to allow imaging of intracellular signaling events in micro-injection or gene 
transfection  studies  (Kramer  et  al.,  2013).  Lastly,  the  scratch  assay  is  a  simple, 
straightforward method to study cell migration in vitro that requires inexpensive supplies 
found in cell culture laboratories.  
  However, there are a number of limitations to the scratch assay. First, it takes a 
relatively longer time to perform the scratch assay compared to other methods due to the 
time it takes to develop a confluent monolayer in culture. Second, it does not utilize a 
chemical  gradient to induce chemotaxis (e.g. Boyden chamber assay;  Boyden, 1962). 
Despite these limitations, the in vitro scratch assay is still the method of choice for most 
investigators  because  it  is  a  convenient  and  inexpensive  method  for  analysis  of  cell 
migration in vitro (Liang et al., 2007). 
  Alternatively,  other  studies  employ  an  injury-free  wound-healing  assay  on 
epithelial cells (Poujade et al., 2007). Although inspired by the scratch assay, the stencil-
based, or microfabrication-based, method is different because it focuses on the influence 
of the free surface and uncouples it from the other possible contributions such as cell 
damage and/or permeabilization. With the stencil-based method, the cleft between cells is 
produced by an elastic polycarbonate microstencil that is placed into a culture dish and 
cells are then plated into the same dish to adhere overnight. The flexible microstencil is 
then removed to leave a free space on the plate surface. The sudden release of available 
plate  surface  by  removal  of  a  stencil-based  scratch  on  a  confluent  cell  monolayer  is 
sufficient to trigger cell motility (Poujade et al., 2007). The primary advantage of the   14 
stencil-based method is that many identical clefts in the culture can be made, thereby 
increasing statistical power, while retaining the advantages of non-injury (Poujade et al., 
2007).    The  disadvantages  to  this  assay  are:  the  cost  of  manufactured  stencils,  the 
inability to allow complete formation of a confluent cell monolayer because cells tend to 
adhere to the stencil, and increased setup time.  
  Another common assay to study trophoblast migration is the Boyden (transwell) 
chamber  assay.  Unlike  the  scratch  and  stencil-based  scratch  assays,  which  observe 
horizontal  cell  migration  in  response  to  mechanical  perturbation,  this  assay  observes 
vertical  migration  stimulated  by  a  chemoattractant  (i.e.  medium  containing  a  higher 
serum  concentration)  (Kramer  et  al.,  2013).  Boyden  (1962)  first  studied  an  in  vitro 
chemotaxis  method  with  leukocytes  using  membrane  filters,  and  the  method  is  still 
commonly used for trophoblast studies. The Boyden chamber consists of an upper and 
lower well separated by a membrane filter with pores just slightly smaller than the cell 
size. The chemoattractant is placed in the lower well and cells are seeded into the upper 
well and after an incubation interval, the cells have migrated towards the chemoattractant. 
The number of migrating cells deposited at the underside of the filter is compared to the 
controls to determine the rate of migration. By eliminating the mechanical perturbation of 
the scratch assay, this technique can be used to elucidate factors that may promote or 
inhibit chemotaxis (Kramer et al., 2013). Disadvantages to the Boyden chamber assay are 
the cost of the chamber system including filter membranes as well as the effort required 
for optimization of the cell concentration and the chemoattractant.    
   15 
1.2.5  Invasion assays 
 
  The processes of cell invasion are integral to the role of trophoblasts in placental 
development. Three-dimensional invasion assays, such as the Matrigel invasion assay, 
explant culture technique, and spheroid culture assay are examples of in vitro invasion 
assays used in studying trophoblast physiology (Table 1.3). Invasion will be defined as 
three-dimensional  cell  movement  through  a  barrier  involving  restructuring  and 
degradation of the ECM (Kramer et al., 2013).  
  The  most  common  invasion  assay  used  in  trophoblast  studies  is  the  Matrigel 
invasion assay, a modified Boyden chamber assay with a coating of Matrigel on top of 
the membrane filter in the upper well. Matrigel is a reconstituted basement membrane 
isolated from the extracellular-rich Engelbreth-Holm-Swarm (EHS) mouse sarcoma. This 
reconstituted  material  contains  laminin,  collagen  IV,  entactin,  heparin,  proteoglycans, 
matrix  metalloproteinases  (MMPs),  various  growth  factors  and  tissue  plasminogen 
activator (BD Biosciences, 2011). Matrigel acts as an in vitro substitute for the ECM thus 
it  contains  similar  components.  Librach  and  associates  (1991)  first  introduced  the 
Matrigel invasion assay to study the invasive capacity of trophoblast in the presence of 
MMPs and serine activators and inhibitors. The procedure is the same as the Boyden 
chamber technique (Boyden, 1962), but includes thawing and rehydration of the Matrigel 
basement  membrane  before  seeding  cells  into  the  upper  well  and  adding  the  
 
 
Table 1.3. A comparison of characteristics of three trophoblast invasion assays.  
 
  Assay characteristic    Matrigel invasion assay    Villi explant culture     Spheroid invasion assay 
  Chemotaxis    Yes    No    No 
  Measurement    Number of cells    Invasion area    Invasion area 
  IF, IHC    Yes    Yes    Yes 
  Substrate    BME, collagen I    BME, collagen I, fibrin    BME, collagen I, fibrin 
  Direction of movement    Vertical    Any    Any 
  Recapitulate in vivo invasion    Invasion through matrix    Single/collective invasion    Single/collective invasion 
  Cell applicability    Adherent/ suspension cells    Heterotypic cell interaction   Heterotypic cell interaction 
  References     Librach et al., 1991; Genbacev,  
  1992; Kramer et al., 2013  
  Korff et al., 2004; Kramer et al.,  
  2013 
  Korff et al., 2004; Kramer et al.,  
  2013 
IF- Immunofluorescence, IHC- Immunohistochemistry, BME- basement membrane extract. 
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chemoattractant to the lower well. There are several advantages to this versatile assay. It 
is  commercially  available,  and  it  involves  an  easy,  straightforward  approach  using 
chemotaxis  to  induce  invasion,  and  it  can  be  combined  with  other  methods  such  as 
immunohistochemistry  (IHC)  and  drug  or  factor  studies.  The  disadvantages  to  the 
Matrigel invasion assay are: the great cost of the Matrigel-coated membrane filters, the 
variability when counting cells manually, and ensuring sterility when handling the assays 
to reduce cell death and decrease invasion. However, this is the most common invasion 
assay applied to trophoblasts, and it is the better method to study trophoblast physiology 
because of the ease of the assay and production of reliable, quantifiable results (Kramer 
et al., 2013).  
  Another common in vitro method is the use of explant culture of chorionic villi of 
the placenta. This method was first applied to trophoblasts by Genbacev and associates 
(1992)  to  study  human  first  trimester  extravillous  cytotrophoblast  differentiation  and 
column formation. Explant culture allows the observation of cell column development, 
showing which cell columns are formed by the proliferation of villous cytotrophoblast 
stem cells to attach the placenta to the uterine wall (Enders, 1968). These cell columns 
supply the invasive extravillous cytotrophoblasts to invade the endometrium and remodel 
maternal vasculature in humans and rodents. The procedure begins with preparation of 
the gel  with  diluted agarose (collagen  I) and Matrigel in  culture medium  and this  is 
allowed  to  gel  overnight  in  a  12-well  tissue  culture  plate  placed  in  the  incubator. 
Meanwhile, tissue is collected from floating chorionic villi and cut into small pieces, 
which are then arranged on top of the prepared gel and flooded with culture medium to   18 
undergo incubation and allow invasive projections to extend into the gel. The area of 
outgrowth from the explant is measured and IHC can be applied. Advantages to the 
explant culture are: it is able to preserve the architecture and behavior of trophoblasts 
observed in vivo as well as to maintain the structure of the placenta at anchorage sites 
(Korff et  al., 2004;  Kramer et  al.,  2013). Also, this  method allows the study of cell 
differentiation,  cell  marker  expression,  and  metabolic  labeling  using  commercially 
available  assay  kits  that  are  less  costly  than  the  Matrigel  invasion  assay.  The  main 
disadvantage of the explant culture is that the size of outgrowth varies greatly between 
cultures because the size of outgrowth depends upon the site where the chorionic villi 
were obtained and the site of origin where villous tips contact the gel surface (Korff et al., 
2004). Another disadvantage of the explants culture is that the measurement of outgrowth 
is not precise due to the lack of uniform borders of the outgrowth area.  
A third alternative method to study trophoblast invasion is to use the spheroid 
culture  technique.  Korff  and  associates  (2004)  first  introduced  this  method  to  study 
growth,  cell  differentiation,  and  invasive  capacity  in  first  and  third  trimester  human 
trophoblasts, although spheroid culture has been widely used in tumor and embryonic 
cells for cell differentiation studies and pharmaceutical applications. Spheroid culture for 
trophoblasts was developed because Matrigel invasion assays do not study differentiation 
and are limited in their application. Also explant culture of chorionic villi do not examine 
cell-cell interaction the way that spheroid culture for trophoblasts does, and the variation 
in cell types in the explant (trophoblasts, fibroblasts, lymphocytes) cause analysis of the 
effects to be difficult (Korff et al., 2004). The technique begins with the generation of   19 
cytotrophoblast spheroids by trypsinization of a confluent cytotrophoblast monolayer to 
resuspend cells in a culture medium containing methylcellulose and then seeding into a 
nonadherent  round-bottom  96-well  plate  for  an  incubation  to  allow  growth  of  the 
spheroids into a defined size and cell number (Korff et al., 2004). The spheroids are 
embedded in a substrate gel of interest (collagen, laminin), transferred into a pre-warmed 
24-well plate to polymerize, and then undergo incubation in a culture medium at standard 
tissue  culture  conditions.  Invasion  is  then  quantified  by  measuring  the  length  of  the 
invasive “sprouts” using imaging software (Korff et al., 2004). The advantages of this 
assay are: it a straightforward approach that has the ability to study invasion as well as 
proliferation and differentiation, it provides a more precise measurement of behavior to 
give easily quantifiable data, and it can be combined with IHC and protein expression 
studies (Korff et al., 2004; Kramer et al., 2013). Although the disadvantages include: the 
extra time required to isolate cells and then form spheroids in culture, and mainly, the 
difficulty  in  producing  uniformly  sized  spheroids,  which  may  cause  variability  in 
measuring the invasive “sprouts”. 
 
1.2.6  Proliferation assays 
 
  Several biological methods have been developed to measure proliferating cells 
(Table 1.4). Traditional methods are not efficient in quantifying large cell counts in the 
thousands or millions at several time points because of the long processing time and 
sample variation that occurs during washing steps. Radioactive isotopes can be automated 20 
 
 
Table 1.4. A comparison of characteristics between trophoblast proliferation assays.  
 
  Assay characteristic    MTT assay    Dojindo assay 
  Type of assay    Rapid colorimetric assay    Rapid colorimetric assay 
  Substrate    MTT    WST-8 
  Incubation with substrate     4 hours    1 - 4 hours 
  Product    Water-insoluble formazan    Water-soluble formazan 
  Solubilization agent    Acid 1-propanol, DMSO    None required 
  Measurement    Optical density    Optical density 
  Recapitulate in vivo proliferation    Collective cell proliferation    Collective cell proliferation 
  Cell applicability    Adherent cells only    Adherent and suspension cells 
  References    Mosmann, 1983;  Carmichael et  
  al., 1987; Twentyman and  
  Luscombe, 1987 
  Ishiyama et al., 1996; Dojindo,  
  2012 
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to quantify larger cell counts but still cannot be used to measure several assay points over 
time (Mosmann, 1983). However, colorimetric assays have the ability to rapidly measure  
large sample sizes with a high degree of precision due to their use of multiwell scanning 
spectrophotometers (ELISA plate readers). Although there are several rapid colorimetric 
assays available for measuring cell proliferation, the tetrazolium salt (MTT) assay is the 
most  commonly  used  method  and  the  Dojindo  assay  is  one  of  the  newest  methods 
(Ishiyama et al., 1996).  
  The  tetrazolium  salt,  (((3-)4,5-dimethylthiazol-2-yl)-2,5-diphenyl  tetrazolium 
bromide), MTT assay was first developed by Mosmann in 1983 to measure mammalian 
cell survival and proliferation. The assay depends upon the cellular reduction of water-
soluble MTT by the mitochondrial dehydrogenase present in viable cells to form a water-
insoluble  blue  formazan  product  that  can  be  measured  on  a  spectrophotometer 
(Carmichael  et  al.,  1987;  Twentyman  and  Luscombe,  1987).  The  optical  density  as 
measured on the spectrophotometer is proportional to the amount of formazan produced 
and  therefore  is  proportional  to  the  concentration  of  viable  cells.    Dead  cells,  cells 
without  mitochondria  (i.e.  red  blood  cells)  and  tissue  culture  medium  are  unable  to 
produce  the  formazan  product,  and  thereby  do  not  interfere  with  the  optical  density 
readings of the MTT assay (Carmichael et al., 1987). 
  There have been several variations of the MTT assay in order to optimize its 
ability to accurately detect and quantify the amount of living cells in a given sample. 
Optimization  studies  include:  altering  total  cell  counts  or  medium  volumes  per  well, 
incubation time with MTT, and solubilizing agents used.  When cells are plated in culture   22 
medium with little to no serum, the greatest amount of formazan production is yielded 
(Twentyman  and  Luscombe,  1987).  Isopropanol  is  the  most  effective  solvent  of  the 
formazan  crystals  due  to  the  complete  solubilization  with  agitation  or  titration 
(Carmichael et al., 1987). Another common solvent is DMSO, although it is erosive to 
tissue culture plasticware and it only partially dissolves the formazan product. Ethanol 
has  also  been  used  as  a  solvent,  but  it  forms  a  precipitate  with  serum  proteins  that 
interferes with the optical density readings (Twentyman and Luscombe, 1987).  
  Advantages  to  the  MTT  assay  are:  it  has  a  straightforward  setup,  it  is 
commercially available, and it provides rapid results. However, the disadvantage to the 
MTT assay is its sensitivity to culture medium remaining in the well before addition of 
the solvent. Even a small volume of culture medium can interfere with the optical density 
reading (Twentyman and Luscombe, 1987). Also, extra care must be taken during cell 
seeding to decrease variability. And, the commercial kit is costly. Although the MTT 
assay has few disadvantages, it is the most effective assay to measure cell viability and 
proliferation due to its ability to give consistent, accurate readings, and it can be easily 
compared to other studies.   
  In  contrast  to  MTT,  a  commercially  available  rapid  colorimetric  assay  (Cell 
Counting  Kit-8  kit,  Dojindo,  Kumamoto,  Japan)  utilizing  WST-8  [2-(2-methoxy-4-
nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium,  monosodium  salt] 
is available as an alternative for cell counting. Generally, the procedure is similar to the 
MTT assay, but instead of using MTT as the substrate, WST-8 is used. WST-8 reacts 
similarly to MTT, in which it is reduced by mitochondrial dehydrogenases in viable cells   23 
to produce an orange formazan product (Dojindo, 2012).  The water-soluble formazan 
product is soluble in tissue culture medium, thus no solvent is required to dissolve the 
formazan product in this assay. Dojindo advertises that WST-8 is a suitable substrate 
because  it  is  a  non-toxic  tetrazolium  salt.  Similar to  the  MTT  assay,  the  amount  of 
formazan produced is directly proportional to the number of living cells.  
  There  are  a  number  of  advantages  and  disadvantages  to  the  Dojindo  assay. 
Similar  to  the  MTT  assay,  the  Dojindo  assay  provides  rapid  results.  Although,  the 
Dojindo assay is less expensive and requires less time to perform than the MTT (no 
solubilization step and shorter incubation with WST-8), it is also suitable for adherent as 
well as non-adherent cells whereas the MTT assay is only applicable to adherent cells. 
On the other hand, the Dojindo assay cross-reacts with some culture mediums by falsely 
undergoing color development. Also, the Dojindo assay can only accurately measure low 
cell concentrations and cannot accurately measure higher cell concentrations (Dojindo, 
2012).  
 
 
     24 
1.3  REGULATORS  OF  TROPHOBLAST  MIGRATION,  INVASION,  AND 
PROLIFERATION 
 
1.3.1  Summary 
 
Trophoblasts interact with the endometrium through synchronized molecular and 
cellular events. Studies have identified factors involved in the regulation of trophoblast 
migration, invasion, and proliferation in carnivores including endopeptidases and their 
inhibitors, cytokines, and growth factors, hormones, and other factors (Kovacs and Ojeda, 
2012). 
 
1.3.2  Matrix metalloproteinases and their tissue inhibitors 
 
Expression  of  matrix-metalloproteinases  (MMPs)  and  their  tissue  inhibitors 
(TIMPs) were detected in the canine trophoblast (Sahlfeld et al., 2012) and endometrium 
(Beceriklisoy et al., 2009). MMPs are identified as key enzymes in the degradation of the 
maternal endometrium, specifically MMP-2 and MMP-9 (Bischof et al., 2000). MMPs 
are  zinc-dependent  endopeptidases  collectively  capable  of  degrading  all  ECM 
components (Bischof et al., 2000). MMPs fall into five classes: (1) gelatinases (MMP-2 
and MMP-9), (2) collagenases (MMP-1, 8, 13), (3) stromelysins (MMP-3, 7, 10, 11 and 
12), (4) membrane-type metalloproteinases (MMP-14, 15, 16), and (5) non-classified 
MMPs  of  unknown  function.  Gelatinases  MMP-2  and  -9  are  involved  in  ECM   25 
degradation and the regulation of growth factors, cytokines and angiogenic factors that 
are important in trophoblast invasion (Bischof et al., 2000). Collagenases digest several 
types of collagen present in the ECM. Stromelysins digest collagens, laminin, fibronectin, 
elastin, proteoglycans and gelatin. Membrane-type MMPs activate MMP-2 at the cell 
surface to promote trophoblast invasion (Bischof et al., 2000). Gene expression of MMP-
2 has been detected in canine trophoblasts and myometrial tissue (Beceriklisoy et al., 
2007) and expression of MMP-9 detected in endometrial crypts and glands (Beceriklisoy 
et  al.,  2007).  Both  MMP-2  and  MMP-9  have  been  detected  in  the  pre-implantation 
embryo  10-12  days  after  mating  (Schäfer-Somi  et  al.,  2008).  Around  the  time  of 
implantation, mRNA expression of these MMPs is at its highest, suggesting that these 
endopeptidases  are  involved  in  the  degradation  of  the  endometrium  required  during 
implantation in canine pregnancy (Beceriklisoy et al., 2007). MMP activity, specifically 
MMP-1 and MMP-13, was also detected in feline trophoblasts (Walter and Schönkypl, 
2006). It was proposed that these factors (with collagen I and IV, laminin and α-smooth 
muscle actin) balance ECM structure and degradation in the feline placental labyrinth for 
proper placental development and function (Walter and Schönkypl, 2006). 
Tissue inhibitors of metalloproteinases (TIMPs) are the main inhibitors of MMPs. 
MMPs are inhibited by a 1:1 stoichiometric preferential binding by TIMPs (Bischof et al, 
2000). In vitro studies suggest that successful implantation and placentation result from 
the balance between trophoblast secretion of MMPs and their inhibition by TIMPs. The 
MMP-TIMP  interaction  controls  trophoblast  invasion  by  restricting  over  or  under-
invasion into the uterus (Staun-Ram and Shalev, 2005). Immunohistochemical expression   26 
of TIMP-2, MMP-2 and MMP-9 was detected in isolated canine trophoblast of term 
placenta (Sahlfeld et al., 2012). Fellows and company (2012) also observed a notable yet 
insignificant increase in TIMP-2 mRNA expression in canine placenta from pre-term to 
parturient  stage,  suggesting  that  as  gestation  progresses  TIMP-2  inhibits  trophoblast 
invasion.  
 
1.3.3   Cytokines 
 
 
 
The cytokine superfamily includes hematopoietic growth factors, interleukins (IL-
1β, IL-6, IL-8) and leukemia inhibitory factor (LIF), and inflammatory cytokine TNF-α, 
which are all involved in canine reproduction. Interleukins are known to play a major role 
in implantation by regulating MMP and adhesion activity (Van Mourik et al., 2009). A 
number of interleukins promote trophoblast invasive behavior. Trophoblast cells produce 
IL-1β, and the IL-1β receptor is present in uterine epithelial cells and trophoblasts. IL-1β 
can stimulate MMP-9 activity in trophoblasts and expression in endometrial stromal cells 
for ECM degradation, thereby promoting trophoblast invasion for successful implantation 
in other species (Van Mourik et al., 2009). Also IL-6 and IL-8 were present at the feto-
maternal interface. IL-6 stimulates MMP-2 and MMP-9 activity and enhances trophoblast 
invasion (Jovanović and Vićovac, 2009). IL-8 stimulates trophoblast viability, migration, 
invasion, and proliferation through the up-regulation of MMP-2, MMP-9, and integrins 
levels (Jovanović et al., 2010). Expression of IL-1β, IL-6 and IL-8 in the pre-implantation 
embryos  of  dogs  suggests  that  they  contribute  to  trophoblast  activity,  in  particular   27 
invasive capacity, at implantation. IL-4 and IL-10 are known to down-regulate MMP-9 
activity and therefore reduce trophoblast invasion (Van Mourik et al., 2009). IL-4 and IL-
10 expression was found to be decreased at the placental sites during implantation to 
possibly regulate canine trophoblast invasion (Beceriklisoy et al., 2009). 
Cytokine interaction with acute phase proteins has also been under investigation 
in dogs. An increase of plasma acute phase proteins (APPs) is known to occur during 
inflammation,  infection,  tissue  injury,  neoplastic  growth  or  immunological  disorders 
(Conner et al., 1988; Eckersall and Conner, 1988). APPs, such as C-reactive protein, 
haptoglobin, fibrinogen, ceruplasmin, seromucoid, and glycoproteins, have been detected 
in the plasma of pregnant bitches 28 and 37 days after mating (Evans and Anderton, 
1992). The rise in APPs was proposed to be involved with an immunological response by 
the maternal immune system during blastocyst hatching (Harvey, 1991). The presence of 
plasma APPs has been linked to an increase in cytokines IL-6 and TNF after inducing a 
localized  inflammation  in  adult  beagles  (Yamashita  et  al.,  1994).  Further,  a   post-
implantation increase of serum C-reactive protein was suggested to coincide with the 
inflammatory response at implantation (Concannon et al., 1996).  
LIF  and  its  receptor,  LIFR,  contribute  to  successful  implantation  in  several 
species through ECM degradation (Arici et al., 1995; Salamonsen et al., 1997; Modric et 
al., 2000; Lei et al., 2004). LIF promotes uterine T helper cells to aid in embryo survival 
(Piccinini et al., 2002) and also prepares the uterus for blastocyst implantation (Passavant 
et al., 2000). LIF mRNA expression was detected in the primate pre-implantation embryo 
(Bischof et al., 2000) and canine pre-implantation embryos and uterus (Schäfer-Somi et   28 
al., 2008). This suggests that LIF contributes to the breakdown of the ECM and regulates 
trophoblast invasion. Another study observed a significant rise in LIF mRNA expression 
in canine uterine tissue from pre-implantation to placentation stage (Schäfer-Somi et al., 
2009),  so  it  was  concluded  that  LIF  is  important  for  the  establishment  of  can ine 
pregnancy.  LIFR  is  also  expressed  in  the  pre -implantation  uterus  and  blastocysts; 
therefore, it is proposed that the factor contributes to the feto-maternal interactions (Lei et 
al., 2004). Likewise, in another carnivore, the Western spotted skunk, LIF receptor β 
(LIFRβ)  mRNA  was  localized  to  syncytiotrophoblast  and  cytotrophoblast  of  post-
implantation  embryos.  In  the  spotted  skunk,  increased  LIF  production  is  positively 
correlated  with  termination  of  embryonic  diapause  and  preparation  for  implantation 
(Passavant et al., 2000).  
TNF-α, now known as TNF, is an inflammatory cytokine present in trophoblasts 
and the endometrium (Staun-Ram and Shalev, 2005). In vitro studies showed that TNF 
increased trophoblastic urokinase-type plasminogen activator (uPA) secretion to promote 
ECM fibronectin degradation during implantation. This up-regulation of uPA increases 
MMP-9, which stimulates trophoblast invasiveness, but TNF decreases MMP-2 (Staun-
Ram and Shalev, 2005). High levels of TNF are present in human pregnancy as part of 
the  inflammatory  response  to  implantation  (Staun-Ram  and  Shalev,  2005). 
Immunolabelling of TNF was also detected during early canine pregnancy at the feto-
maternal  interface  in  trophoblast  and  endometrial  stromal  tissue  and  glands  (Payan‐
Carreira et al., 2011). The presence of TNF suggests that it plays a role in implantation in 
dogs.   29 
1.3.4.  Growth factors 
 
Insulin-like  growth  factors,  IGF-I  and  IGF-II,  are  important  metabolic  and 
mitogenic factors promoting cell growth and metabolism. IGFs are peptide hormones in 
the same peptide family as relaxin and insulin, and are produced in the liver, bone and 
tissues under the influence of growth hormone. Circulating IGFs have endocrine and 
autocrine-paracrine  effects  on  somatic  growth  and  proliferation  of  various  cells  and 
tissues (Kovacs and Ojeda, 2012). IGF-II is known as a major fetal growth factor in 
several  species  (Monzani  and  Cohen,  2002),  although  IGF-I  was  only  expressed  at 
placental sites in the canine endometrium, suggesting an involvement in implantation 
(Beceriklisoy et al., 2009).  
TGF-β inhibits trophoblast invasion and proliferation through stimulating TIMP 
secretion  and  decreasing  MMP  activation  with  a  down-regulation  of  plasminogen 
activators  in  the  plasminogen  activator  system  (Salamonsen,  1999).  TGF-β  in 
conjunction with LIF mRNA expression is thought to inhibit gelatinolysis of the ECM at 
the time of implantation to balance the ECM-degradative properties of TNF-α and IL-6 
(Mathialagan et al., 1992). TGF-β mRNA is expressed in the canine pre-implantation 
uterus. Therefore, the suggested role of TGF-β present in the canine pre-implantation 
uterus is regulation of ECM degradation and trophoblast invasion (Schäfer-Somi et al., 
2008). 
HGF is recognized as a growth-promoting peptide with a stimulatory effect in the 
growth of numerous tissues, organs, as well as tumor growth and metastasis (Kovacs and   30 
Ojeda,  2012).  Expression  of  HGF  in  the  canine  pre -implantation  uterus  and  pre-
implantation  embryos  (Schäfer-Somi  et  al.,  2008)  may  suggest  HGF  regulation  of 
endometrial degradation, tissue reorganization, and possibly trophoblast invasion (Nasu 
et al., 2000).  
 
1.3.5.  Hormones 
 
  Canine syncytiotrophoblast are the main source of relaxin (Tsutsui and Stewart, 
1991). Relaxin is the only pregnancy-specific hormone in dogs (Concannon et al., 1988), 
however the role of relaxin and relaxin-like factor (RLF) in canine reproductive tissues is 
still unclear. Relaxin is a polypeptide homologue of insulin that, in conjunction with 
estrogen and progesterone, induces remodeling of connective tissues in the reproductive 
tract necessary to support and maintain pregnancy and parturition (Steinetz et al., 1989). 
The syncytiotrophoblast of the placenta has been identified as the main or sole source of 
relaxin  in  the  pregnant  bitch  (Tsutsui  and  Stewart,  1991).  Relaxin  expression  was 
localized in isolated term trophoblasts in dogs (Sahlfeld, personal communication). The 
endometrium does not express relaxin mRNA (Klonisch et al., 1999). Similarly, in felines 
the  placenta  is  the  main  source  of  relaxin  during  pregnancy  (Addiegio  et  al.,  1987; 
Klonisch et al., 1999). Canine cytotrophoblasts surrounding maternal blood vessels also 
express  RLF  mRNA  at  early  to  mid-gestation  (Klonisch  et  al.,  2001).  Differential 
expression of relaxin and RLF in the reproductive tissues suggests that these factors have 
a  specific, localized  function  supported  by  cytokines  and  steroid  hormones  (Schäfer-  31 
Somi, 2003). Further, canine mammary tumors also produce relaxin, which correlates 
with MMP-2 mRNA and cell invasion (Lamp et al., 2009). Thus, there is a possible 
interaction between relaxin, MMP-2 and trophoblast invasion in dogs. 
Progesterone is essential for the establishment and maintenance of pregnancy in 
the  bitch  (Concannon  et  al.,  1988)  and  in  all  mammals  (Kovacs  and  Ojeda,  2012). 
Successful maintenance of pregnancy largely relies on progesterone because of its ability 
to block maternal cellular immune response (Kovacs and Ojeda, 2012). Inhibition of 
progesterone  secretion  leads  to  termination  of  pregnancy  at  any  stage  of  gestation 
(Concannon et al. 1988). Abortion of the fetuses was observed in the bitch within 24 to 
48 hours after ovarioectomy, unless exogenous progesterone was administered, therefore 
in dogs it was proposed that the ovaries are the sole source of progesterone (Sokolowski, 
1971). Expression of the progesterone receptor (PR) was also detected in canine uterine 
tissue at implantation (Schäfer-Somi et al., 2009). There was a significant decrease in PR 
expression and a significant rise in LIF expression in uterine tissue from pre-implantation 
to placentation stage (Schäfer-Somi et al., 2009). It was concluded that the decrease in 
PR levels contributes to the increase in LIF levels. It was also concluded that the embryo-
driven preservation of PR mRNA expression at implantation and placentation sites, while 
expression is lost in the remainder of the uterus, may contribute to the establishment and 
maintenance of pregnancy (Schäfer-Somi et al., 2009). Progesterone receptor expression 
was detected in the pre-implantation uterus of the pregnant bitch (Schäfer-Somi et al., 
2008).   32 
Prolactin receptor (PRLr) expression was identified in canine feto-maternal tissue 
by Kowalewski and associates (2011). An increase in PRLr mRNA expression in canine 
was  observed  in  the  placental  attachment  sites  following  implantation. 
Immunohistochemistry and in situ hybridization localized expression to the trophoblast, 
proposing  that  PRL  acts  on  the  trophoblast  PRLr  during  placentation  and  mediates 
trophoblast  invasion  (Kowalewski  et  al.,  2011).  In  the  Western  spotted  skunk,  PRLr 
mRNA expression was localized in the uterine luminal and glandular epithelium as well 
as in the myometrium, where prolactin significantly increased uterine concentrations of 
LIF receptor type-β mRNA during pregnancy, suggesting a role in ending embryonic 
diapause and initiating embryonic development (Passavant et al., 2000). 
   
1.3.6.  Other important factors 
 
Cyclooxygenases  have  recently  been  implicated  in  canine  reproduction. 
Cyclooxygenase-2  (COX2)  enzyme  activates  prostaglandin  synthesis,  thereby 
contributing  to  canine  placental  maturation  during  gestation  and  placental  release  at 
parturition.  COX-2  mRNA  expression  is  localized  to  the  trophoblast  surrounding  the 
maternal vessels (Kowalewski et al., 2010) and in pre-implantation embryos (Schäfer-
Somi et al., 2008), suggesting prostaglandins may regulate embryonic and endometrial 
cytokine  activity.  Similarly  in  the  mink,  COX-2  expression  was  present  at  sites  of 
implantation at the feto-maternal interface, and it was proposed that endometrial COX-2 
expression  is  regulated  by  the  embryo  and  may  contribute  to  implantation  and   33 
placentation in the mink (Song et al., 1998). Prostaglandins are unsaturated fatty acids 
that behave as locally active hormones (Drazner, 1987). Expression of prostaglandin-F2α 
(PFG2α) and prostaglandin-E2 (PGE2) has also been reported in the canine placental 
sites (Kowalewski et al., 2010). It is believed that trophoblasts are the main targets of 
these  prostaglandins  and  are  therefore  controlled  by  prostaglandins.  The  mRNA 
expression of COX-1 in pre-implantation uterus was also detected (Schäfer-Somi et al., 
2008),  which  leads  to  prostaglandin  synthesis  that  may  regulate  embryonic  and 
endometrial cytokine activity.  
Peroxisome proliferator-activated receptor gamma (PPARγ) is known to modulate 
biochemical and morphological placental trophoblast differentiation during implantation 
and  placentation  (Schaiff  et  al.,  2000)  by  regulating  steroidogenic  capacity  of 
reproductive  tissues.  PPARγ  is  a  nuclear  hormone  receptor  of  the  PPAR  family  of 
transcription  factors closely related to  the steroid  hormone receptors serving multiple 
roles in regulating reproductive function (Komar, 2005). PPARγ mRNA expression has 
been localized in canine trophoblasts within the placenta (Kowalewski et al., 2011). The 
up-regulation of PPARγ mRNA after implantation into mid-gestation (Kowalewski et al., 
2011) suggests that this  factor may be involved in  trophoblast invasion.  In the mink 
(Mustela vision), PPARγ mRNA is also localized in the trophoblasts that directly contact 
the endometrium (Desmarais et al., 2007). Treatment with a prostaglandin, 15-deoxy-
delta 12, 14 (15-d-PGJ2) elicited an up-regulation in PPARγ mRNA (Desmarais et al., 
2007),  suggesting  that  prostaglandin  activity  acts  through  the  PPARγ  pathway.  Also,   34 
secretion  of  PGE2  was  detected  in  mink  embryos,  although  not  during  diapause 
(Desmarais et al., 2007). 
CDs are immune cell molecules that act as cell markers on immune cells, B and T 
lymphocytes. T lymphocytes (T cells) of the immune system are divided into CD-4+ T- 
cells and CD-8+ T-cells that have both regulatory and suppressive effects. Detectable 
mRNA expression of CD-8 and not CD-4 was found in the early pregnancy uterus of the 
bitch (Schäfer-Somi et al., 2008), suggesting a possible maternal inflammatory response 
to embryo implantation. 
 
1.4  ABNORMAL TROPHOBLAST INVASION AND PROLIFERATION 
 
1.4.1  Summary 
 
The  depth  of  trophoblast  invasion  in  the  initiation  of  implantation  and 
maintenance of pregnancy varies between species. Canine and feline trophoblasts invade 
into  the  maternal  endometrium  on  a  superficial  level.  In  contrast,  human  and  rodent 
trophoblasts are deeply invasive where they penetrate through the endometrium and into 
the myometrium to allow for endovascular remodeling during pregnancy (Hunkapiller 
and  Fisher,  2008).  Successful  implantation  requires  synchronization  of  cellular  and 
molecular interactions between trophoblasts and the maternal endometrium. Disruption of 
these  interactions  leads  to  development  of  placental  pathologies  from  excessive  or 
insufficient  trophoblast  proliferation  and  invasion.  Complications  in  trophoblast   35 
proliferation and invasion may not become apparent until later in pregnancy (Norwitz et 
al., 2001). Placenta-related pregnancy disorders affect about a third of human pregnancies 
(Wilcox et al., 1989). In the dog, pregnancy loss due to resorption was between 11-13% 
(Andersen and Simpson, 1973; Robertson et al., 1979). Embryo loss leading to stillbirth 
in dogs accounts for 2.2 to 4.5% incidence rate (Johnston and Raksil, 1987). Furthermore, 
peri-implantation failure accounts for nearly 80% of embryonic loss in farm animals 
(Roberts  et  al.,  1990).  The  incidence,  predisposing  factors,  etiopathophysiology, 
symptoms, diagnosis, and treatment of conditions caused from these pathologies will be 
discussed (Table 1.5). 
 
1.4.2.  Subinvolution of placental sites 
 
Subinvolution  of  placental  sites  (SIPs)  is  a  disorder  of  abnormal  trophoblast 
invasion  that  causes  a  failure  or  delay  of  normal  uterine  involution  in  pregnant  and 
postpartum bitches (Al-Bassum et al., 1981). The reported incidence of SIPs varies from 
21% (20 out of 95) (Al Bassam et al., 1981) to 100% (9 out of 9) (Orfanou et al., 2009).   
SIPS is most commonly seen in primiparous bitches under 3 years old following a normal 
delivery (Orfanou et al., 2009). The retention of placenta in SIPs can in some case s 
associate with mild uterine inertia or the inability to produce effective contractions due to 
uterine  dysfunction  (Macrae,  1949).  Predisposing  factors  to  this  placental  retention 
include obesity, calcium-zinc deficiency, hypoglycemia, hypocalcemia, dystocia, uterine 
inertia, uterine torsion, and history of abortion (Mshelia and Chaudhari, 2001).   
 
 
Table 1.5. A summary of conditions of abnormal and induced trophoblast physiology and placentation. 
  Conditions  Species Affected  Trophoblast Behavior Depth of Invasion   References 
  Subinvolution of  
  placental sites  
  H. sapiens, C. domesticus    ↑ Invasion    Glandular layer    Al-Bassum et al., 1981 
  Choriocarcinoma     H. sapiens, M. musculus,  
  C. domesticus   
  ↑ Invasion &  
  proliferation 
  Depends on species   Benirschke and Driscoll,  
  1967c; Soper, 2006 
  Retained placenta     B. taurus, E. caballus,     
  C. domesticus 
  ↑ Invasion    Uterine epithelium    Parer et al., 1968; Roberts, 1971;  
  Coleman et al., 1985; Laven and  
  Peters, 1996; Watts et al., 1997;  
  Sevinga et al., 2004  
  Placenta accreta vera     H. sapiens, primates    ↑ Invasion    Myometrium     Benirschke and Driscoll,  
  1967a; Miller et al., 1997 
  Placenta increta    H. sapiens, primates    ↑↑ Invasion    Myometrium     Benirschke and Driscoll,  
  1967a 
  Placenta percreta    H. sapiens, primates    ↑↑↑ Invasion    Serosa layer    Benirschke and Driscoll,  
  1967a 
  Hydatidiform mole    H. sapiens    ↓ Differentiation    Myometrium     Benirschke and Driscoll,  
  1967b; Bracken et al., 1984 
  Placental site    
  trophoblastic tumor 
  H. sapiens    ↑ Proliferation    Myometrium     Bower et al., 1996 
  Early pregnancy loss    All    ↓ Invasion    Uterine epithelium    Norwitz et al., 2001 
  Preeclampsia    H. sapiens, primates,  
  M. musculus 
  ↓ Invasion    Myometrium    Jauniaux et al., 2006; Zhou  
  et al., 1997 
  Deciduoma    M .musculus    ↑ Proliferation     N/A    Krehbiel, 1937 
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  Subinvolution  of  the  uteroplacental  arteries  of  the  placental  bed  was  also 
described in humans (Andrew et al., 1989). Non-involuted vessels were present in 22 of 
the 25 cases where extravillous trophoblast invaded normally into the myometrium and 
replaced the endothelial  cell lining of the vessel  walls,  leading to  a  failure in  vessel 
involution  resulting  in  postpartum  hemorrhaging  and  increased  maternal  morbidity 
(Andrew et al., 1989). 
The  etiopathophysiology  of  SIPs  is  not  clear.  The  evidence  supports  that  this 
condition involves retained trophoblasts (Al-Bassum et al., 1981) and placenta tags at the 
site of implantation. The uterus  continues to supply blood towards the placental tags 
resulting in the prolonged bleeding presented in SIPs. In normal bitches without SIPs, 
trophoblasts are evident in the loose connective tissue of the lamina propria two weeks 
postpartum (Al-Bassum et al., 1981). However in the bitches with SIPs, trophoblasts 
persist in the lamina propria and continue to invade abnormally deep into the glandular 
layer  of  the  endometrium  (Johnston  et  al.,  2001).  In  some  severe  cases  of  SIPs, 
trophoblast invasion is deeper into the myometrium and can penetrate the serosal surface. 
SIPs causes a delay in normal uterine involution that is usually completed by 12 weeks 
postpartum (Yeager and Concannon, 1990).  
The combination of excessive trophoblast invasion, damage to uterine vasculature 
due to this invasion, and failure of normal endometrial blood vessel thrombus formation 
causing secondary occlusion  result in  the symptoms  associated with  SIPs.  Symptoms 
include a bright red sanguineous discharge ranging to severe hemorrhage from the vulva 
(Al-Bassam et al., 1981; Olson and Hosted, 1984). The discharge persists until after the 38 
 
pups are weaned (up to 8 weeks postpartum) up until the next proestrus (Johnston et al., 
2001). Cases of the severe form of SIPs with extensive blood loss are rare (Johnston et 
al.,  2001).  The  chronic  form  of  SIPs  is  more  common  with  a  prolonged  discharge 
presenting in a healthy bitch (Johnston et al., 2001). 
Presumptive  diagnosis  of  SIPs  is  made  on  the  basis  of  signalment  and 
symptomology. Vaginal cytologic examination may reveal the presence of polynucleated, 
heavily  vacuolated  trophoblasts  (Reberg  et  al.,  1992;  Sontas  et  al.,  2011).  However, 
Orfanou and coworkers have reported that the presence of trophoblasts in vaginal smears 
for up to 84 days postpartum is normal (2009), which coincides with normal uterine 
involution (Al Bassam et al., 1981).  With transabdominal ultrasonography, the normal 
postpartum uterus is no longer distinguishable from the anestrous uterus by 15 weeks 
after whelping (Yeager and Concannon, 1990) therefore ultrasonography is not used to 
diagnose SIPs. Definitive diagnosis can only be made following uterine histopathology. 
Histologic diagnosis depends on extensive collagen sloughing on the placental site, with 
necrotic and hemorrhagic collagen masses, significant endometrial gland dilation, and/or 
presence of syncytiotrophoblast that invaded through the myometrium (Al-Bassum et al., 
1981). 
Treatment depends on the varying extent of hemorrhaging observed in the bitch. 
In a majority of the chronic cases, there is minimal discharge in an otherwise healthy 
bitch, which symptom resolves on its own (Schall et al., 1971; Johnston et al., 2001). 
Severe hemorrhaging requires surgery, commonly ovarian hysterectomy if the bitch is in 
good health and breeding is not an issue (Beck and McEntee, 1966). Other treatments 39 
 
include hysterolaparotomy or partial removal (curettage) of the affected endometrium to 
preserve the reproductive ability of valuable breeding bitches. Methods to specifically 
treat hemorrhaging include ergonovine injection of an ergot alkaloid that may reduce 
bleeding in late gestation and promote uterine involution (Adams and Flowers, 1960), or 
blood transfusion in cases of severe blood loss (Mshelia and Chaudhari, 2001). 
 
1.4.3.   Placenta accreta 
 
  Placenta accreta is a serious condition of abnormal adherence of the placenta to 
the uterus (Benirschke and Driscoll, 1967a) resulting in a high rate of human maternal 
morbidity (60%) and mortality (7%) (Hudon et al., 1998). This condition often leads to 
failure of placenta separation and delivery and postpartum hemorrhaging (Benirschke and 
Driscoll, 1967a). Fetal complications are also increased due to difficulties during labor 
leading  to  pre-term  delivery  of  small  for  gestational  age  babies,  with  50-80%  of 
deliveries requiring neonatal intensive care (Kent, 2009). The incidence varies from 1 in 
540 to 1 in 70,000 deliveries, with an average incidence of approximately 1 in 7000 of 
human births (Breen et al., 1977). It should be noted that the reported incidence depends 
upon how the condition is defined and diagnosed, which varies greatly between studies.  
Predisposing factors include history of a cesarean section or placenta previa, a 
condition in which the placenta forms in the lowest part of the uterus and occludes all or 
part of the cervix (Miller et al., 1997). Other risk factors include maternal age over 34 
year,  multiparity  (>  two  children)  or  having  multiple  grandchildren,  previous  uterine 40 
 
curettage,  submucous  myoma,  Asherman’s  syndrome,  smoking,  chronic  hypertension, 
and prior placenta accreta (Alanis et al., 2006; Sivan et al., 2010). 
  The  etiopathophysiology  of  placenta  accreta  is  unknown  but  the  general 
physiology  is  agreed.  Placenta  accreta  is  an  unusually  firm  adherence  of  placental 
(chorionic) villi to the uterus with an absence of the normally intervening decidua and 
fibrinoid  layers  of  the  uterine  epithelium  (Miller  et  al.,  1997).  Chorionic  villi  are 
trophoblastic  projections  formed  during  placentation,  where  fetal  capillaries  develop 
within  these  villi  to  carry  fetal  circulation.  The  placenta  forms  sinuses  (lacunae)  to 
surround the villi to carry the maternal circulation (Guyton and Hall, 2006). Placenta 
accreta has three variants: (1) placenta accreta vera, (2) placenta increta, and (3) placenta 
percreta. These variants are based on the depth of chorionic villi attachment and disease  
severity.  In  the  most  common  form,  placenta  accreta  vera,  the  placenta  is  attached 
(through chorionic villi) to the myometrium. Less common forms occur with placenta 
attachment  extending  into  the  myometrium  in  placenta  increta,  or  through  the  entire 
myometrial  layer  in  placenta  percreta  (Miller  et  al.,  1997).  In  placenta  percreta,  the 
urinary  bladder  may  become  eroded  by  trophoblasts,  greatly  increasing  maternal 
complications  (Washecka and Behling, 2002). Placenta percreta, although rare, is  the 
most severe form associated with excessive and possibly life-threatening hemorrhaging 
during  and  after  pregnancy  (Faranesh  et  al.,  2007),  and  the  symptoms  of  this  can 
resemble the severe form of SIPs in dogs. 
Two competing hypotheses of etiopathophysiology are supported:  (1) placenta 
accreta  involves  an  abnormal  uteroplacental  neovascularization  related  to  trophoblast 41 
 
invasion (Tseng et al., 2006) and/or (2) absent or defective uterine decidua (Earl et al., 
1987).  Immunohistochemistry identified an up-regulation of trophoblast-secreted growth, 
angiogenesis and invasion related factors in placenta accreta tissue (epidermal growth 
factor receptor (EFGR)) in syncytiotrophoblasts and up-regulation of vasculoendothelial 
growth  factor  (VEGF)  and  angiopoietin-2  (Ang-2)  levels  in  human  placental  lysates. 
EGFR is known to be involved in regulating trophoblast migration (Fitzgerald  et al., 
2005). VEGF is a known angiogenic factor expressed in trophoblasts that regulate protein 
and hormone secretion (De Vries et al., 1992). Ang-2 plays a role in angiogenesis, and in 
situ hybridization studies detected Ang-2 mRNA in the cytotrophoblast of first trimester 
placenta, suggesting a role with trophoblast activity during early embryonic development 
(Wulff  et  al.,  2002).  Alternatively,  it  was  determined  that  placenta  accreta  is  not  a 
condition  of  excessive  trophoblast  invasiveness  or  proliferation  because 
immunohistochemical  expression  of  trophoblast  cell  markers  (CK-7,  hCG,  human 
placental  lactogen  (hPL)  and  pregnancy-specific  β1-glycoprotein  (SP1))  in  placenta 
accreta tissues were identical to those in the normal term placenta (Earl et al., 1987). It 
was concluded by Earl and associates (1987) that the absence of decidua was a prominent 
characteristic of placenta accreta.  
  Several diagnostic methods may be implemented to provide definitive placenta 
accreta  diagnosis.  The  method  of  choice  for  presumptive  diagnosis  is  through 
transabdominal ultrasonagraphy (Alkazaleh et al., 2004), which can detect the condition 
as early as the first trimester (Alkazaleh et al., 2004). The gestational sac appears low-
lying and attaches to the uterine scar, in which the myometrium appears thinner than 42 
 
normal gestational sacs (Alkazaleh et al., 2004).  Follow-up imaging in the second and 
third  trimesters  is  recommended  for  verification.  Second  and  third  trimester  placenta 
characteristics can be detected with three-dimensional Doppler ultrasonagraphy, to be 
used  in  conjunction  with  antenatal  diagnosis  to  detect  distinctive  placenta  accreta 
architecture (numerous coherent vessels) (Shih et al., 2009). Magnetic resonance imaging 
(MRI) with intravenous gadolinium contrast dye can also be performed if the ultrasound 
findings are not definitive or if the placenta lies on the posterior uterine wall. Images 
detect abnormal findings, such as the placenta mass extending into the bladder, placental 
heterogeneity, abnormal placenta shape, absence of myometrium, or nodules within the 
placenta (Levine et al., 1997). Measuring elevated maternal serum biomarkers such as 
human chorionic gonadotropin and alpha fetoprotein is another technique for detection 
(Zelop et al., 1992). Definitive diagnosis is made histologically post-hysterectomy, where 
the chorionic villi are observed to be in direct contact with the myometrium and the 
decidua is absent (Benirschke and Driscoll, 1967a). 
  Recommended  treatment  for  placenta  accreta  is  immediate  hysterectomy  (also 
known as cesarean hysterectomy) after delivery without attempts to remove placenta to 
decrease  maternal  morbidity  and  mortality.  However,  this  method  leaves  the  woman 
sterile  (Clark  et  al.,  2008).  Conservative  management  of  placenta  accreta  through 
adjuvant methotrexate, selective arterial embolization, or intravascular balloon catheter 
can be effective and allow fertility preservation. Methotrexate has been proposed to speed 
up the postpartum involution of the placenta and therefore improve the success rate of 
conservative  treatment  (Oyelese  and  Smulian,  2006).  There  is  a  lack  of  evidence  to 43 
 
support the benefits of adjuvant methotrexate or selective arterial embolization treatments 
(Timmermans et al., 2007). Addition of a preoperative intravascular balloon catheter to 
treat  occlusion,  or  arterial  embolization  aids  in  the  reduction  of  blood  loss,  may  be 
utilized. The purpose of insertion of intravascular balloon catheters is to decrease blood 
flow to the uterus and thereby decrease blood loss. Balloon catheters are placed either as 
proximal as the aorta (Salim et al., 2010) or distally within the internal iliac arteries 
(Dubois et al., 1997). Similarly, arterial embolization is minimally invasive, and it is 
performed  by  locally  inducing  an  embolus  (blood  clot)  with  injection  of  polyvinyl 
alcohol (PVA) into the pelvic artery, causing fibroids (uterine growths of smooth muscle 
cells and fibrous connective tissue) within the circulation to stick to the vessel walls and 
form a clot. The blood supply is blocked and results in shrinking of the fibroids and 
reduction  or  complete  cessation  of  symptoms  (excessive  uterine  bleeding)  (Johns 
Hopkins University, 2013).  
 
1.4.4.  Early pregnancy loss (miscarriage)  
 
  Miscarriage is the spontaneous loss of a pregnancy before the fetus has reached 
viability,  including  pregnancy  losses  from  the  time  of  conception  until  24  weeks  of 
gestation  (Rai  and  Regan,  2006).  Miscarriages  can  be  sporadic  (isolated  losses)  or 
recurrent  (three  or  more  consecutive  losses)  (Stirrat,  1990).  The  incidence  of  early 
pregnancy loss at post-implantation is high in humans, estimated at 25 to 40 percent 
(Wilcox et al., 1988), but occurs at less than 10% in laboratory rodents (Wilmut et al., 44 
 
1986)  and  other  mammalian  species  (including  primates)  (Hassold,  1986).  Prominent 
predisposing factors for miscarriage include advancing maternal and paternal age (both 
maternal  and  paternal  age)  with  significant  increase  in  risk  after  35  years  (De  La 
Rochebrochard and Thonneau, 2002), and prior history of spontaneous abortion (Leridon, 
1976; Regan et al., 1989; Fretts et al., 1995; Andersen et al., 2000). Recent studies have 
included  obesity  (Lashen  et  al.,  2004)  as  well  as  maternal  consumption  of  tobacco, 
maternal  psychological  problems,  interval  between  pregnancies,  previous  use  of  the 
contraceptive pill (Risch et al., 1988; Dominguez et al., 1991) or paternal exposure to 
toxins (Lindbohm et al., 1991). 
Genetic  abnormalities  contribute  to  a  majority  of  early  pregnancy  losses 
(Simpson, 1980), estimating between 50-60% of all miscarriages are due to cyotgenic 
abnormalities (trisomy, polyploidy, monosomy X).  Other than genetic effects, there is 
often no known cause (Stirrat, 1990). With the complexity of early development, it is 
likely that other mechanisms during implantation and placentation contribute to early 
pregnancy loss (Norwitz et al., 2001; Jauniaux et al., 2006). In about two-thirds of early 
pregnancy failures, there is anatomical evidence of defective placentation (Burton et al., 
1999).  Mounting  evidence  supports  that  miscarriages  are  a  placentation  disorder  of 
oxidative stress that result in the chorionic villous changes (Jauniaux et al., 2006). Studies 
support that abnormal changes in villous blood flow result from a thinner and fragmented 
trophoblast layer, reduced cytotrophoblast invasion into the maternal endometrium, and 
incomplete plugging of the lumen at the tips of the spiral arteries established soon after 
implantation (Hustin and Schaaps, 1987; Burton et al., 1999). These characteristics are 45 
 
associated with the absence of spiral artery remodeling by trophoblasts and lead to a 
premature onset of the  maternal  circulation  throughout  the placenta. The presence of 
excessive maternal blood in the intervillous space throughout the placenta causes villous 
tissue to become trapped within large intervillous blood thrombi (blood clots), and also 
leads  to  O2-mediated  trophoblastic  damage  (oxidative  degeneration),  and  increased 
apoptosis due to the abnormally high or rapidly fluctuating concentrations of O2 harming 
the early villous tissue (Kokawa et al., 1998; Hempstock et al., 2003; Jauniaux et al., 
2003).  Ultimately,  this  results  in  placental  degeneration  with  complete  loss  of 
syncytiotrophoblast  function  and  detachment  of  the  placenta  from  the  uterine  wall 
(Hustin and Schaaps, 1987). Further, there is also evidence that levels and profiles of 
circulating cytokines in the decidua are different in women who experience recurrent 
miscarriages (Jenkins et al., 2000; Makhseed et al., 2000; Baxter et al., 2001), but the 
mechanism between cytokines and invading trophoblasts is not understood. 
Several symptoms characterize early pregnancy loss.  A majority of pregnancy 
loss occurs in the first trimester before 12 weeks of gestation and less than 5% occur after 
detection of fetal heart activity (Brigham et al., 1999). Loss in the second trimester (12 to 
24 weeks) occurs in below 4% of pregnancy outcomes (Ugwumadu et al., 2003). Early 
pregnancy loss can be categorized into two groups: (1) spontaneous abortions and (2) 
perinatal  deaths.  Both  involve  early  pregnancy  loss  of  the  conceptus  and  both  have 
overlapping  etiopathophysiolgoy  and  pre-disposing  factors  as  mentioned  above.  The 
groups differ in time of expression, where spontaneous abortions are pre-viable losses or 46 
 
stillbirths occurring during pregnancy, whereas perinatal death of the conceptus occurs 
soon after delivery (Benirschke and Driscoll, 1967a). 
Diagnosis of early pregnancy loss can be detected through ultrasound. After initial 
ultrasound identification of pregnancy, ultrasonagraphy will identify an absence of an 
identifiable pregnancy (fetal heartbeat, bone formation), in combination with a positive 
urine or serum human chorionic gonadotropin (HCG) pregnancy test. Miscarriage can be 
classified as early or late miscarriage (before or after 12 weeks). Mid-trimester loss seen 
in recurrent miscarriage has also been cited to be preceded by a diagnosis of cervical 
incompetence,  based  on  a  history  of  late  miscarriage  due  to  spontaneous  rupture  of 
membranes  or  painless  cervical  dilatation  (Drakeley  et  al.,  1998).  Treatment  of 
miscarriages  includes:  treatment  of  coexistent  thrombophilic  disorders,  bacterial 
vaginosis  infection,  hyperinsulinaemia  (insulin  resistance),  hyperprolactinaemia,  and 
cerclage with prophylactic antibiotics (Rai and Regan, 2006).  
 
1.4.5.   Preeclampsia  
 
  Preeclampsia is a lesser dysfunction of shallow invasion of trophoblasts compared 
to miscarriage. In preeclampsia, trophoblast invasion is insufficient to completely convert 
the  spiral  arteries  into  low-resistance  vessels  (Jauniaux  et  al.,  2006).  This  shallow 
trophoblast condition occurs predominantly in humans, although symptoms associated 
with preeclampsia (hypertension and/or proteinuria) have also spontaneously occured in 
patas monkeys (Palmer et al., 1979) and guinea pigs (Seidl et al., 1979). Preeclampsia is 47 
 
one  of  the  most  common  diseases  of  human  pregnancy,  affecting  5–8%  of  pregnant 
women (Saftlas et al., 1990), accounting for nearly 18% maternal deaths in the United 
States (American College of Obstetricians and Gynecologists, 2004). Preeclampsia is also 
a  leading  cause  of  pre-term  delivery  and  infants  who  are  small  for  gestational  age, 
increasing perinatal mortality by five-fold (Norwitz et al., 2001).  
Predisposing factors for preeclampsia include maternal health disposition as well 
as personal and family history. Factors with significant association with preeclampsia 
include: maternal age, maternal birth weight/BMI, primiparity, multiple pregnancy, more 
than 10 years between pregnancies, underlying renal disease or chronic hypertension, 
mean  arterial  blood  pressure,  personal  history  of  preeclampsia,  family  history  of 
preeclampsia and family history of coronary heart disease (Sibai et al., 1995).   
The cause of preeclampsia is unknown, though it is generally believed that the 
condition  is  associated  with  impaired,  shallow  extravillous  interstitial  trophoblast 
invasion  and  limited  endovascular  trophoblast  invasion.  Zhou  and  associates  (1997) 
observed  that  preeclamptic  extravillous  trophoblast  failed  to  express  endothelial 
phenotypic markers (cadherins, VECAM-2, integrins) within uterine vessels. This failure 
to acquire the vascular phenotype of adhesion molecules impairs trophoblast invasion, 
resulting in high-resistance uterine arteries that cannot respond to the increasing fetal 
demands for blood flow (Zhou et al., 1997). The reduced blood supply to the fetus leads 
to  fetal  prematurity,  fetal  growth  restriction,  and  stillbirth  (Moffett  and  Loke,  2006). 
Another competing hypothesis suggests that preeclampsia is a multifactorial condition of 
the maladaptation and impaired invasion of uteroplacental arteries resulting from both 48 
 
trophoblast dysfunction and abnormal expression of maternal uterine factors involved 
with uteroplacental arteries (Kaufmann et al., 2003).  
Symptoms  associated  with  shallow  trophoblast  invasion  are  presented  as 
hypertension (blood pressure greater than 140 mmHg) or high diastolic blood pressure 
(greater than 90 mmHg), with elevated protein levels in urine (proteinuria) with greater 
than  300  mg  to  characterize  the  mild  form  of  preeclampsia.  Severe  preeclampsia 
symptoms are more even higher levels of blood pressure and proteinuria, and sometimes 
organ dysfunction (American College of Obstetricians and Gynecologists, 2004).  
  Initial diagnosis of preeclampsia includes evaluation of medical history, physical 
examination, and laboratory testing (Wagner, 2004). A complete history should be taken 
to  assess  increased  risk  for  preeclampsia,  such  as  diabetes  mellitus,  hypertension, 
vascular  and  connective  tissue  disease,  nephropathy,  and  antiphospholipid  antibody 
syndrome. Physical exams measure blood pressure and fundal height because size less 
than  dates  may  indicate  intrauterine  growth  retardation  sometimes  associated  with 
preeclampsia. Laboratory tests include a hepatic enzyme level, a platelet count, a serum 
creatinine  level,  and  urine  collection  for  protein  levels  (Wagner,  2004).  Definitive 
diagnosis  is  made  histologically  after  vaginal  delivery  or  c-section,  where  limited 
trophoblast invasion is detected (Zhou et al., 1997).  
Delivery of the placenta is the ultimate treatment for preeclampsia to fully resolve 
the condition  (American College of Obstetricians  and Gynecologists,  2004). Delivery 
may need to occur before a viable fetus can be delivered if the mother’s life is threatened. 
To treat severe preeclampsia, magnesium sulfate is used to prevent eclamptic seizures 49 
 
(Witlin  and  Sibai,  1998).  Further  treatments  under  investigation  for  prevention  of 
preeclampsia include aspirin (Sibai, 2003), calcium (Atallah et al., 2004), and antioxidant 
supplementation (Chappell et al., 1999).  
 
1.4.6.  Hydatidiform mole 
 
  Hydatidiform  mole,  also  referred  to  as  molar  pregnancy,  is  a  disease  of  the 
trophoblast causing placental lesions. Morphologically, hydatidiform moles are abnormal 
placentas  with  swollen  and  vesicular  villi  formation,  producing  grape-like  cysts 
(hydatidiforms) throughout the placenta, replacing the placental tissue. These masses are 
distorted villi formed into chains and clusters of vesicular structures filled with fluid and 
connected by branching stalks (Benirschke and Driscoll, 1967b). Histologically, there is 
hydropic expansion of the vilous stroma (edema, cystic degeneration) with abnormally 
actively hyperplastic trophoblast proliferation. The villous clusters cause swelling of the 
villous branches interconnecting the clusters, where increased trophoblast proliferation 
produces increased masses of syncytiotrophoblast and cytotrophoblasts (Benirschke and 
Driscoll, 1967b). The swollen villi often contain necrotic trophoblasts. 
  Hydatidiform  moles  are  part  of  a  group  of  gestational  trophoblastic  diseases 
(GTDs) to include choriocarcinoma and placental site trophoblastic tumors. GTDs are 
unique because they represent semiallografts, which are conditions derived from the fetus 
and  expressed  in  the  mother  (Shih  and  Kurman,  2002).  The  relation  between  molar 
pregnancy and choriocarcinoma is unclear, where it may be confused whether they are 50 
 
separate diseases or a continuation of the same disease. Hydatidiform mole is the major 
risk factor for choriocarcinoma (Bracken  et  al., 1984), where the incidence of molar 
pregnancy advancing into an invasive mole (choriocarcinoma) is 7 - 17% (Ichinoe, 1979), 
although both have distinct biological characteristics. The incidence of molar pregnancy 
in the United States is 1 in 923 pregnancies (Hayashi et al., 1982). Accurate rates of 
molar  pregnancies  are  difficult  to  obtain  because  86%  of  spontaneous  abortions 
(miscarriages)  were  determined  to  be  hydatidiform  mole  with  triploidy  cytogenetic 
makeup (Szulman et al., 1981). 
  Pre-disposing factors increasing the risk of molar pregnancy include women born 
outside North America, maternal age (greater than 30 years), and mothers who followed 
diets deficient in carotene (Berkowitz et al., 1985). Geographic distribution is a major 
factor, where incidences of molar pregnancy occur at much higher rate in Indonesia (11.5 
per 1,000 deliveries) (Poen and Djojopranoto, 1965) than the United States (1 per 923 
deliveries) (Hayashi et al., 1982). 
Hydatidiform mole is classified into two morphological categories: (1) complete 
(CHM) or (2) partial hydatidiform mole (PHM). In normal pregnancy, as the placenta 
develops  from  the  trophoblast,  the  chorionic  villi  develop.  Chorionic  villi  are  the 
functional and structural region of the placenta that develops within the lacunar spaces 
among the syncytiotrophoblast (Kovacs and Ojeda, 2012). In molar pregnancy, chorionic 
villi are unable to undergo vascularization to develop into secondary or tertiary villi, 
rather, the villi become cystic and become filled with fluid, to form small grape-like 
hydatidiform  structures  (Soper,  2006;  Kovacs  and  Ojeda,  2012).  Complete  molar 51 
 
pregnancy  is  usually  46XX  genetic  composition  and  involves  a  conceptus  where  all 
chorionic  villi  are  abnormal  with  cyst-like  swelling  of  chorionic  villi  and  fluid 
accumulation in the mesenchymal layer with absence of an embryo, umbilical cord, or 
amniotic  membranes.  Partial  molar  pregnancy  is  usually  a  triploidy  chromosomal 
constitution and has some normal chorionic villi with fetal vasculature and presence of a 
fetus, umbilical cord, and amniotic membranes (Vassilakos et al., 1977).  
The genetic etiopathophysiology of molar development is unclear, although some 
aspects are agreed. More than 80% of hydatidiform moles are female (Vassilakos et al., 
1977),  therefore  the  androgenetic  46XX  karyotype  contributing  to  complete  molar 
pregnancy has three possible modes of fertilization: (1) dispermy, (2) diploid sperm, or 
(3)  fertilization  with  a  normal  haploid  spermatozoan  that  replicates  in  the  ovum  to 
produce 46XX diploidy (Bracken et al., 1984). Molar tissue has a 46, XX karyotype 
derived from the father that represents the reduplication of the sperm’s haploid genome 
and the absence of the maternal chromosome complement. With this condition, the fetal 
development and vasculature is absent because the fetus resorbs before the circulatory 
system develops. Partial moles have predominantly triploidy chromosome constitution 
and are almost always dispermic (Bracken et al., 1984). 
Symptoms  of  molar  pregnancy  include  painless  vaginal  bleeding  (spotting  to 
profuse  hemorrhage),  uterine  enlargement  greater  than  expected  for  gestational  age, 
hyperemesis, and hypertension (Soper, 2006).  CHM are usually diagnosed in the first 
half  of  pregnancy  via  transabdominal  ultrasonography  in  combination  with  increased 
hCG for gestational age.  52 
 
  Hydatidiform mole is diagnosed by transabdominal ultrasonography (Kohorn and 
Blackwell,  1968).  Detection  of  major  clinical  signs  include  a  enlarged  uterus  with 
absence of fetus and fetal heartbeat. Additionally, high levels of hCG in the blood or 
urine is indicative of the condition. Delivery of the placenta and histological examination 
(presence of enlarged, cyst-like villi with/without fetus) allows for definitive diagnosis. 
Before ultrasound was developed for diagnosis, moles were often spontaneously aborted, 
which led to extensive maternal hemorrhage (Benirschke and Driscoll, 1967b).    
Treatment  for  CHM  (complete  hydatidiform  mole)  requires  dilation  and 
evacuation  of  the  placenta.  Hysterectomy  and  labor  induction  are  not  recommended 
because they promote increased blood loss and may predispose towards choriocarcinoma 
or placental site trophoblastic tumors following treatment (Soper, 2006). 
 
1.4.7.  Choriocarcinoma 
 
  Choriocarcinoma  is  another  disease  of  the  trophoblast  that  produces  a  highly 
malignant  tumor  arising  from  chorionic  epithelium  during  pregnancy  formed  by 
excessive proliferation of syncytiotrophoblast and cytotrophoblast without chorionic villi 
(Soper, 2006). Nongestational choriocarcinoma occurs in which tumors can arise from 
gonads  or  extragonadal  embryonic  rest  cells  (Bracken  et  al.,  1984).  Pathologically, 
choriocarcinoma is characterized with malignant syncytiotrophoblasts with the absence 
of chorionic villi and where syncytiotrophoblasts have invaded through the endometrium 
and into the myometrium (Brewer et al., 1978), though invasion can also metastasize to 53 
 
any  site  in  the  body  (metastasis  commonly  described  in  the  liver,  brain  and  lung) 
(Bracken et al., 1984). Choriocarcinomas often develop early systemic metastases to the 
nervous  system  and  lungs.  Abnormal  bleeding  occurs  at  the  metastatic  sites. 
Choriocarcinoma has  been described in  humans (Novak, 1950), rodents (spontaneous 
choriocarcinoma)  (Pirak  et  al.,  1991)  and  dogs  (primary  gastric  choriocarcinoma) 
(Poutahidis  et  al.,  2008).  Incidence  rates  of  choriocarcinoma  vary  between  countries 
where it is as low as 1 in 40,000 pregnancies in America (Hertig and Mansell, 1956) or 1 
in 500 pregnancies in the Philippines (Acosta-Sison, 1964). 
The main predisposing factor is hydatidiform mole, where in Japan 80% of moles 
progressed  to  choriocarcinoma  (Tomoda,  1979).  Other  factors  are  Asian,  African  or 
Central American descent, advanced maternal age above 40 years, multiparity, and prior 
history of abortion (Bracken et al., 1984). 
The  etiopathophysiology  of  choriocarcinoma  is  not  well  described.  However, 
evidence  supports  that  the  complete  evacuation  of  molar  pregnancy  may  lead  to 
subsequent choriocarcinoma (Stone and Bagshawe, 1979). A study found that there was 
lower  incidence  of  persistent  trophoblast  invasion  when  the  pregnancy  was  removed 
through curettage or vacuum aspiration rather than hysterectomy or hysterotomy (Stone 
and  Bagshawe,  1979).  This  hypothesis  of  excessive  trophoblast  invasion  through  the 
myometrium and even metastasizing into surrounding tissues, is similar to SIPs where the 
remaining placental tags after parturition lead to trophoblasts invading abnormally deep 
into the glandular tissue.  
Symptoms of choriocarcinoma include vaginal bleeding occurring after pregnancy 54 
 
and uterine subinvolution (Benirschke and Driscoll, 1967c). Also, spontaneous uterine 
rupture and invasion of adjacent tissues and organs are normal sequelae of this condition 
(Wilson et al., 1965). These symptoms may be comparable to SIPs in dogs.  
Measurement of a serum hCG and exclusion of normal pregnancy are all that are 
required to diagnose choriocarcinoma because of the hCG-producing tumors distinct to 
the condition (Soper, 2006).   
Treatments  after  diagnosis,  include  chemotherapy  with  primarily  methotrexate 
(antimetabolite drug that inhibits proliferation of carcinoma cells) (Kim et al., 1986) or 
follow-up  treatment  of  dactinomycin  (antibiotic  that  inhibits/stops  proliferation  of 
carcinoma  cells)  (Limpongsanurak,  2001)  in  high  risk  molar  pregnancies  leads  to  a 
reduction of choriocarcinoma rates. These malignancies are highly responsive and it is 
often possible to cure them while preserving the woman’s reproductive function (Soper et 
al.,  1996).  The  majority  of  women  (93%)  are  able  to  successfully  conceive  after 
chemotherapy (Hertz et al., 1964). 
 
1.4.8.  Placental Site Trophoblastic Tumor 
 
  Placental  site  trophoblastic  tumors  (PSTT)  are  rare  tumors  of  the  trophoblast.  
Histologically,  this  condition  is  presented  as  a  cytotrophoblast  proliferation  and 
differentiation, relatively low hCG levels, little or no syncytiotrophoblast, and complete 
absence of chorionic villi within the tumor (Chang et al., 1999). PSTT can occur locally 
then spread via the lymphatics (Bower et al., 1996). Although PSTT occurs at a much 55 
 
lower  incidence  (1.2%  of  pregnancies  (Dunn,  1959))  than  hydatidiform  mole  or 
gestational choriocarcinoma, PSTT can develop after any type of pregnancy (normal or 
molar pregnancy and abortion) (Soper, 2006) and has malignant potential (Twiggs et al., 
1981).  
Pre-disposing factors for PSTT are widely varied, though a common factor is an 
extended interval between the prior pregnancy and the presentation or diagnosis of PSTT. 
Intervals vary between 12 months to 15 years, with a median of 24 months, but this 
prolonged  interval  between  pregnancy  and  diagnosis  has  been  supported  by  several 
studies (Bower et al., 1996; Finkler et al., 1988; How et al., 1995).  
Etiopathophysiology  of  PSTT  is  not  well  described,  although  a  recent  study 
supports the genetic origin of this condition (Oldt et al., 2002). The origin of PSTT has 
been localized to  the extravillous  trophoblast in a recent  study of molecular genetics 
(Oldt  et  al.,  2002).  This  study  confirmed  that  the  paternal  contribution  of  the  Y 
chromosome and paternal alleles contribute to  PSTT, therefore it was concluded that 
PSTT  has  a  trophoblast  origin.  Also,  immunohistochemical  studies  detected  a  strong 
expression of HLA-G (human trophoblast marker) in extravillous trophoblast and fetal 
thymus to further suggest that PSTT is derived from extravillous trophoblast (Singer et 
al., 2002). Histologically, tumor cells of PSTT express the same markers and share a 
similar phenotype to extravillous trophoblasts in the implantation site, where their pattern 
of  invasion  into  the  myometrium  in  PSTT  is  similar  to  that  of  normal  extravillous 
trophoblast  (Shih  and  Kurman,  2002).  These  recent  findings  support  the  notion  that 56 
 
dysfunctional  cytotrophoblast  behavior  may  lead  to  maldevelopment  of 
syncytiotrophoblast and chorionic villi in the placenta. 
Presentation of this condition varies among individuals.  Common symptoms of 
PSTT are abnormal vaginal bleeding with or without amenorrhea (loss of menstruation) 
(Bower et al., 1996). 
Diagnosis can be performed with tumor biopsy, although the results are variable 
depending upon site of sample origin. With the biopsied tumor samples, PSTT shows a 
typical  immunohistochemical  staining  of  high  proportion  of  hPL-positive  cells  and 
relatively few positive for hCG (Kurman et al., 1984). With very low hCG levels secreted 
by these tumors, hCG testing is not a reliable method of diagnosis (Gillespie et al., 2000). 
Unlike  choriocarcinomas,  PSTT  are  not  sensitive  to  chemotherapy.  Since  the 
tumors  are  usually  confined  to  the  uterus,  hysterectomy  is  the  preferred  method  of 
treatment  (Soper, 2006). The cure rate for low-risk, non-metastatic PSTT approaches 
100% (American College of Obstetricians and Gynecologists, 2004) with recurrence rates 
less than 5% (Mutch et al., 1990).  
 
1.4.9.  Other Conditions of the Placenta 
 
A number of additional conditions of placentation occur in the literature, however  
retained placenta and deciduoma are two which will be discussed in brief. 
  Retained  placenta  has  been  described  in  bovine  as  the  failure  of  placenta 
expulsion  12  hours  postpartum  (Roberts,  1971)  and  may  result  in  systemic  illness, 57 
 
metritis, and infertility (Coleman et al., 1985). This condition has been described most 
commonly  in  bovine  (Laven  and  Peters,  1996),  as  dogs  (Watts  et  al.,  1997),  horses 
(Sevinga et al., 2004), and rhesus monkeys (Parer et al., 1968). In a study of nearly 7,400 
calvings,  10%  presented  with  retained  placenta  (Moller  et  al.,  1967).  Several 
predisposing  factors  including  age,  species,  heredity,  environment,  hormones,  and 
nutrition  have  been  suggested  as  causes  of  RP  (Hurley  and  Doane,  1989),  although 
evidence  is  conflicting.  The  etiopathophysiology  of  retained  placenta  is  unknown, 
however, the common physiology of this condition includes failure of the villi of the fetal 
cotyledons (fetal portion of the placenta) to separate from the crypts of the maternal 
caruncle  (maternal  portion  of  the  placenta)  at  the  placenta  attachment  sites  (Roberts, 
1971). Studies support a link between the decreased leukocyte chemotaxis towards the 
maternal  cotyledon, where leukocytes obtained from cows with retained placenta were 
less  able  to  recognize  cotyledon  tissue  in  a  chemotaxis  assay  than  leukocytes  from 
normal cows (Gunnink, 1984). This study concluded that retained placenta is a condition 
resulting  from  a  failure  of  maternal  recognition  of  the  fetus,  resulting  in  a  maternal 
immunological attack on the fetal placenta as a foreign body. The failure or placental 
expulsion  may  be  comparable  to  placenta  accreta  in  humans  involving  the  abnormal 
adhesion of placenta to the uterine wall. Symptoms are presented during parturition, to 
include dystocia and metritis (Roberts, 1971). Diagnosis of retained placenta involves 
evaluating  the  prior  history  of  metritis,  endometritis  and  pyometra,  which  have  been 
associated  with  retained  placenta,  as  well  as  dystocia  and  abortion  (Tennant  and 
Peddicord, 1968). Treatment methods include monitoring of appetite, milk production, 58 
 
and/or  daily  rectal  temperature  readings  postpartum,  intramuscular 
penicillin/streptomycin  injection  for  temperatures  exceeding  39°C.  Treatment  by  the 
veterinarian  was  given  for  cows  showing  signs  of  systemic  illness  and  parenteral 
antibiotics were given primarily before manual removal of placenta (Sandals et al., 1979). 
  Deciduoma  is  an  induced  condition  characterized  by  a  decidual  response  of 
massive decidual cell proliferation and development-induced mechanical stimulation to 
produce  uterine  progesterone  in  the  absence  of  fertilized  ova  (De  Feo,  1963).  This 
endometrial response can be used as a tool to investigate factors involved in the decidual 
response to blastocyst implantation because it is histologically and hormonally similar to 
implantation  (Krehbiel,  1937)  and  the  subsequent  decidualization  (transformation  of 
uterine mucosa into decidua) seen in humans and rodents with hemochorial placentation. 
Deciduoma has been described in rodents (Finn and Keen, 1963) and canines (Nomura, 
1994). Shelesnyak (1952) was the first to observe that histamine injection into the uterine 
lumen  initiated  deciduoma  in  rats.  Another  study  observed  a  significant  initiation  of 
deciduoma in response to intrauterine injections of oils, sulphated polysaccharides, agar, 
carrageenin, and heparin. These are involved in tissue formation, repair and remodeling 
(Finn  and  Keen,  1963).  In  a  study  by  Nomura  (1994),  canine  deciduoma  could  be 
induced by adding a silk suture into the left uterine lumen during the functional luteal 
stage (early to mid-diestrus) and not the regressive stage. It was proposed that deciduoma 
is dependent on the corpora lutea as seen in rodents. Therefore, it can be proposed that 
the  corpora  lutea  is  involved  in  decidualization  and  preparation  of  the  uterus  for 
implantation and pregnancy.  59 
 
1.4.10. Conclusion  
   
Conditions resulting from excessive trophoblast invasion occur in dogs (SIPs) and 
humans (placenta accreta, choriocarcinoma), where conditions resulting from insufficient 
trophoblast invasion (miscarriage, preeclampsia) or excessive trophoblast proliferation 
(hydatidiform mole, choriocarcinoma, PSTT) have been described in humans, rats and 
dogs. SIPs (canines) and choriocarcinoma (humans) as well as retained placenta (bovine, 
canine,  equine,  murine)  and  placenta  accreta  (humans)  share  similar  symptomatic 
presentation and possibly similar etiopathophysiology, suggesting that these trophoblast 
conditions  can  be  translated  among  species.  Each  condition  can  lead  to  maternal 
morbidity and mortality, although some are more life-threatening than others. Finding 
animal  models  or  in  vitro  methods  to  investigate  these  pathologies  is  essential  for 
developing preventative strategies.  
 
 
   60 
 
1.5  REFERENCES 
 
Acosta-Sison, H., 1964. Changing attitudes in the management of hydatidiform mole. Am 
J Obstet Gynecol 88, 634-636. 
Adams, H., Flowers Jr., C., 1960. Oral oxytocic drugs in the puerperium. Obstet Gynecol 
15, 280-283. 
Aladjem, S.,  Lueck, J., 1981. Morphologic characteristics of the normal  term  human 
trophoblast maintained in prolonged in vitro cultures. Brit J Obs Gyn 88, 287-293. 
Alanis, M., Hurst, B., Marshburn, P., Matthews, M., 2006. Conservative management of 
placenta increta with selective arterial embolization preserves future fertility and 
results in a favorable outcome in subsequent pregnancies. Fertil Steril 86, 1514e3-
7.  
Al-Bassam,  M.,  Thomson,  R.,  O'Donnell,  L.,  1981.  Involution  abnormalities  in  the 
postpartum uterus of the bitch. Vet Pathol Online 18, 208-218. 
Alkazaleh, F., Geary, M., Kachura, J., Windrim, R., 2004. Elective non-removal of the 
placenta and prophylactic uterine artery embolization postpartum as a diagnostic 
imaging approach for the management of placenta percreta: a case report. JOGC 
26, 743. 
American College of Obstetricians and Gynecologists, 2004. Diagnosis and treatment of 
gestational trophoblastic disease. ACOG Practice Bulletin No. 53. Obstet Gynecol 
103, 1365-77. 61 
 
Andersen,  D.,  1927.  The  rate  of  passage  of  the  mammalian  ovum  through  various 
portions of the fallopian tube. Am J Physio 82, 557-569. 
Andersen, A., Simpson, M., 1973. Introduction. In: The ovary and reproductive cycle of 
the dog (Beagle). Los Altos, CA: Geron-X, 11. 
Andersen, A., Wohlfahrt, J., Christens, P., Olsen, J., Melbye, M., 2000. Maternal age and 
fetal loss: population based register linkage study. Br Med J 320, 1708-1712. 
Andrew, A., Bulmer, J., Wells, M., Morrison, L., Buckley, C., 1989. Subinvolution of the 
uteroplacental arteries in the human placental bed. Histopathology 15, 395-405. 
Arici, A., Engin, O., Attar, E., Olive, D., 1995. Modulation of leukemia inhibitory factor 
gene  expression  and  protein  biosynthesis  in  human  endometrium.  J  Clin 
Endocrinol Metab 80, 1908-1915. 
Atallah, A., Hofmeyr, G., Duley, L., 2004. Calcium supplementation during pregnancy 
for preventing hypertensive disorders and related problems. Cochrane Database 
Syst Rev 2, CD001059. 
Austin, C., 1969. Fertilization and development of the egg. In: Cole, H. and Cupps, P., 
eds, Reproduction in Domestic Animals. 2
nd ed.  NY:Academic Press, 355-384. 
Barrau,  M.,  Abel,  J.,  Torbit,  C.,  Tietz,  W.,  1975.  Development  of  the  implantation 
chamber in the pregnant bitch. Am J Anat 143, 115-129. 
Baxter, N., Sumiya, M., Cheng, S., Erlich, H., Regan, L., Simons, A., Summerfield, J., 
2001. Recurrent miscarriage and variant alleles of mannose binding lectin, tumour 
necrosis factor and lymphotoxin α genes. Clin Exp Immunol 126, 529-534. 62 
 
BD Biosciences, 2011. BD Matrigel matrix: Frequently Asked Questions. Retrieved on 
March  30,  2013  from  http://www.bdbiosciences.com/documents/BD_ 
CellCulture_Matrigel_FAQ.pdf 
Beceriklisoy, H. B., Walter, I., Schäfer‐Somi, S., Miller, I., Kanca, H., Izgür, H., Aslan, 
S., 2007. Matrix Metalloproteinase (MMP)‐2 and MMP‐9 activity in the canine 
uterus before and during placentation. Reprod Domest Anim 42, 654-659. 
Beceriklisoy, H., Schäfer‐Somi, S., Kücükaslan, I., Agaoglu, R., Gültiken, N., Ay, S., 
Aslan,  S.,  2009.  Cytokines,  growth  factors  and  prostaglandin  synthesis  in  the 
uterus of pregnant and non‐pregnant bitches: the features of placental sites. Repro 
Domest Anim 44, 115-119.  
Beck, A., McEntee, K., 1966. Subinvolution of placental sites in a postpartum bitch. A 
case report. Cornell Vet 56, 269-277. 
Benirschke, K., Driscoll, S., 1967a. Unusual shapes of the placenta. Placenta accreta. In: 
The Pathology of the Human Placenta. NY: Springer-Verlag, 10-38. 
Benirschke, K., Driscoll, S., 1967b. Hydatidiform mole. In: The Pathology of the Human 
Placenta. NY: Springer-Verlag, 348-380. 
Benirschke, K., Driscoll, S., 1967c. Tumors of the placenta. In: The Pathology of the 
Human Placenta. NY: Springer-Verlag, 381-430. 
Berg, D., Smith, C., Pearton, D., Wells, D., Broadhurst, R., Donnison, M., Pfeffer, P., 
2011. Trophectoderm lineage determination in cattle. Dev Cell 20, 244-255. 63 
 
Berkowitz, R., Cramer, D., Bernstein, M., Cassells, S., Driscoll, S., Goldstein, D., 1985. 
Risk  factors  for  complete  molar  pregnancy  from  a  case-control  study.  Am  J 
Obstet Gynecol 152, 1016. 
Bischof,  P.,  Meisser,  A.,  Campana,  A.,  2000.  Paracrine  and  autocrine  regulators  of 
trophoblast invasion—a review. Placenta, 21, S55-S60. 
Bower, M., Paradinas, F., Fisher, R., 1996. Placental site trophoblastic tumour: molecular 
analysis and clinical experience. Clin Cancer Res 2, 897-902. 
Boyden,  S.,  1962.  The  chemotactic  effect  of  mixtures  of  antibody  and  antigen  on 
polymorphonuclear leucocytes. J Exp Med 115, 453-466. 
Bracken, M.B., Brinton, L.A., Hayashi, K., 1984. Epidemiology of hydatidiform mole 
and choriocarcinoma. Epid Rev 6, 52-75. 
Brigham,S.,  Conlon,  C.,  Farquharson,  R.,  1999.  A  longitudinal  study  of  pregnancy 
outcome following idiopathic recurring miscarriage. Hum Reprod 14, 2868-2871. 
Breen, J., Neubecker, R., Gregori, C., Franklin, J., 1977. Placenta accreta, increta, and 
percreta. Obstet Gynecol 49, 43-7. 
Brewer,  J.,  Torok,  E.,  Kahan,  B.,  Stanhope,  C.,  Halpern,  B.,  1978.  Gestational 
trophoblastic  disease:  origin  of  choriocarcinoma,  invasive  mole  and 
choriocarcinoma  associated  with  hydatidiform  mole,  and  some  immunologic 
aspects. Adv Cancer Res 27, 89-147.  
Burton, G., Jauniaux, E., Watson, A., 1999. Maternal arterial connections to the placental 
intervillous  space  during  the  first  trimester  of  human  pregnancy:  the  Boyd 
collection revisited. Am J Obstet Gynecol 181, 718-724. 64 
 
Carmichael, J., DeGraff, W., Gazdar, A., Minna, J., Mitchell, J., 1987. Evaluation of a 
tetrazolium-based  semiautomated  colorimetric  assay:  assessment  of 
chemosensitivity testing. Cancer Res 47, 936-942.  
Chang, Y., Chang, T., Hsueh, S., Huang, K., Wang, P., Liu, H., 1999. Prognostic factors 
and treatment for placental site trophoblastic tumor-report of 3 cases and analysis 
of 88 cases. Gynecol Oncol 73, 216-22. 
Chappell,  L.,  Seed,  P.,  Briley,  A.,  Kelly,  F.,  Lee,  R.,  Hunt,  B.,  1999.  Effect  of 
antioxidants  on the occurrence of preeclampsia in  women at  increased risk:  a 
randomised trial. Lancet 354, 810-816. 
Clark, S., Belfort, M., Dildy, G., Herbst, M., Meyers, J., Hankins, G., 2008. Maternal 
death  in  the  21st  century:  causes,  prevention,  and  relationship  to  cesarean 
delivery. Am J Obstet Gynecol 199, 36e1-5. 
Coleman, D., Thane, W., Dailey, R., 1985. Factors affecting reproductive performance of 
dairy cows. J Dairy Sci 68, 1793-1803. 
Concannon, P., McCann, J., Temple, M., 1988. Biology and endocrinology of ovulation, 
pregnancy and parturition in the dog. J Rep Fer S 39, 3-25. 
Concannon, P., Gimpel, T., Newton, L., Castracane, V., 1996. Postimplantation increase 
in  plasma  ﬁbrinogen  concentration  with  increase  in  relaxin  concentration  in 
pregnant dogs. Am J Vet Res 57, 1382-1385.  
Conner, J., Eckersall, P., Ferguson, J., Douglas, T., 1988. Acute phase response in the 
dog following surgical trauma. Res Vet Sci 45, 107-110.  65 
 
De Feo, V., 1963. Determination of the sensitive period for the induction of deciduomata 
in the rat by different inducing procedures. Endocrinology 73, 488-497.  
De La Rochebrochard, E., Thonneau, P., 2002. Paternal age and maternal age are risk 
factors for miscarriage; results of a multicentre European study. Hum Reprod 17, 
1649-1656. 
De Vries, C. Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T., 1992. 
The  fms-like  tyrosine  kinase,  a  receptor  for  vascular  endothelial  growth 
factor. Science 255(5047), 989-991. 
Desmarais,  J.,  Lopes,  F.,  Zhang,  H.,  Das,  S.,  Murphy,  B.,  2007.  The  peroxisome 
proliferator-activated receptor gamma regulates trophoblast cell differentiation in 
mink (mustela vison). Biol Reprod 77, 829-839. 
Dojindo, 2012. Cell counting kit-8: cell proliferation and cytotoxicity assay. Technical 
manual.  Retrieved  on  March  30,  2013  from 
http://www.dojindo.com/TechnicalManual/Manual_CK04.pdf. 
Dominguez,  V.,  Calle,  E.,  Ortega,  P.,  1991.  Adjusting  risk  factors  in  spontaneous 
abortion by multiple logistic regression. Eur J Epidemiol 7, 171-174. 
Drakeley,  A.,  Quenby,  S.,  Farquharson,  R.,  1998.  Mid-trimester  loss-  appraisal  of  a 
screening approach. Hum Reprod 13, 1975-1980. 
Drazner, F.H., 1987. Renal endocrinology in small animal endocrinology. New York, 
NY: Churchill Livingstone, 315-339. 66 
 
Dubois,  J.,  Garel,  L.,  Grignon,  A.,  Lemay,  M.,  Leduc,  L.,  1997.  Placenta  percreta: 
balloon  occlusion  and  embolization  of  the  internal  iliac  arteries  to  reduce 
intraoperative blood losses. Am J Obstet Gynecol 176, 723-726. 
Dunn, R., 1959. Haemangioma of placenta (chorio-angioma); report of 9 cases. J Obstet 
Gynec Brit Emp 66, 51. 
Earl, U., Bulmer, J., Briones, A., 1987. Placenta accreta: an immunohistological study of 
trophoblast populations. Placenta 8, 273-282. 
Eckersall,  P.,  Conner,  J.,  1988.  Bovine  and  canine  acute  phase  proteins.  Vet  Res 
Commun 12, 169-178.  
Enders, A., 1968. Fine structure of anchoring villi of the human placenta. Am J Anat 122, 
419-451.  
Evans, J., Anderton, D., 1992. Pregnancy diagnosis in the bitch: the development of a test 
based on the measurement of acute phase proteins in the blood. Annls Zootech 41, 
397-405.  
Faranesh,  R.,  Shabtai,  R.,  Eliezer,  S.,  Raed,  S.,  2007.  Suggested  approach  for 
management of placenta percreta invading the urinary bladder. Obstet Gynecol 
110, 512-515.  
Fellows, E., Hazzard, T., Kutzler, M., 2012. Gene expression in pre-term, pre-labour and 
parturient canine placenta. Reprod Domest Anim 47 (s6):182-5. 
Finkler,  N.,  Berkowitz,  R.,  Driscoll,  S.,  Goldstein,  D.,  Bernstein,  M.,  1988.  Clinical 
experience  with  placental  site  trophoblastic  tumours  at  the  New  England 
Trophoblastic Disease Centre. Obstet Gynecol 71, 854-857. 67 
 
Finn, C., Keen, P., 1963. The induction of deciduomata in the rat. J Embryol Exp Morph 
11, 673-682.  
Fitzgerald, J., Busch, S., Wengenmayer, T., Foerster, K., de la Motte, T., Poehlmann, T., 
Markert,  U.,  2005.  Signal  transduction  in  trophoblast  invasion:  review.  Chem 
Immunol Allergy 88, 181-99. 
Fretts, R.C., Schmittdiel, J., Mclean, F.H., 1995. Increased maternal age and the risk of 
fetal death. N Engl J Med 333, 953-957. 
Genbacev, O., Schubach, S., Miller, R., 1992. Villous culture of first trimester human 
placenta-model to study extravillous trophoblast (EVT) differentiation. Placenta 
13, 439-461.  
Gilbert, S., 2010. Cell-cell communication in development. In: Developmental Biology, 
9
th ed. Sunderland, MA: Sinauer Associates, Inc., 69-106. 
Gillespie,  A.,  Liyim,  D.,  Goepel,  J.,  Coleman,  R.,  Hancock,  B.,  2000.  Placental  site 
trophoblastic  tumour:  a  rare  but  potentially  curable  cancer.  Brit  J  Cancer  82, 
1186.  
Graham, C., Hawley, T., Hawley, R., MacDougall, J., Kerbel, R., Khoo, N., Lala, P., 
1993.  Establishment  and  characterization  of  first  trimester  human  trophoblast 
cells with extended lifespan. Exp Cell Res 206, 204-211.  
Gunnink,  J.,  1984.  Post-partum  leucocytic  activity  and  its  relationship  to  caesarian 
section and retained placenta. Vet Q 6, 55-57. 
Guyton, A., Hall, J., 2006. Pregnancy and lactation. In: Guyton and Hall Textbook of 
Medical Physiology. 11
th ed, 1027-1041. Philadelphia, PA: Saunders Elsevier. 68 
 
Harvey,  M.,  1991.  Changes  in  the  ovum  during  the  time  of  ovulation.  In:  BSAVA 
Congress Proceedings, 50.  
Hassold, T., 1986. Chromosome abnormalities in human reproductive wastage. Trends 
Genet 2, 105-110. 
Hayashi, K., Bracken, M., Freeman, D., 1982. Hydatidiform mole in the United States 
(1970-1977): a statisticaly and theoretical analysis. Am J Epidemiol 115, 67-77. 
Hempstock,  J.,  Jauniaux,  E.,  Greenwold,  N.,  Burton,  G.,  2003.  The  contribution  of 
placental oxidative stress to early pregnancy failure. Hum Pathol 34, 1265-1275. 
Hertig, A., Mansell, H., 1956. Hydatidiform mole and choriocarcinoma. AFIP atlas of 
tumor pathologies. Female sex organs, Part I. Washington, D.C. 
Hertz,  R.,  Ross,  G.,  Lipsett,  M.,  1964.  Chemotherapy  in  women  with  trophoblastic 
disease:  choriocarcinoma,  chorioadenoma  destruens,  and  complicated 
hydatidiform mole. Ann NY Acad Sci 114, 881-885. 
Hohn, H., Denker, H., 2002. Experimental modulation of cell-cell adhesion, invasiveness 
and differentiation in trophoblast cells. Cells Tissues Organs 172, 218-236. 
Holst, P., Phemister, R., 1971. The prenatal development of the dog: preimplantation 
events. Biol Reprod 5, 194-206. 
How, J., Scurry, J., Grant, P., Sapountzis, K., Oster, A., Fortune, O., Armes, J., 1995. 
Placental  site  trophoblastic  tumour.  Report  of  three  cases  and  review  of  the 
literature. Int J Gynecol Cancer 5, 241-249. 
Hudon,  L.,  Belfort,  M.,  Broome,  D.,  1998.  Diagnosis  and  management  of  placenta 
percreta: a review. Obstet Gynecol Survey 53, 509-517. 69 
 
Hunkapiller,  N.,  Fisher,  S.,  2008.  Placental  remodeling  of  the  uterine  vasculature. 
Method Enzymol 445, 281-302. 
Hurley, W., Doane, R., 1989. Recent developments in the roles of vitamins and minerals 
in reproduction. J Dairy Sci 72, 784-804. 
Hustin, J., Schaaps, J., 1987. Echographic and anatomic studies of the 
maternotrophoblastic border during the first trimester of pregnancy. Am J Obstet 
Gynecol 157, 162-168. 
Ichinoe, K., 1979. Incidence of hydatidiform mole and its subsequent chorionic disease in 
reference to the aging of mothers. Acta Obstet Gynaecol Jpn 31, 292-296. 
Ishiyama, M., Tominaga, H., Shiga, M., Sasamoto, K., Ohkura, Y., Ueno, K., 1996. A 
combined assay of cell viability and in vitro cytotoxicity with a highly water-
soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 19, 1518-
1520.  
Jauniaux, E., Hempstock, J., Greenwold, N., Burton, G., 2003. Trophoblastic 
  oxidative  stress  in  relation  to  temporal  and  regional  differences  in  maternal 
placental blood  flow in normal  and abnormal  early pregnancies. Am  J Pathol 
162,115-125. 
Jauniaux,  E.,  Poston,  L.,  Burton,  G.,  2006.  Placental-related  diseases  of  pregnancy: 
involvement  of  oxidative  stress  and  implications  in  human  evolution.  Hum 
Reprod Update 12, 747-755. 70 
 
Jenkins,  C.,  Wilson,  R.,  Roberts,  J.,  Miller,  H.,  McKillop,  J.,  Walker,  J.,  2000. 
Antioxidants: their role in pregnancy and miscarriage. Antioxid Redox Signal 2, 
623-628. 
Johns  Hopkins  University,  2013.    Johns  Hopkins  University,  The  Johns  Hopkins 
Hospital,  and  Johns  Hopkins  Health  System:  Johns  Hopkins  Medicine  Health 
Library.  Uterine  artery  embolization.  Retrieved  on  March  3,  2013  from 
http://www.hopkinsmedicine.org/healthlibrary/test_procedures/gynecology/uterin
e_artery_embolization_92,P08484/.  
Johnston, S., Raksil, S., 1987. Fetal loss in the dog and cat. Vet Clin N Am Sm Anim 
Prac 17, 535. 
Johnston, S., Kustritz, M., Olson, P., 2001. Subinvolution of placental sites. In: Johnston, 
S.D., Kustritz, M.V.R., Olson, P.N.S., eds., Canine and Feline Theriogenology. 
Philadelphia, PA: WB Saunders, 139-141. 
Jovanović, M., Vićovac, L., 2009. Interleukin-6 stimulates cell migration, invasion and 
integrin expression in HTR-8/SVneo cell line. Placenta, 30, 320-328. 
Jovanović, M., Stefanoska, I., Radojčić, L., Vićovac, L., 2010. Interleukin-8 (CXCL8) 
stimulates trophoblast cell migration and invasion by increasing levels of matrix 
metalloproteinase (MMP)2 and MMP9 and integrins α5 and β1. Reproduction 
139, 789-798. 
Kaufmann,  P.,  Black,  S.,  Huppertz,  B.,  2003.  Endovascular  trophoblast  invasion: 
implications  for  the  pathogenesis  of  intrauterine  growth  retardation  and 
preeclampsia. Biol Reprod 69, 1-7. 71 
 
Kent, A., 2009. Management of placenta accreta. Rev Obstet Gynecol 2, 127-128. 
Kilburn, B., Wang, J., Duniec-Dmuchkowski, J., Leach, R., Ramero, R., Armant, D., 
2000. ECM and hypoxia regulate the expression of HLA-G and integrins in a 
human trophoblast cell line. Biol Reprod 62, 739-747. 
Kim,  D.,  Moon,  H.,  Kim,  K.,  Moon,  Y.,  Hwang,  Y.,  1986.  Effects  of  prophylactic 
chemotherapy  for  persistent  trophoblastic  disease  in  patients  with  complete 
hydatidiform mole. Obstet Gynecol 67, 690-694. 
King,  A.,  Thomas,  L.,  Bischof,  P.,  2000.  Cell  culture  models  of  trophoblast  II: 
trophoblast cell lines-a workshop report. Placenta 21, S113. 
Klonisch, T., Hombach-Klonisch, S., Froehlich, C., Kauffold, J., Steger, K., Steinetz, B., 
Fischer, B., 1999. Canine preprorelaxin: nucleic acid sequence and localization 
within the canine placenta. Biol Reprod 60, 551-557. 
Klonisch, T., Kauffold, J., Steger, K., Bergmann, M., Leiser, R., Fischer, B., Hombach-
Klonisch,  S.,  2001.  Canine  relaxin-like  factor:  unique  molecular  structure  and 
differential expression within reproductive tissues of the dog. Biol Reprod 64, 
442-450. 
Kohorn, E., Blackwell, R., 1968. The diagnosis of hydatidiform mole by ultrasonic B-
scanning. J Obstet Gynaecol Br Commonw 75, 1014-1018. 
Kokawa, K., Shikone,  T., Nakano, R., 1998.  Apoptosis  in  human chorionic villi and 
decidua during normal embryonic development and spontaneous abortion in the 
first trimester. Placenta 19, 21-26. 72 
 
Komar,  C.,  2005.  Peroxisome  proliferator-activated  receptors  (PPARs)  and  ovarian 
function:  implications  for regulating steroidogenesis, differentiation, and tissue 
remodeling. Reprod Biol Endocrinol 3, 41. 
Korff,  T.,  Krauss,  T.,  Augustin,  H.,  2004.  Three-dimensional  spheroidal  culture  of 
cytotrophoblast cells mimics the phenotype and differentiation of cytotrophoblasts 
from normal and preeclamptic pregnancies. Exp Cell Res 297, 415-423.  
Kovacs,  W.,  Ojeda,  S.,  2012.  Fertilization,  implantation,  and  endocrinology  of 
pregnancy. In: Textbook of endocrine physiology. NY: Oxford University Press, 
264-291. 
Kowalewski, M., Beceriklisoy, H., Pfarrer, C., Aslan, S., Kindahl, H., Kücükaslan, I., 
Hoffmann, B., 2010. Canine placenta: a source of prepartal prostaglandins during 
normal and antiprogestin-induced parturition. Reproduction 139, 655-664. 
Kowalewski, M., Meyer, A., Hoffmann, B., Aslan, S., Boos, A., 2011. Expression and 
functional  implications  of  peroxisome  proliferator—activated  receptor  gamma 
(PPARγ) in canine reproductive tissues during normal pregnancy and parturition 
and at antiprogestin induced abortion. Theriogenology 75, 877-886. 
Kramer,  N.,  Walzl,  A.,  Unger,  C.,  Rosner,  M.,  Krupitza,  G.,  Hengstschläger,  M., 
Dolznig, H., 2013. In vitro cell migration and invasion assays. Mutat Res 752, 10-
24.  
Krehbiel, R., 1937. Cytological studies of the decidual reaction in the rat during early 
pregnancy and in the production of deciduomata. Physiol Zool 10, 212-34. 73 
 
Kurman,  R.,  Young,  R.,  Norris,  H.,  Main,  C.,  Lawrence,  W.,  Scully,  R.,  1984. 
Immunocytochemical  localization  of  placental  lactogen  and  chorionic 
gonadotrophin in the normal placenta and trophoblastic tumours, with emphasis 
on the intermediate trophoblast and the placental site trophoblastic tumour. Int J 
Gynecol Pathol 3, 101-121. 
Lamp, O., Honscha, K. U., Jakob, J., Lamp, J., Schweizer, S., Reischauer, A., Einspanier, 
A., 2009. Investigation of the local expression of the relaxin system in canine 
mammary tumours. Reprod Domest Anim 44, 224-229. 
Lashen, H., Fear, K., Sturdee, D., 2004. Obesity is associated with increased risk of first 
trimester and recurrent miscarriage: matched case–control study. Hum Reprod 19, 
1644-1646.  
Laven,  R.,  Peters,  A.,  1996.  Bovine  retained  placenta:  aetiology,  pathogenesis  and 
economic loss. Vet Rec 139, 465-471. 
Lei, T., Yang, Z., Xia, T., Gan, L., Chen, X., Yuan, J., Zhu, Y., 2004. Stage-specific 
expression  of  leukaemia  inhibitory  factor  and  its  receptor  in  rabbit  pre-
implantation  embryo  and  uterine  epithelium  during  early  pregnancy.  Reprod 
Domest Anim 39, 13-18. 
Leridon,  H.,  1976.  Facts  and  artifacts  in  the  study  of  intra-uterine  mortality:  a 
reconsideration from pregnancy outcome. Popul Stud 30, 319-335. 
Levine, D., Hulka, C., Ludmir, J., Li, W., Edelman, R., 1997. Placenta accreta: evaluation 
with color Doppler US, power Doppler US, and MR imaging. Radiology 205, 
773-776. 74 
 
Liang, C., Park, A., Guan, J., 2007. In vitro scratch assay: a convenient and inexpensive 
method for analysis of cell migration in vitro. Nat Protoc 2, 329-333.  
Librach, C., Werb, Z., Fitzgerald, M., Chiu, K., Corwin, N., Esteves, R., Fisher, S., 1991. 
92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell 
Biol 113, 437-449. 
Limpongsanurak,  S.,  2001.  Prophylactic  actinomycin  D  for  high-risk  complete 
hydatidiform mole. J Reprod Med 46, 110-116. 
Lindbohm, M., Hemminki, K., Bonhomme, M., Anttila, A., Rantala, K., Heikkilä, P., 
Rosenberg, M., 1991. Effects of paternal occupational exposure on spontaneous 
abortions. Am J Public Health 81, 1029-1033. 
Macrae, D., 1949. Primary uterine inertia. Brit J Obstet Gyn 56, 785-798. 
Makhseed, M., Raghupathy, R., Azizieh, F., Farhat, R., Hassan, N., Bandar, A., 2000. 
Circulating  cytokines  and  CD30  in  normal  human  pregnancy  and  recurrent 
spontaneous abortions. Hum Reprod 15, 2011-2017. 
Mathialagan, N., Bixby, J., Roberts, R., 1992. Expression of interleukin‐6 in porcine, 
ovine, and bovine preimplantation conceptuses. Mol Reprod Dev 32, 324-330.  
Merviel,  P.,  Salat-Baroux,  J.,  Calvo,  F.,  1993.  Epithelial  and  stromal  cell  culture  of 
human endometrium and characterization. Contr Fertil Sex 21, 395.  
Miller,  D.,  Chollet,  J.,  Goodwin,  T.,  1997.  Clinical  risk  factors  for  placenta  previa-
placenta accreta. Am J Obstet Gynecol 177, 210.  
Modric,  T.,  Kowalski,  A.,  Green,  M.,  Simmen,  R.,  Simmen,  F.,  2000.  Pregnancy-
dependent expression of leukaemia inhibitory factor (LIF), LIF receptor-β and 75 
 
interleukin-6  (IL-6)  messenger  ribonucleic  acids  in  the  porcine  female 
reproductive tract. Placenta (Eastbourne) 21, 345-353. 
Moffett, A., Loke, C., 2006. Immunology of placentation in eutherian mammals. Nat Rev 
Immunol 6, 584-594. 
Moller,  K.,  Newling,  P.,  Robson,  H.,  Hansen,  G.,  Meursinge,  J.,  Cooper,  M.,  1967. 
Retained foetal membranes in dairy herds in the Huntly district. New Zeal Vet J 
15, 111-116. 
Monzani, R., Cohen, P., 2002. IGFs and IGFBPs: role in health and disease. Best Prac 
Res Clin Endocrinol Metab 16, 433-447. 
Mosmann,  T.,  1983.  Rapid  colorimetric  assay  for  cellular  growth  and  survival: 
application to proliferation and cytotoxicity assays. J Immunol Methods, 65, 55-
63.  
Mshelia,  G.,  Chaudhari,  S.,  2001.  Continuing  education  article  sub-involution  of 
placental  sites  (SIPS):  possible  predisposing  factors  and  consequences  on  the 
fertility of bitch. Int J Agr Biol 3, 263-265. 
Mutch, D., Soper, J., Babcock, C., Clarke-Pearson, D., Hammond, C., 1990. Recurrent 
gestational  trophoblastic  disease:  experience  of  the  Southeastern  Regional 
Trophoblastic Disease Center. Cancer 66, 978-82. 
Nasu,  K.,  Zhou,  Y.,  McMaster,  M.,  Fisher,  S.,  2000.  Upregulation  of  human 
cytotrophoblast invasion by hepatocyte growth factor. J Reprod Fertil Suppl 55, 
73-80. 76 
 
Nomura, K., 1994. Induction of a deciduoma in the dog. J Vet Med Sci Japanese Soc Vet 
Sci 56, 365. 
Norwitz,  E.,  Schust,  D.,  Fisher,  S.,  2001.  Implantation  and  the  survival  of  early 
pregnancy. New Engl J Med 345, 1400-1408. 
Novak, E., 1950. Pathological aspects of hydatidiform mole and choriocarcinoma. Am J 
Obstet Gynecol 59, 1355.  
Oldt  III, R., Kurman, R., Shih,  I., 2002. Molecular  genetic analysis  of placental site 
trophoblastic  tumors  and  epithelioid  trophoblastic  tumors  confirms  their 
trophoblastic origin. Am J Pathol 161, 1033-1037. 
Olson,  P.N.,  Hosted,  P.,  1984.  Vaginal  cytology  II:  its  use  in  diagnosing  canine 
reproductive disorders. Comp Cont Educ, 6, 385-90. 
Orendi, K., Kivity, V., Sammar, M., Grimpel, Y., Gonen, R., Meiri, H., Lubzens, E., 
Huppertz,  B.,  2011.  Placental  and  trophoblastic  in  vitro  models  to  study 
preventive and therapeutic agents for preeclampsia. Placenta 32, S49-S54.  
Orfanou, D., Ververidis, H., Pourlis, A., Fragkou, I., Kokoli, A., Boscos, C., Taitzoglou, 
I.,  Tzora,  A.,  Nerou,  C.,  Athanasiou,  L.,  Fthenakis,  G.,  2009.  Post‐partum 
involution of the canine uterus–gross anatomical and histological features. Reprod 
Domest Anim 44(s2), 152-155. 
Oyelese, Y., Smulian, J., 2006. Placenta previa, placenta accreta, and vasa previa. Obstet 
Gynecol 107, 927-941. 
Palmer, A., London, W., Sly, D., Rice, J., 1979. Spontaneous preeclamptic toxemia of 
pregnancy in the patas monkey (erythrocebus patas). Lab Anim Sci 29, 102. 77 
 
Parer,  J.,  De  Lannoy,  C.,  Behrman,  R.,  1968.  Uterine  blood  flow  and  oxygen 
consumption in rhesus monkeys with retained placentas. Am J Obstet Gynecol 
100, 806. 
Passavant, C., Zhao, X., Das, S., Dey, S., Mead, R., 2000. Changes in uterine expression 
of leukemia inhibitory factor receptor gene during pregnancy and its up-regulation 
by prolactin in the western spotted skunk. Biol Reprod 63, 301-307. 
Payan‐Carreira, R., Pires, M., Ström Holst, B., Rodriguez‐Martinez, H., 2011. Tumour 
necrosis  factor  in  the  canine  endometrium:  an  immunohistochemical  study. 
Reprod Domest Anim, 46, 410-418. 
Pedersen,  R.,  Wu,  K.,  Balakier,  H.,  1986.  Origin  of  the  inner  cell  mass  in  mouse 
embryos: cell lineage analysis by microinjection. Dev Bio 117, 581-595. 
Pennington,  K.,  Schlitt,  J.,  Jackson,  D.,  Schulz,  L.,  Schust,  D.,  2012.  Preeclampsia: 
multiple approaches for a multifactorial disease. Dis Model Mech 5, 9-18. 
Pfeffer, P., Pearton, D., 2012. Trophoblast development. Reproduction 143, 231-246. 
Piccinini,  G.,  Foli,  A.,  Comolli,  G.,  Lisziewicz,  J.,  Lori,  F.,  2002.  Complementary 
antiviral  efficacy  of  hydroxyurea  and  protease  inhibitors  in  human 
immunodeficiency  virus-infected  dendritic  cells  and  lymphocytes.  J  Virol  76, 
2274-2278. 
Pirak, M.,  Waner, T., Abramovici,  A., Scolnik,  M.,  Nyska,  A., 1991. Histologic and 
immunohistochemical study of a spontaneous choriocarcinoma in a male Sprague 
Dawley rat. Vet Pathol Online, 28, 93-95. 78 
 
Poen, H., Djojopranoto, M., 1965. The possible etiologic factors of hydatidiform mole 
and choriocarcinoma: preliminary report. Am J Obstet Gynecol 92, 510-13. 
Pötgens, A., Gaus, G., Frank, H., Kaufmann, P., 2001. Characterization of trophoblast 
cell isolations by a modified flow cytometry assay. Placenta 22, 251-255.  
Poujade, M., Grasland-Mongrain, E., Hertzog, A., Jouanneau, J., Chavrier, P., Ladoux, 
B.,  Buguin,  A.,  Silberzan,  P.,  2007.  Collective  migration  of  an  epithelial 
monolayer in response to a model wound. PNAS 104, 15988-15993.  
Poutahidis,  T.,  Doulberis,  M.,  Karamanavi,  E.,  Angelopoulou,  K.,  Koutinas,  C.  K., 
Papazoglou, L., 2008. Primary gastric choriocarcinoma in a dog. J Comp Pathol 
139, 146-150. 
Rai, R., Regan, L., 2006. Recurrent miscarriage. Lancet 368, 601-611. 
Reberg, S., Peter, A., Blevins, W., 1992. Subinvolution of placental sites in dogs. Comp 
Cont Educ Pract 14. 
Regan, L., Braude, P., Trembath, P., 1989. Influence of past reproductive performance on 
risk of spontaneous abortion. Br Med J 299, 541-545. 
Risch, H., Weiss, N., Clarke, E., Miller, A., 1988. Risk factors for spontaneous abortion 
and its recurrence. Am J Epidemiol 128, 420-430. 
Roberts, R., Farin, C., Cross, J., 1990. Trophoblast proteins and maternal recognition of 
pregnancy. Oxford Rev Reprod B 12, 147. 
Roberts,  S.,  1971.Veterinary  obstetrics  and  genital  disease,  2
nd  ed.  Ann  Arbor,  MI: 
Edwards Bros., Inc., 317-336.  79 
 
Robertson, R., Allen, H., Bokelman, D., 1979. Aspirin: teratogenic evaluation in the dog. 
Teratology 20, 313-320. 
Saftlas,  A.,  Olson,  D.,  Franks,  A.,  Atrash,  H.,  Pokras,  R.,  1990.  Epidemiology  of 
preeclampsia  and  eclampsia  in  the  United  States,  1979-1986.  Am  J  Obstet 
Gynecol 163, 460-465. 
Sahlfeld, L., Hazzard, T., Kutzler, M., 2012. Cellular characteristics of cultured canine 
trophoblasts. Reprod Domest Anim 47(s6), 161-164.  
Salamonsen, L., Young, R., Garcia, S., Findlay, J., 1997. Mitogenic actions of endothelin 
and other growth factors in ovine endometrium. J Endocrinol 152, 283-290. 
Salamonsen, L., 1999. Role of proteases in implantation. Rev Reprod 4, 11-22. 
Salim, R., Zafran, N., Chulski, A., Shalev, E., 2010. Employing a balloon catheter for 
occlusion and/or embolization of the pelvic vasculature as an adjuvant therapy in 
cases of abnormal placentation. Harefuah 149, 370. 
Sandals, W., Curtis, R., Cote, J., Martin, S., 1979. The effect of retained placenta and 
metritis  complex  on  reproductive  performance  in  dairy  cattle-  a  case  control 
study.  Canadian Vet J 20, 131.  
Schäfer-Somi, S., 2003. Cytokines during early pregnancy of mammals: a review. Anim 
Reprod Sci 75, 73-94. 
Schäfer‐Somi, S., Beceriklisoy, H., Budik, S., Kanca, H., Aksoy, O., Polat, B., Setin, Y., 
Ay, S., Aslan, S., 2008. Expression of genes in the canine pre‐implantation uterus 
and  embryo:  implications  for  an  active  role  of  the  embryo  before  and  during 
invasion. Reprod Domest Anim 43, 656-663. 80 
 
Schäfer‐Somi,  S.,  Klein,  D.,  Beceriklisoy,  H.,  Sabitzer,  S.,  Ay,  S.,  Agaoglu,  A., 
Kücükaslan,  I.,  Kaya,  D.,  Aksoy,  O.,  Aslan,  S.,  2009.  Uterine  progesterone 
receptor and leukaemia inhibitory factor mRNA expression in canine pregnancy. 
Reprod Domest Anim 44, 109-114. 
Schaiff,  W.,  Carlson,  M.,  Smith,  S.,  Levy,  R.,  Nelson,  D.,  Sadovsky,  Y.,  2000. 
Peroxisome  proliferator-activated  receptor-gamma  modulates  differentiation  of 
human  trophoblast  in  a  ligand-specific  manner.  J  Clin  Endocrinol  Metab  85, 
3874-3881. 
Schall,  W.,  Duncan,  J.,  Finco,  D.,  Knecht,  C.,  1971.  Spontaneous  recovery  after 
subinvolution of placental sites in a bitch. J Am Vet Med Assoc 159, 1780. 
Seidl,  D.,  Hughes,  H.,  Bertolet,  R.,  Lang,  C.,  1979.  True  pregnancy  toxemia 
(preeclampsia) in the guinea pig (cavia porcellus). Lab Anim Sci 29, 472. 
Sevinga, M., Barkema, H., Stryhn, H., Hesselink, J., 2004. Retained placenta in Friesian 
mares: incidence, and potential risk factors with special emphasis on gestational 
length. Theriogenology 61, 851-859. 
Shelesnyak, M., 1952. Inhibition of decidual cell formation in the pseudopregnant rat by 
histamine antagonists. Amer J Physiol 170, 522-527. 
Shih, I., Kurman, R., 2002. Molecular basis of gestational trophoblastic diseases. Curr 
Mol Med 2, 1-12. 
Shih, J., Jaraquemada, J., Su, Y., Shyu, M., Lin, C., Lin, S., Lee, C., 2009. Role of three‐
dimensional  power  Doppler  in  the  antenatal  diagnosis  of  placenta  accreta: 81 
 
comparison with gray‐scale and color Doppler techniques. Ultrasound Obst Gyn 
33, 193-203. 
Sibai, B., Gordon, T., Thom, E., Caritis, S., Klebanoff, M., McNellis, D., Paul, R., 1995. 
Risk  factors  for  preeclampsia  in  healthy  nulliparous  women:  a  prospective 
multicenter study. Am J Obstet Gynecol 172, 642-648.  
Sibai,  B.,  2003.  Diagnosis  and  management  of  gestational  hypertension  and 
preeclampsia. Obstet Gynecol 102, 181-192. 
Singer,  G.,  Kurman,  R.,  McMaster,  M.,  Shih,  I.,  2002.  HLA-G  immunoreactivity  is 
specific for intermediate trophoblast in gestational trophoblastic disease and can 
serve as a useful marker in differential diagnosis. Am J Surg Pathol 26, 914-920. 
Simpson, J., 1980. Genes, chromosomes, and reproductive failure. Fertil Steril 33, 107-
116. 
Sivan, E., Spira, M., Achiron, R., Rimon, U., Golan, G., Mazaki-Tovi, S., Schiff, E., 
2010. Prophylactic pelvic artery catheterization and embolization in women with 
placenta accreta: can it prevent cesarean hysterectomy? Am J Perinat 27, 455-461.  
Sokolowski, J., 1971. The effects of ovariectomy on pregnancy maintenance in the bitch. 
Lab Anim Sci 21, 696.  
Song, J., Sirois, J., Houde, A., Murphy, B., 1998. Cloning, developmental expression, 
and  immunohistochemistry  of  cyclooxygenase  2  in  the  endometrium  during 
embryo implantation and gestation in the mink (mustela vison). Endocrinology 
139, 3629-3636. 82 
 
Sontas, H., Stelletta, C., Milani, C., Mollo, A., Romagnoli, S., 2011. Full recovery of 
subinvolution of placental sites in an American Staffordshire terrier bitch. J Small 
Anim Pract 52, 42-45. 
Soper,  J.,  Lewis,  J.  Jr.,  Hammond,  C.,  1996.  Gestational  trophoblastic  disease.  In: 
Hoskins,  W.J.,  Perez,  C.A.,  Young,  R.C.,  eds,  Principals  and  practice  of 
gynecologic oncology, 2
nd ed. Philadelphia, PA: Lippincott-Raven, 1039–1077. 
Soper, J., 2006. Gestational trophoblastic disease. Obstet Gynecol 108, 176-187. 
Staun-Ram, E., Shalev, E., 2005. Human trophoblast function during the implantation 
process. Reprod Biol Endocrin 3, 56. 
Steinetz, B., Goldsmith, L., Harvey, H., Lust, G., 1989. Serum relaxin and progesterone 
concentrations  in  pregnant,  pseudopregnant,  and  ovariectomized,  progestin-
treated pregnant bitches: detection of relaxin as a marker of pregnancy. Am J Vet 
Res 50, 68. 
Stirrat, G., 1990. Recurrent miscarriage I: definition and epidemiology. Lancet 336, 673-
675.  
Stone,  M.,  Bagshawe,  K.  D.,  1979.  An  analysis  of  the  influences  of  maternal  age, 
gestational  age,  contraceptive  method,  and  the  mode  of  primary  treatment  of 
patients with hydatidiform moles on the incidence of subsequent chemotherapy.  
Br J Obstet Gynaecol 86(10), 782-792. 
Stromberg,  K.,  Azizkhan,  J.,  Speeg  Jr.,  K.,  1978.  Isolation  of  functional  human 
trophoblast cells and their partial characterization in primary cell culture. In Vitro 
14, 631-638.  83 
 
Szulman, A., Philippe, E., Boué, J., Boué, A., 1981. Human triploidy: association with 
partial  hydatidiform  moles  and  nonmolar  conceptuses.  Hum  Pathol  12,  1016-
1021.  
Tanaka, S., Kunath, T., Hadjantonakis, A., Nagy, A., Rossant, J., 1998. Promotion of 
trophoblast stem cell proliferation by FGF4. Science 282, 2072-2075. 
Tietz, W., Seliger, W., 1967. Temporal relationships in early canine embryogenesis. Anat 
Rec 157, 333-334.  
Tennant,  B.,  Peddicord,  R.,  1968.The  influence  of  delayed  uterine  involution  and 
endometritis on bovine fertility. Cornell Vet 58, 185-192.  
Thiede, H., Rudolph, J., 1961. A method for obtaining monolayer cultures of human fetal 
cells  from  term  placentas.  In:  Proceedings  of  the  Society  for  Experimental 
Biology  and  Medicine.  Society  for  Experimental  Biology  and  Medicine.  New 
York, NY: Royal Society of Medicine 107, 565-569.  
Timmermans,  S.,  van  Hof,  A.,  Duvekot,  J.,  2007.  Conservative  management  of 
abnormally invasive placentation. Obstet Gynecol Surv 62, 529-539. 
Tomoda,  Y.,  1979.  Registration  and  management  of  trophoblastic  tumors.  Gan  No 
Rinsho 25, 494-499. 
Tseng, J., Chou, M., Hsieh, Y., Wen, M., Ho, E., Hsu, S., 2006. Differential expression of 
vascular endothelial growth factor, placenta growth factor and their receptors in 
placentae from pregnancies complicated by placenta accreta. Placenta 27, 70-78. 
Tsutsui, T., Stewart, D., 1991. Determination of the source of relaxin immunoreactivity 
during pregnancy in the dog. J Vet Med Sci- Japanese Soc Vet Sci 53, 1025. 84 
 
Twentyman, P., Luscombe, M., 1987. A study of some variables in a tetrazolium dye 
(MTT) based assay for cell growth and chemosensitivity. Brit J Cancer 56, 279.  
Twiggs, L., Okagaki, T., Phillips, G., Stroemer, J., Adcock, L., 1981. 
Trophoblastic pseudotumour – evidence of malignant disease potential. Gynecol Oncol 
12, 238-248. 
Van Mourik, M., Macklon, N., Heijnen, C., 2009. Embryonic implantation: cytokines, 
adhesion  molecules,  and  immune  cells  in  establishing  an  implantation 
environment. J Leukocyte Biol 85, 4-19. 
Vassilakos,  P.,  Riotton,  G.,  Kajii,  T.,  1977.    Hydatidiform  mole:  two  entities.    A 
morphologic  and  cytogenetic  study  with  some  clinical  consideration.    Am  J 
Obstet Gynecol 127(2), 167-170. 
Wagner, L., 2004. Diagnosis and management of preeclampsia. Am Fam Physician 70, 
2317-2324.  
Walter, I., Schönkypl, S., 2006. Extracellular matrix components and matrix degrading 
enzymes in the feline placenta during gestation. Placenta 27, 291-306. 
Washecka, R., Behling, A., 2002. Urologic complications of placenta percreta invading 
the urinary bladder: a case report and review of the literature. Hawaii Med J 61, 
66-69. 
Watts, J., Wright, P., Lee, C., Whithear, K., 1997. New techniques using transcervical 
uterine cannulation for the diagnosis of uterine disorders in bitches. J Reprod Fert 
Suppl 51, 283. 85 
 
Wilcox,  A.,  Weinberg,  C.,  O’Connor,  J.,  Baird,  D.,  Schlatterer,  J.,  Canfield,  R., 
Armstrong, E., Nisula, B., 1988. Incidence of early loss of pregnancy. N Engl J 
Med 319, 189-94. 
Wilcox,  A.,  Weinberg,  C.,  O’Connor,  J.,  Baird,  D.,  Schlatterer,  J.,  Canfield,  R., 
Armstrong, E., Nisula, B., 1989.  Incidence of  early loss of pregnancy. Obstet 
Gynecol Surv 44, 147-148. 
Wilmut, I., Sales, D., Ashworth, C., 1986. Maternal and embryonic factors associated 
with prenatal loss in mammals. J Reprod Fert 76, 851-864. 
Wilson, R., Beecham, C., Symmonds, R., 1965. Conservative surgical management of 
chorioadenoma destruens. Obstet Gynecol 26, 814-820.  
Witlin, A., Sibai, B., 1998. Magnesium sulfate therapy in preeclampsia and eclampsia. 
Obstet Gynecol 92, 883-889. 
Wulff,  C.,  Wilson,  H.,  Dickson,  S.,  Wiegand,  S.,  Fraser,  H.,  2002.  Hemochorial 
placentation  in  the  primate:  expression  of  vascular  endothelial  growth  factor, 
angiopoietins, and their receptors throughout pregnancy. Biol Reprod 66, 802-
812. 
Wynn, R., Corbett, J., 1969. Ultrastructure of the canine placenta and amnion. Am J 
Obstet Gynecol 103, 878. 
Yamashita, K., Fujinaga, T., Miyamoto, T., Hagio, T., Izumisawa, Y., Kotani, T., 1994. 
Canine acute phase response: relationship between serum cytokine activity and 
acute phase protein in dogs. J Vet Med Sci 56, 487-492. 86 
 
Yeager,  A.,  Concannon,  P.,  1990.  Serial  ultrasonographic  appearance  of  postpartum 
uterine involution in beagle dogs. Theriogenology 34, 523-535. 
Zelop, C., Nadel, A., Frigoletto Jr., F., Pauker, S., MacMillan, M., Benacerraf, B., 1992. 
Placenta  acereta/percreta/increta:  a  cause  of  elevated  maternal  serum  alpha-
fetoprotein. Obstet Gynecol 80, 693-694. 
Zhou, Y., Fisher, S., Janatpour, M., Genbacev, O., Dejana, E., Wheelock, M., Damsky, 
C.,  1997.  Human  cytotrophoblasts  adopt  a  vascular  phenotype  as  they 
differentiate. A strategy for successful endovascular invasion? J Clin Invest 99, 
2139. 
   87 
 
CHAPTER II 
 
ROLE OF IL-8 AND TIMP-2 ON TERM CANINE TROPHOBLAST MIGRATION, 
INVASION, AND PROLIFERATION 
 
 
2.1  INTRODUCTION 
 
  Complications during pregnancy and postpartum can be due to abnormal 
trophoblast behavior later in gestation. Successful release of the placenta requires 
synchronization of cellular and molecular interactions between trophoblasts and the 
maternal endometrium (Norwitz et al., 2001). Disruption of these interactions can lead to 
the development of placental pathologies, which can result from abnormal trophoblast 
migration, invasion, or proliferation. Excessive trophoblast invasion causes a failure or 
delay of normal uterine involution in pregnant and postpartum dogs (Al-Bassam et al., 
1981), known as subinvolution of placental sites (SIPs). Choriocarcinoma is another 
condition of excessive trophoblast or tumor invasion that results in metastasis to any site 
in the body has been described in humans (Novak, 1950; Bracken et al., 1984), rodents 
(Pirak et al., 1991), and dogs (Poutahidis et al., 2008). Knowledge of normal late 
gestation canine trophoblast physiology will provide a basis for future research on these 
types of placenta-related disorders. 
  Matrix-metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are key 
regulators in signaling at the trophoblast-endometrial interface. The MMP-TIMP 
interaction controls trophoblast invasion by restricting over or under-invasion into the 88 
 
endometrium (Staun-Ram and Shalev, 2005). MMPs are zinc-dependent endopeptidases 
important in the degradation of the maternal endometrium (Bischof et al., 2000). TIMP-2, 
which preferentially binds and inhibits MMP-2, is a 21.8 kDa protein that has been 
documented in the primate trophoblast and endometrium (Bischof et al, 2000). Gene 
expression of MMP-2 was localized in canine trophoblast and fetal blood vessels at the 
time of implantation and high levels of MMP-2 expression was observed in the 
endometrium and myometrium from pre-implantation to term (Beceriklisoy et al., 2007; 
Fellows et al., 2012). On the other hand, TIMP-2 mRNA expression had a notable yet 
insignificant increase from pre-term to parturient stage (Fellows et al., 2012), suggesting 
that TIMP-2 has a role at the end of gestation to restrict additional trophoblast invasion in 
dogs. However, the function of TIMP-2 in late gestation trophoblasts has not been 
evaluated. 
  Interleukins and growth factors of the cytokine family are dependent on MMP 
activity (Van Mourik et al., 2009). Interleukin-8 (IL-8/CXCL8), an 8 kDa inflammatory 
chemokine, mediates its effect through the IL-8 receptors, CXCR1 and CXCR2 (Leong et 
al., 1997). Human trophoblasts produce IL-8 (Shimoya et al., 1992) and CXCR1 (Hanna 
et al., 2006; Jovanović et al., 2010) and IL-8 stimulates first trimester human trophoblast 
proliferation in vitro (Hirota et al., 2009; Jovanović et al., 2010). In addition, IL-8 
stimulates first trimester human trophoblast migration and invasion through up-regulation 
of MMP-2 (Jovanović et al., 2010). IL-8 is expressed in canine trophoblasts of the pre-
implantation embryo (Schäfer-Somi et al., 2008), but its role in late gestation has not 
been described. 89 
 
  The objective of this study was to determine the effect of IL-8 and TIMP-2 on 
term canine trophoblast (TCT) migration, invasion, and proliferation. We hypothesized 
that TCT would respond similarly to term human trophoblasts in vitro, where IL-8 
stimulates TCT migration, invasion, and proliferation, and TIMP-2 suppresses TCT 
migration and invasion. 
 
2.2   MATERIALS AND METHODS 
 
2.2.1   Reagents and factors  
 
  The cell isolation medium was prepared with 95% Dulbecco’s Modified Eagle’s 
Medium (DMEM) obtained from Gibco, Life Technologies (Grand Island, NY, USA) 
with 2.5% FBS (Gibco, Life Technologies), 1% Glutamine Plus obtained from Atlanta 
Biologicals (Lawrenceville, GA, USA), 1% Penicillin/Streptomycin (Life Technologies), 
and 0.5% Gentamycin (Life Technologies). The collagenase solution was prepared with 
99.7% 1X phosphate buffer saline (PBS) (Gibco), 0.062% collagenase obtained from 
Sigma (St. Louis, MO, USA), 0.04% DNase (Sigma), 0.069% hyaluronidase (Sigma), 
and 0.1% bovine serum albumin (Sigma). The trypsin solution was prepared with 99.9% 
PBS (Gibco), 0.0069% trypsin (Sigma), 0.04% DNase (Sigma), and 
ethylenediaminetetraacetic acid (EDTA,Sigma). 
   The cell culture medium for the migration assay (medium A) consisted of 86.5% 
DMEM (Gibco, Life Technologies) with 1% Hepes (Life Technologies), 1% Glutamine 90 
 
Plus (Atlanta Biologicals), 1% Penicillin/Streptomycin (Life Technologies), 0.5% 
Gentamycin (Life Technologies), and 10% FBS (Gibco).  
  The cell culture medium for the invasion assay and proliferation assay (medium 
B) consisted of 96.5% DMEM (Gibco) with 1% Hepes (Life Technologies), 1% 
Glutamine Plus (Atlanta Biologicals), 1% Penicillin/Streptomycin (Life Technologies), 
and 0.5% Gentamycin (Life Technologies).  The chemoattractant for the invasion assay 
was the same as the cell culture medium with the addition of 10% FBS (Gibco). For the 
proliferation assay, MTT (((3-)4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide) (5 mg/ml MTT in RPMI-1640 without phenol red) and 1-propanol (0.1 N HCl 
in anyhydrous isopropanol) of the Cell Growth Determination Kit MTT-based were 
obtained from Sigma. 
  Recombinant human IL-8 was obtained from Peprotech (Rocky Hill, NJ, USA) 
and was used at a concentration of 10 ng/ml for each assay. Recombinant human TIMP-2 
(Peprotech) was used at a concentration of 0.5 µg/ml for each assay, respectively. 
 
2.2.2   Tissue collection 
 
   Term canine placentas were collected following elective C-section at the time of 
prepartum luteolysis (progesterone˂2.5 ng/ml) but prior to the onset of first stage labor 
(n=5 dogs). Following tissue collection, the villous chorioallantois was dissected away 
from adjacent placental tissues. Villous chorioallantois was minced and washed in cell 91 
 
isolation medium by centrifugation to be further processed for primary trophoblast 
isolation. 
 
2.2.3   Cell isolation and culture 
 
  Term canine trophoblasts (TCT) were isolated from the villous chorioallantois as 
previously described (Sahlfeld et al., 2012). Briefly, following serial collagenase and 
trypsin tissue digestions, cells were separated by Percoll density gradient centrifugation. 
The trophoblast-containing gradient layer was washed twice and resuspended in cell 
culture medium. The cell culture conditions were the same for all assays at 37 ºC in 5% 
CO2. 
 
2.2.4  Migration assay 
 
 The migration (wound healing) assay was performed as previously described 
(Liang et al., 2007). Briefly, primary TCT (1000X10
3 cells/well) were suspended in 2 ml 
of medium A and cultured in 12-well tissue culture plates. Cells were grown to form a 
70-80% confluent monolayer. A wound was added with a sterile 200 µl pipette tip. The 
monolayer was rinsed with medium A to remove loosened cells. Medium A with no 
factor (control), with IL-8 or TIMP-2 was then added. Photomicrographs of the wound 
were taken with phase-contrast microscopy (100X magnification) after 8 h in culture 92 
 
(Fig. 2.1). The area of the wound was measured using ImageJ v.1.34 software (Rasband, 
2012). The experiment was performed in triplicate. 
 
2.2.5   Invasion assay 
 
  An invasion (Matrigel) assay was performed as previously described (Librach et 
al., 1991) using Matrigel invasion chambers (BD Biosciences, San Jose, CA, USA). 
Briefly, primary TCT (250X10
3 cells/well) were suspended in 0.5 ml medium B with no 
factor (control), with IL-8 or TIMP-2 and then cultured on Matrigel-coated filter 
membranes for 22 h. Non-invading cells were removed from the filter and the filters were 
then fixed and stained with DiffQuik (Harleco®, EMD Chemicals, Inc., Gibbstown, NJ, 
USA). Cells from ten randomly selected non-overlapping fields were counted under light 
microscopy (400X magnification). The experiment was performed in triplicate. 
 
2.2.6   Proliferation assay 
 
  The proliferation (MTT) assay (Sigma), was performed as previously described 
(Carmichael et al., 1987). Primary TCT (100X10
3 cells/well) were suspended in 100 µl 
medium B with no factor (control), with IL-8 or TIMP-2 and cultured in 96-well tissue 
culture plates for 28 h. MTT (10 μl) was added to each well for 4 h. The MTT and 
medium B was replaced with 100 μL 1-propanol and the plates were vigorously shaken 
for 5 minutes using a microplate reader (SpectraMax 190, Molecular Devices, LLC, 93 
 
Sunnyvale, CA, USA), absorbances were measured at 570 nm and 690 nm. 
Measurements were analyzed with SoftMax Pro 5.2 program SoftMax® Pro Data 
Acquistion & Analysis Software (Molecular Devices, LLC, Sunnyvale, CA). The 
experiment was performed in quadruplicate. 
 
2.2.7   Statistical analysis 
 
  The data were analyzed statistically by Repeated Measures, One-Way or Two-
Way ANOVA in PROC MIXED using SAS (Version 9.2, SAS Institute Inc., Cary, NC, 
USA) for each assay, respectively. For the migration assay, the mean of the control 
wound area at 0 h was set to 0% wound closure and the data were expressed as the 
percent wound closure of the control for each dog. For the invasion assay and 
proliferation assay, the mean of the controls was set to 100% and the data was expressed 
as the percentage of the control for each dog. For the proliferation assay, measurements at 
690 nm were subtracted from measurements at 570 nm to account for background. Data 
were expressed as mean ± SEM and significance was defined as P<0.05. 
 
2.3   RESULTS 
 
  Representative fields for the migration assay are illustrated in Figure 2.1. For the 
migration assay, IL-8 increased cell migration by 35% compared to the control (P=0.003; 
Figure 2.2). TIMP-2 had no significant effect on cell migration (P=0.38; Figure 2.2).    94 
 
Figure 2.1. Representative wells illustrating migration after 0 and 8 hours in culture for 
the control (C; no IL-8 or TIMP-2 treatment), IL-8-treated, and TIMP-2-treated primary 
term canine trophoblast cells (phase contrast;100X magnification). 
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Figure 2.2. The effect of IL-8 and TIMP-2 on primary term canine trophoblast cell 
migration (mean ± SEM). IL-8 increased cell migration by 35% compared to no 
treatment (C; **P<0.01). TIMP-2 had no significant effect on cell migration (wound 
closure) (P=0.38). Experiments were performed in triplicate (n=5 dogs). 
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Representative fields for the invasion assay are illustrated in Figure 2.3. There was no 
significant effect of IL-8 on cell invasion compared to the control (P=0.42; Figure 2. 4). 
On the other hand, TIMP-2 decreased cell invasion by 57% compared to the control 
(P=0.03; Figure 2.4). For the proliferation assay, IL-8 had no significant effect on cell 
proliferation (P=0.18; Figure 2.5). 
 
2.4   DISCUSSION 
  In vitro canine trophoblast physiology has not been previously described. 
Therefore, the objective of this study was to characterize normal in vitro term canine 
trophoblast (TCT) physiology using migration, invasion, and proliferation assays. In 
addition, the objective was to investigate the effect of IL-8 and TIMP-2 on these 
behaviors. Concentrations selected for IL-8 and TIMP-2 were based on dosages found to 
elicit maximum effects in previous studies with human trophoblasts (Librach et al., 1991; 
Jovanović et al., 2010).  
  In the current study, IL-8 increases TCT migration, which is similar to 
observations in first trimester human HTR-8/SVneo trophoblasts where IL-8 increases 
cell migration (Jovanović et al., 2010). Studies have also shown that IL-8 increases first 
trimester human trophoblast invasion and proliferation (Hanna et al., 2006; Jovanović et 
al., 2010). In addition, the application of IL-8-neutralizing antibodies reduces primary 
first trimester human trophoblast invasion (Hanna et al., 2006). However in the current 
study, IL-8 did not increase invasion and proliferation in primary TCT. Although TCT do 
retain invasive capacity, it is important to note that human trophoblasts do not retain any  97 
 
Figure 2.3. Representative fields of cell invasion for control (A), IL-8-treated (10 ng/ml, 
B), and TIMP-2-treated primary term canine trophoblast cells (0.5 µg/ml, C). Arrows 
indicate the trophoblast nuclei and arrowheads indicate the 8 µm filter membrane pores 
(Diff-Quik staining; 400X magnification, scale bar=20 µm). 
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Figure 2.4. The effect of IL-8 and TIMP-2 on primary term canine trophoblast cell 
invasion (mean ± SEM). There was no significant effect of IL-8 (10 ng/ml) on invasion 
compared to the no treatment (C; P=0.42). TIMP-2 (0.5 µg/ml) decreased cell invasion 
by 57% compared to the control (*P<0.05). Experiments were performed in triplicate 
(n=5 dogs). 
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Figure 2.5. IL-8 (10 ng/ml) had no effect on mean ± SEM primary term canine 
trophoblast proliferation compared to no treatment (C; P=0.18). Experiments were 
performed in quadruplicate (n=4 dogs). 
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invasive capacity at term (Librach et al., 1991). It is possible than TCT do not retain 
receptors for IL-8 at term. In humans, IL-8 mediates its effect through the CXCR1 and 
CXCR2 receptors (Tsui et al., 2004; Hanna et al., 2006). It is not known if a similar 
receptor exists in dogs or if it is temporally expressed during gestation. Investigations are 
needed to determine if canine CXCR1 and CXCR2 receptors exist.  
  Whereas the effects of IL-8 are dependent on MMP activity (Jovanović et al., 
2010), MMP activity is regulated by TIMP in human trophoblast invasion (Librach et al., 
1991; Zhang et al., 2012). Down-regulation of TIMP-2 mRNA increases migration and 
invasion of human first trimester HTR-8/SVneo trophoblasts (Zhang et al., 2012). The 
role of TIMP-2 in canine trophoblast migration and invasion has not been previously 
studied. Therefore, in the current study, it was shown that TIMP-2 decreases TCT 
invasion, but not migration. The role of TIMP-2 on cell migration in early gestation 
canine trophoblast should be investigated.  
  In conclusion, this is the first study to examine canine trophoblast physiology in 
vitro. The current study provides evidence that IL-8 promotes migration, whereas TIMP-
2 decreases invasion in normal primary TCT. This information provides a basis for 
understanding placental pathologies that occur during the canine peripartum period. 
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CHAPTER III 
 
CONCLUSION AND FUTURE STUDIES 
 
  The studies contained within this thesis were the first to investigate term canine 
trophoblast  (TCT)  physiology  in  vitro.  We  found  that  IL-8  stimulates  primary  TCT 
migration, whereas TIMP-2 inhibits invasion. These findings provide a basis for future 
research on placental-related disorders resulting from a disruption of normal trophoblast 
proliferation or invasion, such as in cases of subinvolution of placental sites.   
  Future  studies  should  investigate  canine  trophoblast  differences  in  migration, 
invasion, and proliferation at different stages of gestation, especially during the period of 
apposition and implantation. Knowledge of early gestation canine trophoblast physiology 
would  allow  for  direct  comparison  to  other  studies  using  human  first  trimester 
trophoblasts. Factors important in the signaling between the trophoblast and endometrium 
during implantation in humans (such as integrins α1, α5, and β1 and extracellular matrix 
proteins have not been investigated in dogs. It is expected that integrins and extracellular 
matrix  proteins  will  promote  invasion  and  migration,  which  is  key  to  successful 
implantation and the establishment and maintenance of pregnancy.  
Studies investigating the presence of the IL-8 receptors, CXCLR1 and CXCLR2, 
in TCT should also be pursued, to support modeling for human placental conditions. It is 
expected  that  dogs  retain  a  form  of  the  IL-8  receptors  based  on  the  IL-8-induced 
stimulation of cell migration presented in this research.  106 
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APPENDIX A. SOLUTIONS AND REAGENTS 
 
Cell isolation medium 
  The cell isolation medium (500 ml) was prepared with 475 ml DMEM (11965-
092, Gibco, Life Technologies, Grand Island, NY) with 12.5 ml FBS (16000, Gibco, Life 
Technologies), 5 ml Glutamine Plus (B90210, Atlanta Biologicals, Lawrenceville, GA),  
5 ml Penicillin/Streptomycin (15140-122, Life Technologies), and 2.5 ml Gentamycin 
(15750, Life Technologies).  
 
Enzyme digestion solutions 
  The collagenase solution (100 ml) was prepared with 100 ml 1X DPBS (14109-
144, Gibco), 0.062 g collagenase (C2674, Sigma, St. Louis, MO), 0.04 g DNase (DN25, 
Sigma), 0.069 g hyaluronidase (H3506, Sigma), and 0.10 g bovine serum albumin 
(A7906, Sigma).  
  The trypsin solution (100 ml) was prepared with 100 ml 1X DPBS (14109-144, 
Gibco), 0.0069 g trypsin (T8003, Sigma), 0.04 g DNase (DN25, Sigma), and 0.02 g 
EDTA (E5134, Sigma). 
 
Percoll density gradient solutions  
  The Percoll density gradient consisted of 7 stock solutions: 90%, 70%, 60%, 50%, 
40%, 30%, and 20% Percoll solutions. Each Percoll solution consisted of Percoll (17-
0891-01, GE Healthcare Bio-Sciences  AB, Pittsburgh, PA), 10X Hank’s BSS without 
Phenol Red (14185, Invitrogen), 1X Hank’s BSS without Phenol Red (14175, 108 
 
Invitrogen), and 1X Hank’s BSS with Phenol Red (14170, Invitrogen/Life Technologies, 
Grand Island, NY). The 1X Hank’s BSS with and without Phenol Red was used to 
produce the discontinuous layers of the Percoll gradient, to aid in the separation of cells 
based on density. For 90% Percoll, 270 ml Percoll was combined with 30 ml 10X Hanks 
BSS without Phenol Red. For 70% Percoll, 35 ml 90% Percoll was combined with 10 ml 
1X Hanks BSS without Phenol Red. For 60% Percoll, 30 ml 90% Percoll was combined 
with 15 ml 1X Hanks BSS with Phenol Red. For 50% Percoll, 25 ml 90% Percoll was 
combined with 20 ml 1X Hanks BSS without Phenol Red. For 40% Percoll, 20 ml 90% 
Percoll was combined with 25 ml 1X Hanks BSS with Phenol Red. For 30% Percoll, 15 
ml 90% Percoll was combined with 30 ml 1X Hanks BSS without Phenol Red. For 20% 
Percoll, 10 ml 90% Percoll was combined with 35 ml 1X Hanks BSS with Phenol Red, 
tubes were stored at 4ºC until use. After stock solutions were made, 6 ml of each solution 
was slowly layered in a 50 ml conical tube starting with 70% Percoll at the bottom, 60%, 
50%, 40%, 30%, and up to 20% Percoll at the top. The Percoll gradient should be 
prepared the same day as the tissue collection, with 36 ml Percoll gradient for every 8 g 
of starting tissue.   
 
Phosphate buffered saline (PBS) wash medium  
  PBS wash medium was made to perform washes during immunohistochemical 
studies, and is different from the 1 X DPBS used in the enzymes solutions above. PBS 
wash medium consisted of 80 g NaCl, 2 g KCl, 11.5 g Na2HPO4·7H20, 2 g KH2PO4 (all 
from Sigma), diluted in 1 L H20. The PBS was then filtered through filter paper (0.45 109 
 
µm, #HAWP02500, Millipore, Bedford, MA) and sterilized in the autoclave (Steam-It 
Dual-matic Sterilmatic, Market Forge, Everett, MA).    
 
Bovine serum albumin (BSA) buffer solution  
  BSA buffer solution for the reconstitution of lyophilized IL-8 and TIMP-2. The 
0.1% BSA buffer (10 ml) was prepared with 10 ml 1X DPBS (14109-144, Gibco) and 
0.01 g BSA (A7906, Sigma). 
 
Migration assay culture medium   
For Experiment 1, the migration assay used both medium A and medium B to 
examine the effect of serum and serum-free medium on TCT cell culture and migration. 
  Medium A (500 ml) consisted of 482.5 ml DMEM (11995, Gibco, Life 
Technologies) with 5 ml Hepes (15630, Life Technologies), 5 ml Glutamine Plus 
(B90210, Atlanta Biologicals), 5 ml Penicillin/Streptomycin (15140-122, Life 
Technologies), 2.5 ml Gentamycin (15750, Life Technologies).  
Medium B (500 ml) is the same as medium A with the addition of serum, so it 
consisted of 432.5 ml DMEM with 5 ml Hepes, 5 ml Glutamine Plus, 5 ml 
Penicillin/Streptomycin, 2.5 ml Gentamycin, and supplemented with 50 ml FBS (16000, 
Gibco, Life Technologies).  
For Experiment 2, the migration assay only used medium B, because it was the 
best medium for TCT cell culture and cell migration.  
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Invasion assay culture medium 
For Experiment 1, the invasion assay used mediums A, B, and C to determine the 
best medium and chemoattractant conditions to allow for maximal TCT invasion. 
Mediums A and B were prepared as described above. Briefly, medium A consisted of 
482.5 ml DMEM, 5 ml Hepes, 5 ml Glutamine Plus, 5 ml Penicillin/Streptomycin, and 
2.5 ml Gentamycin. Medium B is the same as medium A with the addition of serum, so it 
was prepared with 432.5 ml DMEM, 5 ml Hepes, 5 ml Glutamine Plus, 5 ml 
Penicillin/Streptomycin, 2.5 ml Gentamycin, and 50 ml FBS. 
  Medium C was made with Nutridoma, a reduced protein alternative with ˂50 
µg/ml for a 1% Nutridoma solution. Medium C (100 ml) consisted of 98 ml medium A 
supplemented with 2 ml Nutridoma (11011375001, Roche, Indianapolis, IN). 
  For Experiment 1, primary TCT were suspended in medium A (without serum) 
and seeded into the upper wells. The chemoattractant (medium B with serum or medium 
C reduced protein) was placed in the lower well. This gradient allows for maximal 
chemotaxis as the TCT degrade and invade the Matrigel from a lower serum or protein 
environment to the chemoattractant with a higher serum environment.  
  For Experiment 2, primary TCT were suspended in medium A with or without 
factor (IL-8 or TIMP-2) and the chemoattractant was medium B. These conditions 
allowed for the most number of invading cells using this assay.  
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Proliferation assay culture medium 
For Experiment 1, the proliferation assay used both medium A and medium B, as 
described above to examine the effect of serum and serum-free medium on TCT 
proliferation. Primary TCT were cultured in medium A prepared with 482.5 ml DMEM 
with 5 ml Hepes, 5 ml Glutamine Plus, 5 ml Penicillin/Streptomycin, 2.5 ml Gentamycin. 
Primary TCT were also cultured in medium B, which is the same as medium A with the 
addition of serum, so it was prepared with 432.5 ml DMEM with 5 ml Hepes, 5 ml 
Glutamine Plus, 5 ml Penicillin/Streptomycin, 2.5 ml Gentamycin, and supplemented 
with 50 ml FBS.The proliferation assay kit MTT (CGD-1, Cell Growth Determination 
Kit MTT-based, Sigma, St. Louis, Missouri) consisted of 5 mg/ml MTT in RPMI-1640 
without phenol red and 1-propanol (0.1 N HCl in anyhydrous isopropanol). 
 
Preparation of factors for Migration, Invasion, and Proliferation Assays 
 
  Recombinant canine and human IL-8 and recombinant human TIMP-2 factors and 
conversions are summarized in Tables A.1 through A.3. Concentrations selected for IL-8 
and TIMP-2 were based on dosages found to elicit maximum effects in previous studies 
with human trophoblasts (Librach et al., 1991; Jovanović et al., 2010). 
  After determining the amount of IL-8 (ng/ml) and TIMP-2 (µg/ml) desired, stock 
solutions and dilutions of IL-8 and TIMP-2 for each experiment were summarized in 
Tables A.4 through A.9. For Experiment 2, human IL-8 was compared to canine IL-8 to 
determine which factor had the greater effect on TCT migration, and that factor would be 
used in Experiment 3.  
 
Table A.1. Factors used for proliferation, migration, and invasion in vitro assays. 
 
Factor  IL-8  IL-8  TIMP-2 
Species  Canine  Human  Human 
Migration assay  10, 100 ng/ml  10, 50, 100 ng/ml  0.05, 0.1, 0.5 µg/ml 
Invasion assay  None  10, 50 ng/ml  0.5 µg/ml 
Proliferation assay  None  10, 50 ng/ml  None 
Catalog #  70009-DNAE  200-08M  410-02 
Company  Sino Biological, Inc., Beijing, China  PeproTech, Rocky Hill, NJ  PeproTech, Rocky Hill, NJ 
 
   
1
1
2
  
 
Table A.2. Unit conversion of IL-8 unit conversion from kDa to ng/ml.  
 
IL-8 starting 
concentration (nM) 
 
kDa to  kg/mol  kg/mol to µg/L  µg/L to µg/ml  µg/ml to ng/ml 
65 nM = 65 nmol/L  8 kDa = 8 kg/mol  8 kg/mol X 65 nmol/L = 
520 µg/L 
520 µg/L X 10
-3 L/ml = 
0.520 µg/µl 
0.520 µg/µl X 100 ng/µg = 
520 ng/ml  
15 nM = 15 nmol/L  8 kDa = 8 kg/mol  8 kg/mol X 15 nmol/L = 
120 µg/L 
120 µg/L X 10
-3 L/ml = 
0.120 µg/ml 
0.120 µg/µl X 100 ng/µg = 
120 ng/ml 
6 nM = 6 nmol/L  8 kDa = 8 kg/mol  8 kg/mol X 6 nmol/L = 48 
µg/L 
48 µg/L X 10
-3 L/ml = 0.048 
µg/ml 
0.048 µg/µl X 100 ng/µg = 48 
ng/ml 
1 nM = 6 nmol/L  8 kDa = 8 kg/mol  8 kg/mol X 1 nmol/L = 8 
µg/L 
8 µg/L X 10
-3 L/ml   = 0.008 
µg/ml 
0.008 µg/µl X 100 ng/µg = 8 
ng/ml 
 
   
1
1
3
  
 
 Table A.3. Unit conversion of TIMP-2 from kDa to µg/ml.  
 
TIMP-2 starting 
concentration (nM) 
 
kDa to  kg/mol  kg/mol to µg/L  µg/L to µg/ml 
25 nM = 25 nmol/L  21.8 kDa = 21.8 kg/mol  21.8 kg/mol X 25 nmol/L = 545 µg/L  545 µg/L X 10
-3 L/ml = 0.55 µg/ml 
5 nM = 5 nmol/L  21.8 kDa = 21.8 kg/mol  21.8 kg/mol X 5 nmol/L = 109 µg/L  109 µg/L X 10
-3 L/ml = 0.109 µg/ml 
2.5 nM = 2.5 nmol/L  21.8 kDa = 21.8 kg/mol  21.8 kg/mol X 2.5 nmol/L = 55 µg/L  55 µg/L X 10
-3 L/ml = 0.055 µg/ml 
1
1
4
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Table A.4. Preparation of IL-8 & TIMP-2 stock solutions.  
 
Factor  Starting mass  Reconstitution medium  Final concentration 
Canine IL-8  20 µg  200 µl sterile water  100 ng/µl 
Human IL-8  25 µg  250 µl 0.1 % BSA   100 ng/µl  
Human TIMP-2  10 µg  100 µl 0.1 % BSA  0.1µg/µl 
  
 
Table A.5. Preparation of canine IL-8 dilutions for the migration assay. 
 
IL-8 final 
concentration 
Volume of canine IL-8   Volume of 10% FBS  Location & volume of aliquot 
100 ng/ml  5 µl of stock IL-8 (100 ng/µl)  5.0 ml  Migration assay test wells (1 ml/well) 
10 ng/ml  0.5 ml of the above solution (100 ng/ml)  4.5 ml  Migration assay test wells (1 ml/well)  
 
   
1
1
6
  
 
Table A.6. Preparation of human IL-8 dilutions for the migration assay. 
 
IL-8 final 
concentration 
Volume of human IL-8   Volume of 10% FBS  Location & volume of aliquot 
100 ng/ml  10 µl of stock IL-8 (100 ng/µl)  10 ml  Migration assay test wells (1 ml/well) 
50 ng/ml  3.25 ml of the above solution (100 ng/ml)  3.25 ml  Migration assay test wells (1 ml/well)  
10 ng/ml  2.0 ml of the above solution (50 ng/ml)  8.0 ml  Migration assay test wells (1 ml/well) 
 
   
1
1
7
  
 
Table A.7. Preparation of human TIMP-2 dilutions for the migration assay.  
 
TIMP-2 final 
concentration 
Volume of human TIMP-2   Volume of 
10% FBS 
Location & volume of aliquot 
0.5 µg/ml  32.5 µl of stock TIMP-2 (0.1µg/µl)  6.5 ml   Migration assay test wells (0.5 or 1 ml/well) 
0.1 µg/ml  1.0 ml of the above solution (0.5 µg/ml)  4.0 ml  Migration assay test wells (1 ml/well) 
0.05 µg/ml  2.0 ml of the above solution (0.5 µg/ml)  2.0 ml  Migration assay test wells (1 ml/well) 
 
   
1
1
8
  
 
Table A.8. Preparation of human IL-8 dilutions for the invasion assay. 
 
IL-8 final 
concentration 
Volume of human IL-8   Volume of PFM  Location & volume of aliquot 
500 ng/ml  20 µl of stock IL-8 (100 ng/µl)  2 ml  None, proceed to next dilution 
100 ng/ml  0.6 ml of the above solution (500 ng/ml)   2.4 ml  None, proceed to next dilution 
50 ng/ml  2.5 ml of the above solution (100 ng/ml)  2.5 ml  Invasion assay test wells (250µl/well)  
10 ng/ml  0.6 ml of the above solution (100 ng/ml)   2.4 ml  Invasion assay test wells (250µl/well) 
 
   
1
1
9
  
 
Table A.9. Recombinant human TIMP-2 dilutions for the invasion assay. 
 
TIMP-2 final concentration  Volume of human TIMP-2   Volume of PFM  Location & volume of aliquot 
0.5 µg/ml  10 µl of stock TIMP-2 (0.1µg/µl)  1.0 ml   Invasion assay test wells (250µl/well) 
 
   
1
2
0
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APPENDIX B. TERM CANINE TROPHOBLAST ISOLATION AND CULTURE 
 
Summary 
  Using methods originally described Thiede and Rudolph (1961), scientists have 
isolated and cultured trophoblasts from freshly collected placentas in several species. 
Technical reviews of these methods for humans (Hunkapillar and Fisher, 2008) and dogs 
(Sahlfeld et al., 2012) have been published.  The following techniques were modified 
from the work of Sahlfeld and coworkers (2012) for the purposes of the current thesis 
research.  
 
Animals 
Placenta was collected from pregnant bitches (n=21 dogs) that underwent elective c-
section at term. The animals are described in Table B.1.  
   
Tissue Collection  
Canine placental tissue was collected following elective C-section with 
progesterone ˂ 2.5 ng/ml at the time of pre-partum luteolysis (degradation of corpus 
luteum) but prior to labor onset. Following collection of the placenta, the villous 
chorioallantois was dissected free from the marginal hematoma, nonvillous 
chorioallantois, and connective tissues; and blood was also removed by blotting with a 
paper towel. Chorioallantois tissue was minced into 0.5-cm sections. The tissue was 122 
 
placed in 50 ml conical tubes and suspended in ice-cold (4ºC refrigeration) cell isolation 
medium (Appendix A) at 1:4 tissue to medium dilution. 
 
Cell Isolation 
  Trophoblast isolation and culture was successfully developed by Thiede and 
Rudolph (1961), which they removed debris and undisaggregated tissue by a series of 
agitation and filtration steps until cells appeared loosened from the dissected placental 
villi and the cells were suspended in the surrounding cell isolation medium. In the current 
study, primary term canine trophoblast (TCT) isolation was performed as previously 
described (Sahlfeld et al., 2012), with modifications in enzyme solutions (1:4 rather than 
1:6), addition of a third enzyme digestion (collagenase), and the volume of Percoll 
density gradient (1 tube:8 g tissue rather than 1 tube:6 g tissue, Appendix A). These 
mnodifications were made to conserve resources as lower concentrations of enzyme 
solutions and higher tissue concentrations in the Percoll density gradient were found to be 
just as effective for cell isolation. 
Briefly, after collection, the chorioallantois was washed twice by centrifugation 
(1300 rpm for 5 min at 4ºC) replacing with ice-cold medium after each wash. After the 
second wash, the medium was removed and warm (37ºC) 0.062% collagenase solution 
(Appendix A) was added to the tissue at 1:4 dilution for the first enzyme digestion. The 
tubes of tissue and collagenase were then placed into a 37ºC shaking incubator (175 rpm 
for up to 20 min) at ˂45º angle. After tissues have reached the desired amount of 
degradation (tissue fibers appear slightly eroded and loosened from the rest of the tissue 123 
 
to making a “soupy” solution). The tubes of degraded tissues were placed upright in a 
bucket of ice for no longer than a minute to allow tissues to settle to the bottom, and 
supernatant was removed. Warm 0.0069% trypsin solution (Appendix A) was then added 
to the tissues at 1:4 dilution and were again placed in the shaking incubator (175 rpm for 
up to 10 min) for the second enzyme digestion. Once tissues have reached the desired 
amount of degradation (“soupy” appearance), the tubes were again placed in ice for the 
tissues to settle at the bottom. Although this time, after 1 min the loosened cells of 
interest are now suspended in the supernatant, which was collected and placed in new 
conical tubes up to 30 ml and the remainder of the tube was filled up to 45 ml with ice-
cold medium. Tubes were then washed twice by centrifugation (1300 rpm for 8 min at 
4ºC), replacing with ice-cold medium after each wash, being careful to not disturb the 
cell pellet at the bottom. After the second wash, the medium was removed and warm 
collagenase solution (1 ml) was added to the cells and placed in the shaking incubator 
(150 rpm for up to 3 min) for the third enzyme digestion. Immediately, ice-cold medium 
was added to the tubes up to 45 ml and was washed once by centrifugation (1300 rpm for 
8 min). The supernatant was removed and the cell pellet was suspended in ice-cold 
medium up to 25 ml. The cell suspension was then added to the top of the Percoll density 
gradient (Appendix A) and placed in long centrifugation (2500 rpm for 20 min at 4ºC) to 
separate the cells according to their densities, so that the trophoblasts are isolated from 
other cells similar in size. The top two trophoblast-containing layers were collected 
between 30-36 ml of the tube, with medium collected just below 30 ml to ensure 
collection of isolated trophoblasts. Up to 25 ml of the collected trophoblast layer are 124 
 
placed in a new conical tube, adding medium up to 45 ml and the cells was washed twice 
by centrifugation (1300 rpm for 8 min), replacing with medium A (Appendix A) after the 
first wash. After the second wash, medium A is aspirated and resuspended with more 
medium A up to 5 ml to count the cell concentration in a hemocytometer. After cell 
concentration is determined, the cells are suspended in PFM and aliquoted into each 
assay or placed in culture. An additional centrifugation step (1300 rpm for 5 min) is 
necessary to remove the supernatant and resuspend the cells in medium B (Appendix A) 
for immunohistochemistry, migration assay, and spontaneous migration experiments. 
 
Cell Culture 
  For the original work by Thiede and Rudolph (19161), cells were plated on glass 
in 10 % fetal bovine serum medium with antibiotics and were placed in 37 ºC with 7% 
CO2 until trophoblasts attached to the glass to form monolayers. Recent studies utilize the 
standard tissue culture conditions of 37 ºC with 7% CO2, which has allowed for 
successful culture of trophoblast across species in humans (Hunkapillar and Fisher, 
2008), dogs (Sahlfeld et al., 2012), and rodents (Rossant and Tamura-Lis, 1981). Cells 
were cultured at 37 ºC with 5% CO2 for this thesis work.  
  For immunohistochemistry, isolated primary TCT (1000X10
3 cells/well) were 
suspended in medium B (2.5 ml/dish) and seeded onto glass coverslips that were placed 
inside 6- 33 mm
2 tissue culture dishes. Dishes were incubated and fed with new, warm 
(37ºC) 10% FBS 24 h after seeding and every 48 h thereafter, until cells formed a 70-
80% confluent monolayer after 10-14 days in culture. 125 
 
  For the migration assay (Appendix C), in Experiment 1 primary TCT (1000X10
3 
cells/well) were suspended in medium A or medium B (2 ml/well) and plated into a 6-
well tissue culture plate (BD Falcon, Franklin Lakes, NJ). For Experiment 2, primary 
TCT (1000X10
3 cells/well) were suspended in medium B (1 ml/well) with or without 
human IL-8 or canine IL-8 and plated into a 12-well tissue culture plate (BD Falcon). For 
Experiment 3, primary TCT (1000X10
3 cells/well) were suspended in medium B (1 
ml/well) with or without IL-8 or TIMP-2 and plated into a 12-well tissue culture plate 
(BD Falcon). For all experiments, plates were then incubated and fed with fresh medium 
B until a confluent monolayer of cells was formed after 7-10 days in culture.  
  For the spontaneous migration assay, primary TCT (250X10
3 cells/well) were 
suspended in medium A or medium B (0.5 ml/well) and seeded onto 12- control filter 
membrane inserts in the upper wells. The chemoattractant (medium A or medium B) was 
placed into the lower wells (0.75 ml/well) and the 12-well tissue culture plates were 
incubated for 22 h in culture. 
  For the invasion assay, in Experiment 1 primary TCT (0.25, 2.5, 25, 50, 100, and 
250 X 10
3 cells/well) were suspended in medium A or medium C (0.5 ml/well, Appendix 
A) and seeded onto 6- Matrigel-coated filter membranes in the upper wells. In 
Experiment 2, primary TCT (250 X 10
3 cells/well) in medium A with or without IL-8 or 
TIMP-2 were used. For both experiments, medium B was the chemoattractant (0.75 
ml/well) and was placed into the lower wells and the 12-well tissue culture plates were 
then incubated for 22 h in culture. 126 
 
  For the proliferation assay, in Experiment 1 primary TCT (10 x10
3, 50 x10
3, 100 
x10
3, 200 x 10
3, and 500 x10
3 cells/well) were suspended in medium A or medium B 
(100 µl/well) and seeded into a 96-well tissue culture plate. Plates were incubated for 24 
h. In Experiment 2, primary TCT (20 x10
3, 50 x10
3, 100 x10
3, 200 x 10
3, and 500 x10
3 
cells/well) in medium A with or without IL-8 were seeded. Plates were then incubated for 
8, 32, 36, and 44 h in culture.  
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Table B.1. A summary of bitches that donated placenta for primary trophoblast isolation.after elective c-section at term. 
 
Dog  Samba  Gemma  Bugs Scott  Cher  Elvira  Sassy  Abby 
Date collected  10/27/11  11/3/11  11/18/11  12/2/11  12/10/11  12/13/11  3/15/12 
Breed  Australian 
Labradoodle 
Bulldog  Clumber 
Spaniel 
Rottweiler  Dandy 
Dinmont 
Terrier 
Labradoodle  Mini Bull 
Terrier 
Age (years)  4 1/2   2   3 ½   6  2 ½  1  3 
Litter size  7   6   4  3  1  6  4 
Parity  2  1  1  4  1  1  2 
Source  WVC  WVC  WVC  WVC  GAC  WVC  WVC 
Experiments  I  I  I  I  I  I  M, I 
Source: GAC- Gresham Animal Clinic, OSU- Oregon State University Small Animal Clinic, WVC- Wilsonville Veterinary 
Clinic. Experiments: CC- Immunocytochemistry, M- Migration assay, I- Invasion assay, P- Proliferation assay. 
   
1
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Table B.1 (continued). A summary of bitches that donated placenta for primary trophoblast isolation.after elective c-section at 
term. 
 
Dog  Bella Seaberg  Rosie  Fancy  Cleo  Shiloh  Body  Mithril 
Date collected  3/26/12  3/26/12  6/25/12  6/25/12  11/14/12  12/14/12  12/15/12 
Breed  Bulldog  Labradoodle  Australian 
Labradoodle 
Dachshund  Bulldog  Labradoodle  Bull Mastiff 
Age (years)  2 ½  3  9  2  1  2  3 
Litter size  4  12  4  4  1  12  4 
Parity  1  3  2  2  1  1  1 
Source  WVC  WVC  WVC  WVC  WVC  WVC  OSU 
Experiments  M, I  M, I  CC, M, I  CC, M, I  M, I, P  M, I, P  M, I 
Source: GAC- Gresham Animal Clinic, OSU- Oregon State University Small Animal Clinic, WVC- Wilsonville Veterinary 
Clinic. Experiments: CC- Immunocytochemistry, M- Migration assay, I- Invasion assay, P- Proliferation assay. 
   
1
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Table B.1 (continued). A summary of bitches that donated placenta for primary trophoblast isolation.after elective c-section at 
term. 
 
Dog  Tory  Force  Berry  CJ  Claire  Sophie  Pandora 
Date collected  1/8/13  1/10/13  2/1/13  2/5/13  2/7/13  2/22/13  3/13/13 
Breed  Bulldog  Yellow 
Labrador 
Retriever 
Bulldog  Sharpei  Corgi  Bulldog  Bull Mastiff 
Age (years)  2  3  2  2  5  5  6 
Litter size  1  8  7  4  10  9  2 
Parity  2  2  1  2  2  2  2 
Source  OSU  WVC  WVC  WVC  WVC  WVC  WVC 
Experiments  M, I, P  M, I, P  M, I, P  M, I, P  M, I, P  M, I, P  I, P 
Source: GAC- Gresham Animal Clinic, OSU- Oregon State University Small Animal Clinic, WVC- Wilsonville Veterinary 
Clinic. Experiments: CC- Immunocytochemistry, M- Migration assay, I- Invasion assay, P- Proliferation assay. 
 
1
2
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APPENDIX C. MIGRATION ASSAY  
 
Summary 
  The objective for using the migration assay, also known as a wound-healing or 
scratch assay, Experiment 1 first determined the best culture and migration medium 
(medium A or medium B, Appendix A). In addition, varying dosages of IL-8 and TIMP-2 
(Appendix A, Table A.1) were added to observe their effect on TCT migration in 
Experiment 2.  
 
Experiment 1 
  The migration assay was performed as previously described (Liang et al., 2007). 
Term canine trophoblasts (TCT; n=5 dogs) were suspended in medium A or medium B (2 
ml/well) and seeded (1000X10
3 cells/well) in a 6-well tissue culture plate. The plate 
remained in culture at 37ºC with 5% CO2 until a monolayer of cells was formed after 7-
10 days. When cultured in medium A, TCTs were unable to adhere to the coverslip and 
aggregate to form cell clusters and the lack of protein or serum supplement resulted in 
cell death after 7-10 days in culture. From then on, TCTs were cultured in 10% FBS to 
form a monolayer. After reaching 70-80% confluence, a scratch was added into the cell 
monolayer using sterile pipette tip and loosened cells were removed by rinsing the wound 
with warm (37ºC) medium A and replacing with medium A or medium B (2 ml/well). 
Cells were then incubated for 24 h. The wound width was photographed with a digital 
camera (Fujufilm Fine AX300 14 MP Digital Camera with Fujinon 5x Wide Angle 131 
 
Optical Zoom Lens, Tokyo, Japan) and measured with digital calipers (General® Tools 
Corp., New York City, NY) after 0, 8, 12 and 24 h in culture. The wound width at t=0 h 
served as the baseline at 0% wound closure. Migration assay experiments were 
performed in triplicate. Data was analyzed with Repeated Measures ANOVA (NCSS 
Statistical Software-8, NCSS LLC, Kaysville, Utah). 
   
Experiment 2 
  Migration assays were performed to compare the effect of human IL-8 and canine 
IL-8 on primary TCT migration. Primary TCT (n=4 dogs) were plated in medium B at 
1X10
6 cells/well into three 12-well tissue culture plates (1.25 ml/well). Cells were 
cultured at 37ºC in 5% CO2 until a 70-80% confluent cell monolayer was formed. After 
reaching 70-80% confluence, a scratch was added into the cell monolayer using sterile 
pipette tip and loosened cells were removed by rinsing and then replacing with 1 mL of 
medium B with or without recombinant canine IL-8 (0, 10, and 100 ng/mL) or with or 
without recombinant human IL-8 (0, 10, and 100 ng/mL). Cells were then incubated for 
24 h and microphotographs were taken with a Nikon Eclipse Ti inverted microscope with 
attached digital camera (Nikon Instruments Inc., Melville, NY) after 8, 12, and 24 h in 
culture. Experiments were performed in triplicate. Data was analyzed with Repeated 
Measures ANOVA (NCSS LLC). Fixed effects of the model were treatment type (canine 
IL-8 vs. human IL-8), dosage (0, 10, and 100 ng/mL), and time after treatment (0, 8, 12, 
and 24 h).  
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Experiment 3 
  Migration experiments were performed using recombinant human IL-8 and 
human TIMP-2 to determine effect of IL-8 and TIMP-2. Primary isolated TCTs (n=5 
dogs) were plated at 1X10
6 cells/well in medium B into three 12-well tissue culture plates 
(1.25 ml/well). Cells were cultured at 37ºC in 5% CO2 until a monolayer was formed. 
After reaching 70-80% confluence, a scratch was added into the cell monolayer using 
sterile pipette tip and loosened cells were removed by rinsing and then replacing with 1 
mL of medium B with or without IL- 8 (0, 10, 50, and 100 ng/mL), TIMP-2 (0, 0.05, 0.1, 
and 0.5 µg/mL). In addition, a combination of IL-8 (50 ng/mL) and TIMP-2 (0.5 µg/mL) 
were added to plates in a smaller subset of dogs (n=3 dogs). Cells were then incubated for 
24 h and microphotographs were taken as stated in Experiment 1. Experiments were 
performed in triplicate. Data was analyzed with Repeated Measures ANOVA (NCSS 
LLC). Fixed effects of the model were treatment type (IL-8 vs. TIMP-2), dosage, and 
time after treatment (0, 8, 12, and 24 h).  
 
Results 
   For Experiment 1, canine trophoblasts cultured in medium B in a 33 mm
2 culture 
dish grew to 70-80% confluence into a cell monolayer starting with approximately 
100X10
3 cells/well. However, in medium A, trophoblasts remained at 5-10% confluence 
and cell death occurred within 7 days after plating. Based upon these results, the 
remaining experiments were all performed with TCTs cultured to 70-80% confluence 
using medium B. For the coverslips that were grown in medium B, at 8 h after the adding 133 
 
the wound, there was no difference in wound closure between medium A and medium B 
(p=0.48), where the wound closure was 10.8% ± 1.9% and 19.3% ± 8.2 % (mean ± 
SEM).. After 12 h, there was also no difference in the percent wound closure between 
medium A or medium B (p=0.21), where the wound closure was 23.6% ± 6.5% and 
42.9% ± 7.8%, respectively. However, after 24 h wound closure was reduced in medium 
A compared to medium B (p=0.05), where the wound closure was 39.9% ± 16.7% and 
80.1% ± 7.8%, respectively. 
  For Experiment 2, there was no significant difference on cell migration between 
the treatment type X dosage interaction (p=0.72), and treatment type X time interaction 
(p=0.97). For Experiment 3, there was no difference between the dosage of IL-8 on 
migration (p=0.56), and no IL-8 X time interaction on migration (p=0.95). In the 
presence of TIMP-2, there was no difference between the dosage of TIMP-2 on migration 
(p=1.00), and no TIMP-2 X time interaction (p=0.89) on migration. For the Experiment 3 
comparison, there was no TIMP-2 and IL-8 X time interaction (p=0.91) on migration. 
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Figure C.1. Representative fields of TCT migration for Experiment 1. After culturing to 
70-80% confluence in medium A, a wound was added and the migration of cells with 
medium A or medium B (shown below) was observed at 0, 8, 12, and 24 h in culture (n= 
5 dogs) and wound closure was measured.  
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Figure C.2. A comparison of culture medium (medium A or medium B) on cell migration 
(n=5). At t= 24 h, 80% of the wound was closed with medium B media (10% FBS) 
whereas 40% of the wound was closed with medium A (protein-free medium, PFM) 
(p=0.0503). 
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Figure C.3. A comparison of Sino Biologicals Inc. (Sino) canine recombinant IL-8 or 
PeproTech (Pep) human recombinant IL-8 (0, 10, and 100 ng/mL) on cell migration (n=3 
dogs). IL-8 did not increase wound closure (p=0.72). Data was expressed as percent 
wound closure of control at 0% baseline ± SEM.  
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Figure C.4. The effect of human IL-8 (0, 10, and 100 ng/mL) on cell migration (n=5 
dogs). IL-8 dosage had no effect on cell migration (p=0.56), also there was no IL-8 X 
time interaction (p=0.95). Data was expressed as percent wound closure of control at 0% 
baseline ± SEM.  
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Figure C.5. TIMP-2 had no effect on cell migration at any of the dosages tested (0, 0.05, 
0.1, and 0.5 µg/mL) (p=1.00) (n=5 dogs), also there was no TIMP-2 X time interaction 
(p=0.89). Data was expressed as percent wound closure of control at 0% baseline ± SEM. 
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Figure C.6. The combinatorial effect of IL-8 & TIMP-2 on cell migration. There was no 
TIMP-2 and IL-8 X time interaction (p=0.91) on migration (n=3 dogs). Data was 
expressed as percent wound closure of control at 0% baseline ± SEM.  
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APPENDIX D. USE OF IMAGEJ PROGRAM FOR ANALYSIS 
 
  ImageJ is an image analysis program offered free by the National Institutes of 
Health, which was downloaded at http://rsb.info.nih.gov/ij/. This program was used to 
measure the wound area at each time point to calculate percent of wound closure. First, 
the program is started and the ImageJ Window appears on the desktop. To open a saved 
image file, on the Menu Bar under File, Open was selected to open the image file of 
choice. Alternatively, the image file can be dragged with a cursor to the Menu Bar. Next, 
the cursor can be used as a drawing tool to draw a perimeter around the denuded wound 
region. Then, the area of the wound is measured by selecting Analyze on the Menu Bar 
and Measure by typing Ctrl+M or just M. Measurement values will appear in a new data 
window to be recorded and to continue the percent wound closure calculation. Photo 
representation of steps taken for wound measurements are depicted in Figure D.1.  
 
    
Figure D.1. A step-wise guide to using ImageJ to measure wound area for the migration assay. 
 
   
Step 1  Step 2 
1
4
1
  
Figure D.1 (continued). A step-wise representation of wound measurements for the migration assay.   
 
Step 3  Step 4 
1
4
2
  
Figure D.1 (continued). A step-wise representation of wound measurements for the migration assay.   
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APPENDIX E. IMMUNOCYTOCHEMISTRY 
 
  Immunocytochemistry was performed to verify trophoblast phenotype as 
previously described by Sahlfeld et al (2012). Expression of cytokeratin-7 (CK-7) was 
used for confirming canine trophoblast purity following isolation. 
  Briefly, primary term canine trophoblasts (TCT) from 2 dogs were seeded 
(1000X10
3 cells/well) on glass coverslips in a 6-well tissue culture plate. The effect of 
medium (medium A or medium B) on cell migration in 6-well tissue culture plates were 
examined. The migration assay was performed as previously described (Appendix C). 
The plate was cultured in medium B at 37ºC with 5% CO2 until a monolayer of cells was 
formed after 10-14 days. After reaching 70-80% confluence for a subset of coverslips, a 
scratch was added into the cell monolayer using sterile pipette tip and loosened cells were 
removed by rinsing the wound with warm (37ºC) medium A and replacing with medium 
A or medium B (2 ml/well). Cells were then incubated for 24 h. The wound width was 
photographed with a digital camera (Fujufilm Fine AX300 14 MP Digital Camera with 
Fujinon 5x Wide Angle Optical Zoom Lens, Tokyo, Japan) and measured with digital 
calipers (General® Tools Corp., New York City, NY) after 0, 8, 12 and 24 h in culture. 
The wound width at t=0 h served as the baseline at 0% wound closure. Migration assay 
experiments were performed in triplicate. Data was analyzed with Repeated Measures 
ANOVA (NCSS Statistical Software-8, NCSS LLC, Kaysville, Utah). 
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  Coverslips were fixed with 3 ml 70% methanol in water and culture dishes were 
placed in an air-tight container and stored at 4ºC. Coverslips were washed with phosphate 
buffered saline wash medium (PBS, Appendix A), and treated with 5% donkey serum in 
PBS (blocking buffer) for 3 min at 20 ºC to block non-specific secondary antibody 
binding. The coverslips were washed with PBS and then incubated overnight with the 
CK-7 primary antibody diluted in blocking buffer (1:20, p103620, DAKO, Carpinteria, 
CA) at 4 ºC in a humidified chamber. Immunostaining specificity was verified by 
omission of the primary antibody. Following another wash with PBS, coverslips were 
incubated with the donkey anti-mouse Alexa Flour 488 secondary antibody diluted in 
blocking buffer (1:1000, A21202, Life Technologies) for 2 h at 20 ºC. Nuclei were 
detected with Hoechst 33342 (1:20,000, #H1399, Life Technologies) stain that was 
applied for 15 min at 20 ºC.  Finally, the coverslips were washed with PBS and mounted 
using Molecular Probes Prolong® Antifade Kit (#p7481, Life Technologies).  Images 
were captured on a Leica DM4000B microscope with a QImaging QICAM 12-bit (#QIC-
F-M-12-C, QImaging, Surrey, BC) digital camera and QCapture PRO (QImaging, 
Surrey, BC) image capture software.  Images were merged using Adobe Photoshop CS2 
(Adobe, San Jose, CA). CK-7 immunopositive cells were counted from 200 cells cultured 
on coverslips in this study. A cryopreserved primary TCT cell line 3&4 previously used 
in our laboratory as a positive control, was thawed, cultured in medium B on glass 
coverslips to 70-80% confluence, and fixed in 70% methanol.  
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Results 
Irrespective of culture medium and wound placement, >94% of culture trophoblasts 
(Table E.1) were immunopositive for CK-7 (Figure E.1). 
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Figure E.1.  Irrespective of culture medium (medium A or medium B), >95% of culture 
trophoblasts were immunopositive for CK-7. A) CK-7-positive trophoblasts in medium A 
and B) medium B (n= 2 dogs, 400X).  
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Table E.1. The effect of medium on CK-7 immunocytochemistry results of TCT with or 
without wound (n=2 dogs). 
 
   % CK-7 Positive 
Control Line 3&4, Medium B   99.50 
Dog 1 No wound, Medium B   94.00 
Dog 1 Wound, Medium A  97.00 
Dog 1 Wound, Medium B  94.50 
Dog 2 No wound, Medium B  97.50 
Dog 2 Wound, Medium A  97.50 
Dog 2 Wound, Medium B  96.50 
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APPENDIX F. SPONTANEOUS MIGRATION ASSAY 
 
Summary 
  Cells travel towards a chemoattractant through a process chemotaxis. Chemotaxis 
mechanisms can be studied using a transwell chamber, commonly referred to as a Boyden 
chamber (Boyden, 1962). The objective of this appendix was to compare spontaneous 
migration of primary term canine trophoblasts (TCT) with that of a chemoattractant 
(medium B).  
   
Spontaneous migration assay 
  A 24-well fitted plate is set up with 12 control filter membrane inserts (354578, 
BD Biosciences, Bedford, MA) using sterile forceps. The treatments were performed in 
triplicate as follows (upper well: lower well) with medium A (A) and medium B (B):  
1) A:A, 2) A:B, 3) B:B, and 4) B:A. After primary TCTs were isolated, cells were 
suspended in medium A or medium B to make a final concentration of 250X10
3 
cells/well. With forceps, inserts were pushed to the side of the well while adding 0.750 
mL medium A or medium B to the lower chambers, then the control inserts were adjusted 
into the center of the wells containing the chemoattractant, ensuring that no air bubbles 
were trapped beneath the filters. Avoid bubbles by tipping the insert at a slight angle as it 
is lowered into the chemoattractant.  
Immediately, 0.5 mL of the prepared cell suspensions was seeded onto the upper 
chambers. The 24-well plate with filters was then incubated for 22 hours in a tissue 150 
 
culture incubator at 37ºC with 5% CO2 atmosphere. After the incubation stage, non-
invading cells were gently removed with a cotton swab moistened with medium A, and 
this is repeated. Invading cells deposited at the underside of the filter were fixed and 
stained for 2 min with Solutions 1-3 of the DiffQuik Staining kit (Hemacolor, Merck, 
Darmstadt, Germany). With a sterile scalpel, filters were removed from their upper well 
chamber and placed bottom-side down onto a microscope slide with a drop of immersion 
oil used as mounting medium. Another small drop of immersion oil is placed on top of 
the stained filter and covered with a gridded glass coverslip. Invaded cells were counted 
at ten random, non-overlapping fields under light microscopy at 400X. Data was 
analyzed with one-way ANOVA and expressed as mean % migration of control ± SEM.  
 
Results 
  The treatment of medium  in the upper well and medium B in the lower well 
showed a tendency to attract more migrating cells than the other treatment conditions, 
although this increase was insignificant (p˃0.05; Figure F.1).  
 
Appendix F. References 
Boyden, S., 1962. The chemotactic effect of mixtures of antibody and antigen on 
polymorphonuclear leucocytes. J Exp Med 115, 453-466. 
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Figure F.1. A comparison of various conditions on cell migration (n=3 dogs) in transwell 
chambers. The treatment of medium A (protein-free medium PFM) in the upper well and 
medium B (10% FBS) in the lower well showed more spontaneous migration than the 
other treatments (134 ± 7), although this was not significant (p˃0.33). Data were 
expressed as mean ± SEM migrating cells per filter.  
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APPENDIX G. TIME-LAPSE PHOTOGRAPHY 
 
Summary 
  Time-lapse photography is a useful tool to observe cell behavior while in culture 
(Liang et al., 2007). This method was applied to the migration assay using primary canine 
term trophoblasts (TCT) and the objective was to monitor wound closure during the 
incubation. 
   
Preparation of time lapse apparatus 
  The tissue culture incubator was set to 37ºC with 5% CO2 on the day prior to 
taking time-lapse photographs of the wound (100X). The phase-contrast microscope 
(Model TMS-F, Nikon, Japan) was placed inside the incubator to ensure that the 
microscope maintained the same temperature as the incubator conditions throughout the 
length of the experiment. 
  The apparatus was consisted of a camera secured to the microscope and a circuit 
to limit the light exposure to the cells and control cell death due to extreme heat. The 
camera was a Cognex In-Sight 1403 (Natick, MA) and it should be noted that this camera 
is more of a computer. The camera was plugged into the network to allow off-site 
manipulation of the camera program regulate the pictures taken and then send these 
pictures to the computer as well as turn the microscope on and off to limit the amount of 
light on the cells. The camera was attached to an adapter that connected from the 
microscope to the c-mount with a 0.5x teleconverter (D50NLC, 0.5X c-mount for 38mm 153 
 
port, Diagnostic Instruments, Inc., Sterling Heights, MI). The teleconverter was then 
attached to the photo port on the microscope  
  The lights were controlled by a home-built circuit that used a signal from the 
camera to switch a relay that could turn the power to the microscope on and off as if it 
were plugged or unplugged.  A program was ran inside the camera to turn the microscope 
power on to take a picture, and then turn the power off and wait a set amount of time 
between pictures.  Pictures were taken at 60 second intervals and the microscope light 
was switched on for two- 5 second blocks so that the light was on for 10 sec total per 60 
sec block. The focus was adjusted periodically throughout the experiment to allow for 
maximal clarity of picture.  The pictures were then sent to a computer on the same 
network as the camera via FTP for a total of 24 h in culture to allow complete closure of 
the wound.   When the experiment was complete, all of the images that were sent to the 
computer were compiled using Windows Movie Maker to create a time-lapse. This was 
done by copying all the images into movie maker and then setting them to play back as a 
slide show at approximately 30 frames per second.  This was then saved as a .wmv movie 
file. This experiment was performed 4 times with 4 dogs.  
 
Results 
  Using time-lapse photography to observe the cell behavior as the wound closed, it 
was evident that although cells along the periphery of the wound were proliferating, the 
cells displayed migratory behavior to close the wound with “leader cells” that would 
form filopodia-like extensions to reach across the freed surface of the plate to make cell 154 
 
to cell interactions with the cells across the wound as the wound closed, previously 
described by Aladjem and Lueck (1981). This home-built time lapse apparatus was 
performed successfully, although adjustments such as light exposure and timing of 
pictures were made with 4 different dogs. For the first dog, the camera did not take 
pictures for the entire incubation duration and so all subsequent experiments the camera 
program was restarted to take pictures for 24 h. For the second dog, the camera would go 
out of focus. To adjust for this, we normalized the temperature of the entire apparatus by 
incubating the microscope with camera in the incubator for one day prior to taking photos 
for all subsequent experiments. For the third dog, we found that the microscope light 
would kill the cells due to the extreme heat, so a home-built switch was made to regulate 
the amount of light exposure. For the last dog, we adjusted the time intervals of pictures 
taken and found the most success with taking photos for once for every 60 seconds, with 
the light being on for 10 seconds for every 60 seconds. The images obtained from this 
time-lapse experiment reveal that the primary TCT undergo migration to close the wound 
but some proliferation may occur at the edge of the wound. Now that the protocol has 
been established, additional experiments to determine the extent to which proliferation 
contributes to wound closure. 
 
Appendix G. References 
Aladjem, S., Lueck, J., 1981. Morphologic characteristics of the normal term human 
trophoblast maintained in prolonged in vitro cultures. Brit J Obs Gyn 88, 287-293. 
Liang, C., Park, A., Guan, J., 2007. In vitro scratch assay: a convenient and inexpensive 
method for analysis of cell migration in vitro. Nat Protoc 2, 329-333.  
    
 
Figure G.1. A representative set of 4 time-lapse photographs (A-D), which were merged to form a video of cells migrating to 
close the wound using the migration assay after 24 h in culture (n=1 dog).  
 
   
 
 
 
   
A  B  C  D 
1
5
5
 156 
 
APPENDIX H. INVASION ASSAY 
 
Summary 
 
  The effects of cell seeding concentrations, chemoattractant, and incubation time 
on invasive behavior were determined for term canine trophoblasts (TCT) from 3 dogs 
using the Matrigel invasion assay (BDBioCoat Matrigel Invasion Chamber, #354480, BD 
Biosciences, Bedford, MA). Our studies utilized the invasion assay and applied IL-8 and 
TIMP-2 to observe their effect on canine trophoblast invasion, as seen within this thesis.  
 
Experiment 1 
 
  The seeding concentrations compared were 0.25, 2.5, 25, 50, 100, and 250 X 10
3 
cells/well (n=9 dogs) in medium A (Appendix A). The chemoattractants tested were 
medium B and medium C (Appendix A) using 100 X 10
3 cells/well (n=3 dogs). Lastly, 
the incubation times tested were 22 h and 46 h using 100 X 10
3 cells/well (n=3 dogs). 
The invasion assay was performed as previously described (Librach et al., 1991). Briefly, 
the Matrigel and control (without Matrigel) filters (0.8 μm pores, polyethylene 
terephthalate) of the invasion assay are rehydrated with 0.5 mL warm (37ºC) medium A 
to the lower and upper chamber of each well for at least 2 hours in a humidified tissue 
culture incubator at 37ºC, 5% CO2 atmosphere. After rehydration, the medium was 
carefully removed by pipetting and without disturbing the layer of Matrigel layer on the 
membrane. Primary culture cytotrophoblast cell suspensions (0.25, 2.5, 25, 50, 100, and 
250 X 10
3 cells/well) were prepared in medium A to make 0.5 mL cell suspensions to 157 
 
observe the effect of seeding concentration on the percent of invading cells. 
Chemoattractant (medium B or medium C) was added at 0.750 mL to the lower chambers 
of the 24-well plate (BD Falcon) atmosphere to observe the effect of chemoattractant on 
the percent of invading cells. Immediately, 0.5 mL of the prepared primary 
cytotrophoblast cell suspensions was added to the upper chambers. One 24-well plate 
with inserts was incubated for 22 h or 46 h in a humidified tissue culture incubator at 
37ºC, 5% CO2 atmosphere to observe the effect of incubation time on the percent of 
invading cells. Non-invading cells are removed with sterile cotton tipped swab moistened 
with medium A and apply gentle but firm pressure while moving the tip over the 
membrane surface. Each filter is scrubbed twice for complete removal. Bottom of the 
filters are then stained with DiffQuik (Harleco®, EMD Chemicals, Inc., Gibbstown, NJ) 
stain at 2 minutes per stain to quantify the number of invading cells under 400x light 
microscopy. The number of invading cells through filters with Matrigel is compared to 
the number of invading cells through filters without Matrigel (control) to calculate the 
percent invasion. Invasion assays are performed in triplicate. Data was analyzed with a 
one-way ANOVA and expressed as percent invasion ± SEM.  
 
Experiment 2 
  The seeding concentration used in the factor studies was 250 X 10
3 cells/well 
suspended in medium A in the upper well (Table F.1), and the chemoattractant was 
medium B in the lower well of the invasion chambers. For the factor studies, the 
procedure was performed as above, with one modification. The only modification was 
that primary TCT were suspended in 0.5 ml medium A with no factor (control), with IL-8 158 
 
(10 or 50 ng/ml) or TIMP-2 (0.5 µg/ml) and then cultured onto the Matrigel-coated filters 
for 22 h. The chemoattractant (medium B) was placed in the lower well. As above, the 
filters were then scrubbed to remove non-invading cells, and filters were then fixed and 
stained, and invading cells were counted under light microscopy (400X). The number of 
invading cells through filters with Matrigel is compared to the number of invading cells 
through filters without Matrigel (control) to calculate the percent invasion. Invasion 
assays are performed in triplicate (n=5 dogs).  
 
Results 
  Percent invasion did not differ between seeding concentrations (p=0.36, n=9 
dogs), although 250X10
3 cells/well were selected for future studies because it increased 
invasion by 62 ± 22.11%, desirable when we undergo addition of stimulatory or 
inhibitory factors. Also, there was no difference in percent invasion between 
chemoattractants (p=0.06), although nearing significance. However, with 100 X 10
3 
cells/well the percent invasion increased when incubation time was extended by 24 hours 
(p=0.28), although not significantly. There was no significant effect of IL-8 or TIMP-2 
on invasion compared to the control (p=0.06), although nearing significance.  
 
Summary 
  For the optimization studies, the effect of media (medium B or medium C) and 
incubation time (22 h or 46 h) was not significantly different (p=0.1661 and 0.2793, 
respectively). The cell seeding concentration of 250X10
3 cells/well was used for future 159 
 
studies because it showed the least variability between dogs and a mean invasion of 60% 
at 22 h. For the factor studies, TIMP-2 decreased invasion (p˂0.05), whereas IL-8 had no 
effect on invasion (p˃0.05).  
 
Appendix H. References 
Librach, C., Werb, Z., Fitzgerald, M., Chiu, K., Corwin, N., Esteves, R., Fisher, S., 1991. 
92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell 
Biol 113, 437-449. 
 
  
 
Table H.1. Cell suspensions for the invasion assay for Experiment 2. 
 
Starting cell concentration   Volume of suspension medium (medium A)  Location & volume of aliquot  
250X10
3 cells/ml  5 ml with or without IL-8 or TIMP-2 
 
12 wells of matrigel-coated filters (0.5 ml/well)  
 
   
1
6
0
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Figure H.1. The effect of seeding concentration on primary TCT invasion. There was no 
effect of the seeding concentration on the percent invasion (p˃0.05), however 250X10
3 
cells/well elicited 62% invasion to allow for future studies using factors to promote or 
decrease invasion. Experiments were performed in triplicate (n=9 dogs). Data was 
expressed as percent invasion of control ± SEM. Significance was defined as p˂0.05. 
 
 
 
 
 
 
 
 
 
 162 
 
Figure H.2. The effect of chemoattractant on primary TCT invasion. There was no 
significant difference between the chemoattractants (medium B or medium C) on primary 
TCT (100X10
3 cells/well) invasion (p˃0.05) after 22 h in culture. Experiments were 
performed in triplicate (n=3 dogs). Data was expressed as percent invasion of control ± 
SEM. Significance was defined as p˂0.05. 
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Figure H.3. The effect of incubation duration on primary TCT invasion. There was no 
significant effect of the length of incubation on TCT (100X10
3 cells/well) invasion after 
22 and 46 h in culture (p˃0.05). Experiments were performed in triplicate (n=3 dogs). 
Data was expressed as percent invasion of control ± SEM. Significance was defined as 
p˂0.05. 
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Figure H.4. The effect of IL-8 and TIMP-2 on primary TCT invasion. There was no 
significant effect of IL-8 (10 and 50 ng/ml) or TIMP-2 (0.5 µg/ml) on TCT (250X10
3 
cells/well) invasion (p˃0.05) after 22 h in culture. Experiments were performed in 
triplicate (n=5 dogs). Data was expressed as percent invasion of control ± SEM. 
Significance was defined as p˂0.05. 
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APPENDIX I. PROLIFERATION ASSAY  
 
Summary 
 
  The objectives for validating the MTT proliferation assay for term canine 
trophoblasts (TCT) included: 1) determining the optimal cell seeding concentrations, 2) 
comparing culture medium for cell proliferation; and 3) determining the IL-8 
concentration most likely to effect canine trophoblast proliferation.  
 
Experiment 1 
  Using a sterile 96-well microtiter plate, each column was seeded with a different 
cell concentration at 0, 10, 100, 1,000, 10,000, 100,000, 200,000-cells/well and incubated 
overnight in medium A or medium B (Appendix A). Briefly, after trophoblast cell 
isolation, cells were suspended in 100 μl of medium (medium A or medium B) in varying 
concentrations (0, 1 x10
3, 10 x10
3, 50 x10
3, 100 x10
3, 200 x10
3 cells/well and seeded in a 
96-well plate.  
 
Experiment 2 
  Proceeding from the optimization studies, factors were then added to the MTT 
assay to observe their effect on TCT. After primary trophoblast cell isolation, 100X10
3 
cells/well were suspended in 100 μl of medium A. Five 96-well tissue culture plates were 
prepared to study cell proliferation: 1) standard plate at t=4 h, 2) factor plate at t=32 h, 3) 166 
 
factor plate at t=36 h, 4) factor plate at t=36 h, 5) factor plate at t=48 h. Experiments were 
performed in quadruplicate in 5 dogs. 
 
Standard plate 
 
  Only ¼ of a 96-well plate were used to determine the standard curve. For the 
standard plate, cells were suspended in 100 μl medium A to yield varying cell 
concentrations (0, 20 x10
3, 50 x10
3, 100 x10
3, 200 x 10
3, and 500 x10
3 cells/well) and 
seeded into Lanes 1-6 and Rows A-D of a 96-well plate. Immediately after cell seeding, 
10μl MTT (5 mg/ml) was added to each well. The plate was then incubated at 37ºC with 
5% CO2 for 4 h. After the incubation period, old medium was aspirated and replaced with 
100 μl 1-propanol per well and the plate was shaken on a rotator (Model #3520, Orbit 
Shaker, Lab-line Instruments, Inc., Melrose Park, IL) for 5 min until formazan salts were 
fully solubilized. If crystals were still visible, pipetting up and down (trituration) was 
required to dissolve the formazan. Keep in mind that plates must be read on a plate reader 
within 1 hour of adding the1-propanol solvent. Absorbance was measured at 570 nm 
using a Microplate reader (LKB) and absorbance measured at 690 nm was subtracted as 
background. 
 
Factor plates 
 
  The factors plates were developed the same as the standard plate, with 
modifications. Briefly, Only ¼ of a 96-well plate were used for factor experiments. For 
the factor plate,cells were suspended in 100 μl medium A (10 x10
3 cells/well) and seeded 
into Lanes 1-6 and Rows A-D of a 96-well plate. Lane 4 contained 100 x10
3 cells/well 167 
 
with 50 ng/ml IL-8 and Lane 5 contained 100 x10
3 with 10 ng/ml IL-8. Three- 96-well 
plates were seeded in this manner to account for the different time points. Cells were 
allowed to adhere overnight then incubated an additional 8, 12, or 24 h to make the time 
points at t = 32, 36, 48 h after cell seeding in a tissue culture incubator at 37°C with 5% 
CO2. At the end of each given incubation (t= 32, 36, 48 h), 10 μl of MTT (5 mg/ml) was 
added to each well and incubated for 4 h at 37°C with 5% CO2. The formazan 
solubilization and measurements were performed as previously stated in the optimization 
experiments. The cell suspensions for the proliferation assay and invasion assay is 
described below. 
 
Suspensions and dilutions 
   
  Cell suspensions and factor dilutions were performed as described in Tables I.1 
and I.2. 
 
Results 
  No protein precipitate was observed in the wells, which may interfere with 
absorbance readings. Data was analyzed with Two-way ANOVA. For the optimization 
studies, there was a cell seeding effect (p˂0.001), but there was no observed difference in 
proliferation between medium A and B (p=0.96) and no seeding and medium interaction 
(p=0.91). The optimal seeding concentration was determined to be 100X10
3 cells/well 
because the remaining concentrations elicited too low of an absorbance to allow for 
future studies that would stimulate or inhibit proliferation. For the factor studies, medium 168 
 
A was used for the TCT cell suspensions. IL-8 and time had no effect on proliferation 
(p=0.96 and p=0.49, respectively) and there was no IL-8 and time interaction (p=0.87). A 
linear regression test was performed to convert optical density measurements into 
corresponding cell concentration, which the r value= 0.66. It was determined that at 20, 
50, 100, 200X10
3 cells/well allow accurate measurement of cell proliferation and 
500X10
3 cells/well is beyond the assay’s sensitivity. 
 
 
Summary 
  There was no significant difference between using medium A or medium B. From 
0 to 1,000 cells/well the OD is virtually undetectable, therefore future experiments will 
be continue with higher seeding concentrations of 10X10
3 cells/well and above. 
 
Appendix I. References 
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Table I.1. Cell suspensions for the proliferation assay for Experiment 2. 
Starting cell 
concentration  
Volume of medium A  Location & volume of aliquot   Final cell count  
5000X10
3 cells/ml  Suspended in 10 ml  a) Lane 1of standard & factor plates (100 µl)  a) 500X10
3 cells/well 
5000X10
3 cells/ml  1.5X remaining cell 
suspension volume 
a) Lane 2 of standard & factor plates (100 µl) 
 
b) Lane 4 & Lane 5 of factor plates (50 µl) + PFM with or 
without IL-8 (50 µl) 
 
c) Lanes 2 - 5 of dose response plates 
a) 200X10
3 cells/well 
 
b) 100X10
3 cells/well 
 
 
c) 100X10
3 cells/well 
2000X10
3 cells/ml  1X remaining cell 
suspension volume 
a) Lane 3 of standard & factor plates (100 µl) 
  
b) Lanes 1 of dose response plates (100 µl) 
a) 100X10
3 cells/well 
 
b) 100X10
3 cells/well 
500 X10
3 cells/ml  1X remaining cell 
suspension volume 
a) Lane 4 of standard plate (100 µl) 
 
b) Lane 5 of the standard plate (20 µl) + PFM (80 µl) 
a) 50X10
3 cells/well 
 
b) 10X10
3 cells/well 
 
 
1
6
9
  
 
Table I.2. Recombinant human IL-8 dilutions for Experiment 2 of the proliferation assay. 
 
IL-8  
concentration 
Volume of human IL-8   Volume of medium A  Location & volume of aliquot 
500 ng/ml  20 µl of stock IL-8 (100 ng/µl)  2 ml  Lane 5 dose response plate (50 µl/well) 
100 ng/ml  0.6 ml of the above solution (500 ng/ml)   2.4 ml  Lane 4 dose response plate (50 µl/well) 
50 ng/ml  2.5 ml of the above solution (100 ng/ml)  2.5 ml  Lane 3 dose response plate (50 µl/well) 
Lane 4 of factor plate (50 µl/well)  
Invasion assay test wells (250 µl/well)  
10 ng/ml  0.6 ml of the above solution (100 ng/ml)   2.4 ml  Lane 2 of dose response plate (50 µl/well) 
Lane 5 of factor plate (50 µl/well)  
Invasion assay test wells (250 µl/well) 
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Figure I.1. A comparison of optical density (OD) using varying seeding concentrations 
and culture medium. There was a cell seeding effect (p˂0.001), but there was no 
observed difference in proliferation between medium A (protein-free) and medium B 
(10% FBS) and no interaction effect (p˃0.05, respectively). Experiments were performed 
in quadruplicate (n=5 dogs). Mean ± SEM absorbance positively corresponds to cellular 
proliferation using the MTT assay. Significance was defined as p˂0.05.  
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Figure I.2. A conversion of OD to cell concentration using the MTT assay. Linear 
regression determined that OD corresponds positively to the increasing cell proliferation 
(r value=0.66).  A comparison of optical density using varying trophoblast seeding 
concentrations and culture medium. Experiments were performed in quadruplicate (n=5 
dogs). Mean ± SEM absorbance positively corresponds to cellular proliferation using the 
MTT assay. Significance was defined as p˂0.05. 
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Figure I.3. The effect of IL-8 on primary TCT proliferation using the MTT assay. IL-8 
and time had no effect on proliferation (p=0.96 and p=0.49, respectively) and there was 
no IL-8 and time interaction (p=0.87). The effect of IL-8 at t=32 h is shown below. 
Experiments were performed in quadruplicate (n=5 dogs). Mean ± SEM absorbance 
positively corresponds to cellular proliferation. Significance was defined as p˂0.05.  
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APPENDIX J. COMPARISON OF TWO PROLIFERATION ASSAYS 
 
Summary 
 
  A comparison between the MTT and Dojindo proliferation assays was performed 
to examine which test had a better sensitivity and precision for measuring term canine 
trophoblasts (TCT) proliferation in vitro in the presence of IL-8.  
 
History 
  According to Mosmann, the creator of the MTT assay, stock MTT (M2128, 
Sigma, Appendix A) was dissolved in phosphate buffered saline (PBS) at 5 mg/ml and 
then filtered to sterilize and remove insoluble MTT remnants (1983). Mouse lymphoma 
cells were seeded into a 96-well plate in 100μL RPMI medium supplemented with 5-
10%. fetal bovine serum (FBS) The stock MTT was added into each well at 10μL MTT 
per 100μL medium and cells were incubated with MTT for 4 hours at 37°C, 6% CO2 
atmosphere. Then 100μL acid-isopropanol (0.04 N HCl in isopropanol, Appendix A) was 
added to the wells and mixed to thoroughly dissolve the dark blue crystal produced and 
allowed to rest at room temperature for a few minutes. Plates were then read within an 
hour of adding the acid-isopropanol on an ELIZA reader at 570 nm with a reference 
wavelength of 630 nm. MTT served as the most useful reagent when several tetrazolium 
salts were incubated with cells for preliminary tests (Mosmann, 1983), due to the 
production of a dark blue formazan crystal product.  175 
 
  Importantly, studies by Mosmann found that the various cell types examined - 
mitogen stimulated T and B cells, myeloma, T lymphoma, and tumor cell lines - were 
able to reduce MTT to produce formazan suggesting that the MTT assay is widely 
applicable in the proliferation and survivability of various cell types. Shortly thereafter, 
Carmichael and associates found that significant modification of experimental conditions 
was required to optimize the application for drug sensitivity, or chemosensitivity, tests 
(1987)  in Chinese hamster lung fibroblasts and human lung cancer cell lines. Although, 
Mosmann established the first protocol for the MTT proliferation assay (1983) in 
measuring live mammalian cells. Mainly, the issue of completely dissolving the blue 
formazan product was examined by using different solvents. Carmichael and associates 
followed the method established by Mosmann (1983), but used DMSO to achieve full 
solubilization of formazan in non-adherent cells and mineral oil in adherent cells. 
Absorbances were read at 540nm and 570nm for DMSO solvents and mineral oil, 
respectively.  
  Other cell viability and proliferation assays utilized various tetrazolium salts as 
substrates to add to the cells. XTT, sodium 3'-[1-[(phenylamino)-carbonyl]-3,4-
tetrazolium]-bis(4-methoxy-6- nitro)benzene-sulfonic acid hydrate, formed a water-
soluble, highly colored formazan product when cleaved by metabolically-active, viable 
cells. The water-soluble formazan product can be fully dissolved in tissue culture 
medium, thus a solvent is not needed, thereby reducing the assay time and cell handling 
and allowing for comparable assay sensitivity. Although, the reduction of XTT was 176 
 
incomplete in their various murine cell lines, requiring an addition of electron coupling 
agents such as phenazine methosulfate (PMS) or menadione (MEN) (Roehm et al., 1991). 
  Recently, Dojindo has presented an alternative proliferation assay to the MTT 
assay, with the claim that Dojindo’s Cell Counting Kit 8 (CCK-8, Dojindo Molecular 
Technologies, Rockville, MD) is a sensitive colorimetric assay for the determination of 
viable cells using a non-toxic substrate, WST-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-
nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt]. The company 
proposes that their proliferation assay is faster (requiring no solubilization step) and more 
sensitive than the MTT assay and WST-8 has longer stability and is non-toxic to cells in 
culture, whereas MTT is toxic and causes cell death within 24 h in culture (Dojindo, 
2012).  
 
Factor Plates  
  The proliferation was performed as previously described (Carmichael et al., 1987; 
Dojindo, 2012). After overnight incubation to allow cell adherence to the plate, IL-8 (10 
and 50 ng/ml) were then added to the Dojindo assay to observe their effect on TCT. After 
primary trophoblast cell isolation, 1X10
6 cells/well were suspended in 100 μl of medium 
A. Five 96-well tissue culture plates were prepared to study cell proliferation: 1) standard 
plate at t=4 h, 2) factor plate at t=32 h, 3) factor plate at t=36 h, 4) factor plate at t=36 h, 
5) factor plate at t=48 h, as stated in Appendix G. In addition, an extra plate was prepared 
as a IL-8 dose response with 0, 10, 50, 100 ng/ml using 100X10
3 cells/well. Experiments 
were performed in quadruplicate in 5 dogs. 177 
 
Comparison Studies 
  The dose response plates were developed for the MTT and Dojindo assay the 
same way as the standard plate, with modifications. Briefly, ¼ of a 96-well plate were 
used for dose response experiments with or without 0, 10, 50, 100, 500 ng/ml. TCTs were 
suspended in 100 μl medium A (100 x10
3 cells/well) and seeded into Lanes 1-5 and 
Rows A-D of a 96-well plate. Lane 1 contained 100 x10
3 cells/well with 0 ng/ml IL-8, 
lane 2 contained cells with 10 ng/ml, lane 3 contained cells with 50 ng/ml, lane 4 
contained cells with 100 ng/ml, lane 5 contained PFM only. Cells were allowed to adhere 
overnight then incubated an additional 8, 12, or 24 h to make the time points at t = 32, 36, 
48 h after cell seeding in a tissue culture incubator at 37°C with 5% CO2. At the end of 
each given incubation (t= 32, 36, 48 h), 10 μl of MTT or WST-8 was added to each well 
and incubated. The formazan is then solubilized with 1-propanol for 5 min shaking 
vigorously. No formazan solubilization step is required for the Dojindo assay. 
Absorbance is measured at 570 nm for the MTT assay or 450 nm for the Dojindo assay 
using a Microplate reader (LKB). Background absorbance was measured at 690 nm. 
Experiments are performed in quadruplicate (n=3 dogs) to obtain optical density levels 
and cell concentrations are determined using a Linear Regression analysis. 
 
Results 
  No protein precipitate was observed in the wells, which may interfere with 
absorbance readings. Data was analyzed with Two-way ANOVA. For the Dojindo factor 
studies, IL-8 and time had no effect on proliferation (p=0.86 and p=0.88, respectively) 178 
 
and there was no IL-8 and time interaction (p=1.0). A linear regression test was 
performed to convert optical density measurements into corresponding cell concentration 
(r value= 0.76). It was determined that at 20, 50, 100, 200X10
3 cells/well allow accurate 
measurement of cell proliferation and 500X10
3 cells/well is beyond the assay’s 
sensitivity. For the dose response comparison studies, there was an assay effect on cell 
proliferation (p˂0.001), however there was no IL-8 dose response effect or assay and IL-
8 (p=0.88 and p=0.72, respectively). 
 
 
Summary 
  There was a significant difference between using the MTT assay and Dojindo 
assay. It was observed that Dojindo has a higher sensitivity in measuring cell 
proliferation compared to MTT (p˂0.001), due to the higher OD measurements and less 
variation of viable cell counts between dogs (n=3 dogs). For the Dojindo assay, it was 
determined that between 20 - 200X10
3 cells/well the assay gives accurate readings of 
proliferation. Lastly, there was no effect of IL-8 (p=0.88) or interaction between assay 
and IL-8 (p=0.72).  
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Figure J.1. A conversion of OD to cell concentration using the Dojindo assay. Linear 
regression determined that OD corresponds positively to the increasing TCT proliferation 
(r value=0.76). A comparison of optical density using varying TCT seeding 
concentrations and culture medium. Experiments were performed in quadruplicate (n=3 
dogs). Mean ± SEM absorbance positively corresponds to cellular proliferation. 
Significance was defined as p˂0.05. 
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Figure J.2. The effect of IL-8 on primary TCT proliferation using the Dojindo assay. IL-8 
and time had no effect on proliferation (p=0.86 and p=0.88, respectively) and there was 
no IL-8 and time interaction (p=1.0). Experiments were performed in quadruplicate (n=3 
dogs). Mean ± SEM absorbance positively corresponds to cellular proliferation. 
Significance was defined as p˂0.05.  
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Figure J.3. The effect of IL-8 on primary TCT proliferation using the MTT and Dojindo 
assays. There was an assay effect (p˂0.001), although IL-8 and IL-8 and assay interaction 
had no effect on proliferation (p=0.86 and p=0.72, respectively). Experiments were 
performed in quadruplicate (n=3 dogs). Mean ± SEM absorbance positively corresponds 
to cellular proliferation. Significance was defined as p˂0.05.  
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APPENDIX K. IMMUNOSTAINING OF MATRIGEL INVASION FILTERS 
 
  The immunostaning of the Matrigel-coated filter membranes was performed as 
previously described (Musch et al., 2007; Sahlfeld et al., 2012) to validate the trophoblast 
identity of invading cells in the invasion assay. Cells were isolated from term canine 
placentas (n=1 dog) and seeded into the Matrigel invasion assay and incubated for 22 h. 
Filters were fixed with 70% methanol (35 ml methanol with 15 ml sterile water) and 
washed three times. Using forceps to hold the upper well chamber with filter membrane 
intact, the filter was gently rinsed by adding PBS (dropwise from transfer pipet, 
Appendix A) indirectly onto the filter to prevent washing off cells. The filter was then 
tipped into the waste container to drain excess PBS. After three washes, the filter was 
removed from the upper well chamber using a scalpel and placed bottom-side up where 
the invading cells were deposited into a Parafilm® lined 33 mm
2 culture dish.  
A blocking buffer (1:20 dilution) was prepared with 180 µl donkey serum in 3420 
ml sterile, filtered PBS to make 3600 µl. A drop (approximately 25 μl) of blocking buffer 
was added to form a dome on each filter and incubated for 3 minutes. Filters were then 
again washed three times by adding 25 μL PBS onto the filter for 3 minutes at room 
temperature. The primary antibody of cytokeratin-7 (CK-7, Dako, p103620) was 
prepared in blocking buffer at a 1:200 dilution and 25 μL was applied to each filter. The 
filters were placed into humidified chambers created by placing PBS-moistened 
kimwipes in the bottom of a plastic box for overnight incubation at 4ºC.  Filters were then 
washed again three times with PBS as earlier described.  183 
 
The secondary antibody was prepared by diluting a donkey anti-mouse Alexa 
Flour 488 (Life Technologies, A21202) at 1:1000 in blocking buffer. Secondary antibody 
(25 μL) was added to form a dome on each filter and coverslips were wrapped in foil and 
place in dark, humidified box to incubate at room temperature for 2 hours. After the 
incubation, filters were again washed 3 times for 3 minutes each with PBS. To stain 
nuclei, 25 µl of Hoechst 3342 nuclear stain (H1399, Invitrogen, Carlsbad, CA) was 
prepared (1:20,000) and added for a 15 minute incubation at room temperature for 15 
minutes in a dark, humidified chamber. Finally, the coverslips were washed twice with 
PBS for 3 minutes and then mounted onto glass microscope slides using Molecular 
Probes Prolong antifade kit (p7481, Invitrogen, Carlsbad, CA). Specific fluorescence 
staining was visualized at 100X magnification on a Leica DM 4000B microscope. Digital 
images were captured using a mounted digital camera (QImaging QICAM 12-bit, QIC-F-
M-12-C, QImaging, Surrey, BC) with image capture software (QCapturePro, QImaging, 
Surrey, BC).  
 
 
Results 
  There was too much Hoechst (blue) background fluorescence to allow for 
accurate counting of Hoechst-positive nuclei and CK-7-positive cells. 
 
   184 
 
Appendix K. References 
Musch, M., Walsh-Reitz, M., Kosovsky, M., 2007. Preparation of BD Falcon™ Cell 
Culture Inserts for Confocal Indirect Immunofluorescence: Fixation and Staining 
of Caco-2/bbe (C2) Cells with Various Dyes. BD Biosciences Technical Bulletin 
#459. 
Sahlfeld, L., Hazzard, T., Kutzler, M., 2012. Cellular Characteristics of Cultured Canine 
Trophoblasts. Reprod Domest Anim 47, 161-164. 
   185 
 
APPENDIX L. ABSTRACTS AND POSTER 
 
 
 
Summary 
 
  I was fortunate to have the opportunity to present my research at regional, 
national and international conferences throughout my graduate career. 
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Abstract presented at the 2012 Northwest Reproductive Sciences Symposium (NWRSS) 
in Portland, OR and the 2012 International Symposium on Canine and Feline 
Reproduction (ISCFR) in Whistler, British Columbia, Canada. 
Determining seeding concentrations for in vitro canine cytotrophoblast invasion 
studies. 
Justine M. Gullaba, Michelle A. Kutzler 
Department of Animal Sciences, Oregon State University, Corvallis, Oregon, USA, 
97331. gullabaj@onid.orst.edu 
  
INTRODUCTION: Cytotrophoblasts are specialized epithelial cells of the placenta that 
proliferate and invade the endometrium at implantation. After formation of a 
chorioallantois villous labyrinth in early pregnancy, canine cytotrophoblasts continue to 
advance into the maternal endometrium and remodel the endometrial tissues throughout 
gestation (1). Little is known about the mechanisms that regulate these processes in dogs, 
much less the mechanisms that go awry when pathologic cytotrophoblast conditions 
occur (e.g., subinvolution of placental sites). In humans and rodents, cytotrophoblast 
invasion has been studied in vitro using Matrigel invasion assays (2,3). To yield the 
desired 50% cell invasion, research in these species has shown that the optimal seeding 
concentration for Matrigel invasion assays is 250 X 103 cells/ml (4). The objective of the 
current study was to determine the optimal seeding concentration of canine 
cytotrophoblasts for Matrigel invasion assays.  Based upon the previously mentioned 
research in humans, we hypothesized that 250 X 103 cells/ml would yield the desired 
50% cell invasion.  
 
METHODS: Canine chorioallantois tissue was collected without the marginal hematoma 
following elective term C-sections (n=3) and cytotrophoblasts were isolated as described 
by Sahlfell and coworkers (5). Briefly, cytotrophoblasts were isolated using collagenase 
and trypsin digestions with Percoll density gradient centrifugation.  Four seeding 
concentrations were compared (0.25, 2.5, 25 and 250 X 103 cells/ml). Cytotrophoblasts 
were cultured for 22 hours at 37°C, 5% CO2 in a protein-free media using the Matrigel 
invasion assay (8µm pore diameter, polyethylene terephthalate, BD Falcon) using 5% 
fetal bovine serum as a chemoattractant. Cytotrophoblasts were grown on inserts without 
Matrigel and treated in the same manner to serve as controls. Cells were stained with Diff 
Quik® (Harleco, Inc.), and all invading cells were counted at 400X magnification.  
Percent invasion was determined for each of the conditions by dividing the number of 
cytotrophoblasts that invaded through the Matrigel by the number of cytotrophoblasts 
that invade through the control inserts without Matrigel.  Results were summarized as 
mean ± SEM and significance was defined as p<0.05. 
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RESULTS: Percent invasion did not differ significantly between the four seeding 
concentrations (Figure 1). However, the concentration that was closest to the desired 50% 
cell invasion was 250 X 103 cells/ml. 
 
CONCLUSION: Canine cytotrophoblast invasion is an unexplored field. This study 
demonstrated that canine cytotrophoblast invasion can be investigated in vitro using 
Matrigel invasion assays. Our results suggest that 250 X 103 cells/ml is the seeding 
concentration that would yield approximately 50% cell invasion.   
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Figure 1. Influence of seeding concentration on cell invasion. Four cell concentrations 
(0.25, 2.5, 25 and 250 X 103 cells/ml) were seeded onto Matrigel inserts. After a 22-hour 
incubation, the invading trophoblasts were counted to determine mean±SEM percent 
invasion.  
 
Figure L.1. Poster presented at the 2012 NWRSS in Portland, OR and the 2012 ISCFR in Whistler, British Columbia, Canada. 
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Abstract presented at the 2013 Society for Theriogenology Annual Conference in 
Louisville, KY. 
 
Utilizing a Wound Healing Assay to Study Canine Trophoblast Physiology In Vitro 
Justine M. Gullaba, Michelle A. Kutzler
 
Department of Animal and Rangeland Sciences, Oregon State University, Corvallis, OR 
97331  
Introduction The wound healing assay is used to study a cell’s ability to proliferate and 
migrate  in  culture  [1].  Interleukin-8  (IL8)  and  tissue  inhibitor  of  metalloproteinase-2 
(TIMP2) stimulate and inhibit, respectively, term human trophoblast proliferation and 
migration in vitro [2, 3]. We hypothesized that term canine trophoblasts (TCTs) would 
respond  similarly.  The  objectives  were  to  compare  wound  healing  rates  in  TCTs  at 
increasing concentrations of IL8 and TIMP2.  
Methods Chorioallantois was collected from 4 dogs following term elective C-sections. 
TCTs  were  isolated  from  the  chorioallantois  as  previously  described  [4]  and  seeded 
(1X10
6  cells/well)    in  24-well  plates  in  DME/H-21  medium  (Gibco,  #11965,  Life 
Technologies,  Grand  Island,  NY)  supplemented  with  10%  FBS  (Atlanta  Biologicals, 
L11061, Lawrenceville, GA). TCTs were cultured at 37 ºC with 5% CO2 until confluent. 
Cell proliferation and migration was studied using the wound healing assay as previously 
described [1]. The effects of recombinant human IL8 (#200-08M, Peprotech, Rocky Hill, 
NJ) and recombinant human TIMP2 (#410-02, Peprotech) were evaluated at 0, 10, 50, 
100 ng/ml or 0, 0.05, 0.1, 0.5 μg/ml, respectively. The wound was photographed at 100X 
phase-contrast magnification with a digital camera (Fujufilm Fine AX300 14 MP, Tokyo, 
Japan) at 0, 8, and 12 hours of incubation. The wound area was measured using ImageJ 
v.1.34 software (http://imagej.nih.gov/ij/). The wound width at t=0 h was defined as 0% 
wound  closure.  Experiments  were  performed  in  triplicates.  Data  was  analyzed  by 
Repeated Measures ANOVA using SAS (Version 9.2, SAS Institute Inc., Cary, NC) in 
PROC MIXED. Results were summarized as mean±SEM % wound closure. Significance 
was defined as p<0.05. 
Results Compared to controls, wound healing rates were promoted with IL8 (10 and 50 
ng/ml) at t=8 hr (p=0.0172 and 0.0046, respectively) and 12 hr incubation (p=0.0133 and 
0.0005, respectively) and were reduced with TIMP2 (0.5 μg/ml) at t=8 hr (p=0.0097) 
(Figure 1).  
Discussion An understanding of normal TCT physiology will provide a basis for research 
on abnormal TCT conditions (e.g. placental retention or subinvolution of placental sites). 
Further  research  is  needed  to  determine  if  differences  in  wound  healing  result  from 
effects on migration, proliferation or both. 
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Figure 1. Effect of IL8 (open bars) or TIMP2 (solid bars) on wound healing in TCT 
(*p<0.05). 
 
 
 